FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Pinheiro, SN
   de Souza, MFB
   Oliveira, CBS
   Neto, VFA
   Lanza, DCF
AF Pinheiro, Sthephanie N.
   de Souza, Maria Fernanda B.
   Oliveira, Claudio Bruno S.
   Andrade Neto, Valter F.
   Lanza, Daniel C. F.
TI Alternative primers to identify a range of apicomplexan parasites
SO JOURNAL OF MICROBIOLOGICAL METHODS
LA English
DT Article
DE 18S rRNA; Plasmodium; Toxoplasma; Neospora; Metagenomics; Molecular
   detection
ID 18S RIBOSOMAL-RNA; NESTED-PCR; DIAGNOSIS; INFECTIONS; SEQUENCE; GENE
AB Here we present an alternative polymerase chain reaction (PCR) approach using 18S rDNA to identify apicomplexan parasites. A new primer set was designed and evaluated in silico and in vitro. This new PCR could detect some apicomplexan genera based on amplicon size and identify at least 45 species after sequencing.
C1 [Pinheiro, Sthephanie N.; de Souza, Maria Fernanda B.; Lanza, Daniel C. F.] Univ Fed Rio Grande do Norte, Dept Bioquim, Lab Biol Mol Aplicada LAPLIC, Natal, RN, Brazil.
   [Pinheiro, Sthephanie N.; Lanza, Daniel C. F.] Univ Fed Rio Grande do Norte, Programa Posgrad Bioinformat, Natal, RN, Brazil.
   [de Souza, Maria Fernanda B.; Andrade Neto, Valter F.; Lanza, Daniel C. F.] Univ Fed Rio Grande do Norte, Programa Posgrad Bioquim, Natal, RN, Brazil.
   [Oliveira, Claudio Bruno S.; Andrade Neto, Valter F.] Univ Fed Rio Grande do Norte, Dept Microbiol & Parasitol, Lab Biol Malaria & Toxoplasmose, Natal, RN, Brazil.
RP Lanza, DCF (corresponding author), Univ Fed Rio Grande do Norte, Ctr Biociencias, Dept Bioquim, Lab Biol Mol Aplicada LAPLIC, BR-59072970 Natal, RN, Brazil.
EM danielclanza@gmail.com
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)CAPES
FX The authors thank the High Performance Computing Center (NPAD) of UFRN
   for provision of computational resources and Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES) for financial
   support.
CR Akerele D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179178
   Al Masalma M, 2012, CLIN INFECT DIS, V54, P202, DOI 10.1093/cid/cir797
   Arisue N, 2015, PARASITOL INT, V64, P254, DOI 10.1016/j.parint.2014.10.005
   Costa MESM, 2016, ACTA TROP, V159, P120, DOI 10.1016/j.actatropica.2016.03.035
   Dubourg G, 2013, EUR J CLIN MICROBIOL, V32, P637, DOI 10.1007/s10096-012-1787-3
   Dunthorn M, 2012, J EUKARYOT MICROBIOL, V59, P185, DOI 10.1111/j.1550-7408.2011.00602.x
   Hadziavdic K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087624
   Hugerth LW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095567
   Jamy M, 2020, MOL ECOL RESOUR, V20, P429, DOI 10.1111/1755-0998.13117
   Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199
   Kong HH, 2012, J INVEST DERMATOL, V132, P933, DOI 10.1038/jid.2011.417
   Kounosu A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-52422-z
   Lane D. J., 1991, NUCL ACID TECHNIQUES, P115
   Lee JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038203
   Leveque MF, 2019, INT J INFECT DIS, V79, P131, DOI 10.1016/j.ijid.2018.11.368
   Maritz JM, 2017, MICROB ECOL, V74, P923, DOI 10.1007/s00248-017-0996-9
   MEDLIN L, 1988, GENE, V71, P491, DOI 10.1016/0378-1119(88)90066-2
   Mullins M.T., 2017, SAMPLE COLLECTION DN
   Poschl B, 2010, AM J TROP MED HYG, V83, P56, DOI 10.4269/ajtmh.2010.09-0630
   Ricciardi A, 2015, J BIOMOL SCREEN, V20, P6, DOI 10.1177/1087057114548065
   Seeber Frank, 2016, F1000Res, V5, DOI 10.12688/f1000research.7924.1
   Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75
   Stoeck T, 2010, MOL ECOL, V19, P21, DOI 10.1111/j.1365-294X.2009.04480.x
   Van de Peer Y, 1997, J MOL EVOL, V45, P619, DOI 10.1007/PL00006266
   Verweij JJ, 2014, CLIN MICROBIOL REV, V27, P371, DOI 10.1128/CMR.00122-13
   WATERS AP, 1989, NUCLEIC ACIDS RES, V17, P2135, DOI 10.1093/nar/17.5.2135
   Watts MP, 2017, APPL MICROBIOL BIOT, V101, P5889, DOI 10.1007/s00253-017-8313-6
   Xie Q, 2011, PROTEIN CELL, V2, P161, DOI 10.1007/s13238-011-1017-2
   Yang B, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-0992-y
   Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134
NR 30
TC 0
Z9 0
U1 2
U2 2
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0167-7012
EI 1872-8359
J9 J MICROBIOL METH
JI J. Microbiol. Methods
PD AUG
PY 2020
VL 175
AR 105985
DI 10.1016/j.mimet.2020.105985
PG 5
WC Biochemical Research Methods; Microbiology
SC Biochemistry & Molecular Biology; Microbiology
GA MU5FM
UT WOS:000555699100003
PM 32561164
DA 2020-11-30
ER

PT J
AU de Azevedo, JWV
   Fernandes, TAAD
   Fernandes, JV
   de Azevedo, JCV
   Lanza, DCF
   Bezerra, CM
   Andrade, VS
   de Araujo, JMG
   Fernandes, JV
AF de Azevedo, Judson Welber Verissimo
   de Medeiros Fernandes, Thales Allyrio Araujo
   Fernandes, Jose Verissimo, Jr.
   de Azevedo, Jenner Chrystian Verissimo
   Lanza, Daniel Carlos Ferreira
   Bezerra, Christiane Medeiros
   Andrade, Vania Sousa
   de Araujo, Joselio Maria Galvao
   Fernandes, Jose Verissimo
TI Biology and pathogenesis of human osteosarcoma
SO ONCOLOGY LETTERS
LA English
DT Review
DE bone tumor; osteosarcoma; osteosarcoma biology; osteosarcoma
   pathogenesis
ID MESENCHYMAL STEM-CELLS; TUMOR-SUPPRESSOR GENE; DNA METHYLATION; CIRCULAR
   RNA; OSTEOBLAST DIFFERENTIATION; OSTEOGENIC DIFFERENTIATION; INHIBITS
   PROLIFERATION; EPIGENETIC ALTERATIONS; HISTONE MODIFICATIONS;
   DOWN-REGULATION
AB Osteosarcoma (OS) is a bone tumor of mesenchymal origin, most frequently occurring during the rapid growth phase of long bones, and usually located in the epiphyseal growth plates of the femur or the tibia. Its most common feature is genome disorganization, aneuploidy with chromosomal alterations, deregulation of tumor suppressor genes and of the cell cycle, and an absence of DNA repair. This suggests the involvement of surveillance failures, DNA repair or apoptosis control during osteogenesis, allowing the survival of cells which have undergone alterations during differentiation. Epigenetic events, including DNA methylation, histone modifications, nucleosome remodeling and expression of non-coding RNAs have been identified as possible risk factors for the tumor. It has been reported that p53 target genes or those genes that have their activity modulated by p53, in addition to other tumor suppressor genes, are silenced in OS-derived cell lines by hypermethylation of their promoters. In osteogenesis, osteoblasts are formed from pluripotent mesenchymal cells, with potential for self-renewal, proliferation and differentiation into various cell types. This involves complex signaling pathways and multiple factors. Any disturbance in this process can cause deregulation of the differentiation and proliferation of these cells, leading to the malignant phenotype. Therefore, the origin of OS seems to be multifactorial, involving the deregulation of differentiation of mesenchymal cells and tumor suppressor genes, activation of oncogenes, epigenetic events and the production of cytokines.
C1 [de Azevedo, Judson Welber Verissimo] Deoclecio Marques Hosp, Orthoped Trauma Clin Serv, BR-59141085 Parnamirim, RN, Brazil.
   [de Medeiros Fernandes, Thales Allyrio Araujo] Univ Rio Grande do Norte State, Dept Biomed Sci, Rua Miguel Antonio da Silva Neto S-N, BR-59607360 Mossoro, RN, Brazil.
   [Fernandes, Jose Verissimo, Jr.] Getulio Vargas Hosp, Orthoped Trauma Clin Serv, BR-50630060 Recife, PE, Brazil.
   [de Azevedo, Jenner Chrystian Verissimo] Univ Fed Rio Grande do Norte, Dept Pediat, Univ Hosp Onofre Lopes, BR-59012300 Natal, RN, Brazil.
   [Lanza, Daniel Carlos Ferreira] Univ Fed Rio Grande do Norte, Dept Biochem, BR-59072970 Natal, RN, Brazil.
   [Bezerra, Christiane Medeiros; Andrade, Vania Sousa; de Araujo, Joselio Maria Galvao; Fernandes, Jose Verissimo] Univ Fed Rio Grande do Norte, Dept Microbiol & Parasitol, BR-59072970 Natal, RN, Brazil.
RP Fernandes, TAAD (corresponding author), Univ Rio Grande do Norte State, Dept Biomed Sci, Rua Miguel Antonio da Silva Neto S-N, BR-59607360 Mossoro, RN, Brazil.
EM thalesallyrio@uern.br
RI Andrade, Vania Sousa/AAR-3922-2020
CR Al-Romaih K, 2008, NEOPLASIA, V10, P471, DOI 10.1593/neo.08174
   Alfranca A, 2015, CELL MOL LIFE SCI, V72, P3097, DOI 10.1007/s00018-015-1918-y
   Ali A, 2018, J STEM CELL RES THER, V8, P3, DOI [10.4172/2157-7633.1000418, DOI 10.4172/2157-7633.1000418]
   Amente S, 2011, NUCLEIC ACIDS RES, V39, P9498, DOI 10.1093/nar/gkr638
   Baglio SR, 2017, CLIN CANCER RES, V23, P3721, DOI 10.1158/1078-0432.CCR-16-2726
   Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22
   Black JC, 2012, MOL CELL, V48, P491, DOI 10.1016/j.molcel.2012.11.006
   Broadhead Matthew L., 2011, Sarcoma, V2011, P959248, DOI 10.1155/2011/959248
   Calin GA, 2019, MOL ONCOL, V13, P3, DOI 10.1002/1878-0261.12418
   Cantelli G, 2017, SEMIN CANCER BIOL, V42, P60, DOI 10.1016/j.semcancer.2016.08.009
   Chen DM, 2018, BONE RES, V6, DOI 10.1038/s41413-018-0009-8
   Chen KS, 2016, CSH MOL CASE STUD, V2, DOI 10.1101/mcs.a000992
   Chen Y, 2018, CELL PHYSIOL BIOCHEM, V51, P1313, DOI 10.1159/000495550
   Chen Z, 2016, DIS MARKERS, DOI 10.1155/2016/4639575
   Del Mare S, 2015, SCI REP-UK, V5, DOI 10.1038/srep12959
   Del Mare S, 2011, AM J CANCER RES, V1, P585
   Denduluri SK, 2016, J BIOMED RES, V30, P5, DOI 10.7555/JBR.30.20150075
   Deng R, 2019, INT J MOL MED, V43, P1157, DOI 10.3892/ijmm.2018.4039
   Deng ZL, 2008, FRONT BIOSCI-LANDMRK, V13, P2001, DOI 10.2741/2819
   Fernandes Juliane C. R., 2019, Non-Coding RNA, V5, P17, DOI 10.3390/ncrna5010017
   Foucher ED, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056045
   Geller David S, 2010, Clin Adv Hematol Oncol, V8, P705
   Goldszmid RS, 2012, NAT IMMUNOL, V13, P932, DOI 10.1038/ni.2422
   Goll MG, 2006, SCIENCE, V311, P395, DOI 10.1126/science.1120976
   Gross AC, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.99791
   Gu WF, 2018, BIOMED PHARMACOTHER, V106, P890, DOI 10.1016/j.biopha.2018.06.173
   Guo W, 2019, TECHNOL CANCER RES T, V18, DOI 10.1177/1533033819841438
   Guo X, 2010, ONCOGENE, V29, P3908, DOI 10.1038/onc.2010.143
   Hamidi T, 2015, EPIGENOMICS-UK, V7, P247, DOI [10.2217/EPI.14.80, 10.2217/epi.14.80]
   Han G, 2012, ONCOL RES, V20, P149, DOI 10.3727/096504012X13522227232237
   Han Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06304-x
   Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013
   He C, 2019, CLIN EPIGENETICS, V11, DOI 10.1186/s13148-018-0605-x
   Henley SA, 2012, CELL DIV, V7, DOI 10.1186/1747-1028-7-10
   Honorati MC, 2007, J CANCER RES CLIN, V133, P1017, DOI 10.1007/s00432-007-0296-8
   Huang GX, 2012, CANCER RES, V72, P908, DOI 10.1158/0008-5472.CAN-11-1460
   Ishikawa T, 2013, CANCER SCI, V104, P880, DOI 10.1111/cas.12163
   Jeziorska DM, 2017, P NATL ACAD SCI USA, V114, pE7526, DOI 10.1073/pnas.1703087114
   Jiang R, 2017, AM J CANCER RES, V7, P88
   Jones KB, 2012, CANCER RES, V72, P1865, DOI 10.1158/0008-5472.CAN-11-2663
   Kanherkar RR, 2014, FRONT CELL DEV BIOL, V2, DOI 10.3389/fcell.2014.00049
   Kato H, 2015, ONCOLOGY-BASEL, V88, P139, DOI 10.1159/000368414
   Kelly TK, 2010, NAT BIOTECHNOL, V28, P1069, DOI 10.1038/nbt.1678
   Kim H, 2018, P NATL ACAD SCI USA, V115, pE11128, DOI 10.1073/pnas.1814044115
   Klein MJ, 2006, AM J CLIN PATHOL, V125, P555, DOI 10.1309/UC6KQHLD9LV2KENN
   Klimczak A, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/4285215
   Komori T, 2018, HISTOCHEM CELL BIOL, V149, P313, DOI 10.1007/s00418-018-1640-6
   Kovac M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9940
   Kresse SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048262
   Lamora A, 2016, J CLIN MED, V5, DOI 10.3390/jcm5110096
   Lawlor ER, 2012, CLIN CANCER RES, V18, P2768, DOI 10.1158/1078-0432.CCR-11-1921
   Lebrun Jean-Jacques, 2012, ISRN Mol Biol, V2012, P381428, DOI 10.5402/2012/381428
   Li BH, 2014, MOL BIOL REP, V41, P3303, DOI 10.1007/s11033-014-3193-7
   Li E, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a019133
   Li FF, 2014, CELL PHYSIOL BIOCHEM, V34, P2169, DOI 10.1159/000369660
   Li Q, 2017, INT J BIOL SCI, V13, P1038, DOI 10.7150/ijbs.19476
   Li SS, 2012, INT J MOL SCI, V13, P12461, DOI 10.3390/ijms131012461
   Li XG, 2017, J CANCER RES CLIN, V143, P2189, DOI 10.1007/s00432-017-2478-3
   Li Y, 2009, HUM PATHOL, V40, P1441, DOI 10.1016/j.humpath.2009.03.003
   Li YS, 2016, ONCOTARGETS THER, V9, P3101, DOI 10.2147/OTT.S96561
   Lin HS, 2008, SCIENCE, V320, P807, DOI 10.1126/science.1154370
   Lin PP, 2009, CARCINOGENESIS, V30, P1789, DOI 10.1093/carcin/bgp180
   Liu WH, 2017, CELL PHYSIOL BIOCHEM, V43, P969, DOI 10.1159/000481650
   Long FX, 2012, NAT REV MOL CELL BIO, V13, P27, DOI 10.1038/nrm3254
   Lopes-Junior LC, 2016, ONCOLOGY COMMUNICATI, V2, pe1167
   Lu JC, 2015, ONCOTARGET, V6, P16802, DOI 10.18632/oncotarget.4696
   Luo ZQ, 2016, J BONE ONCOL, V5, P167, DOI 10.1016/j.jbo.2016.06.002
   Mannerstrom B, 2019, EPIGENETICS-US, V14, P352, DOI 10.1080/15592294.2019.1585177
   Martin J. W., 2011, Sarcoma, V2011, P282745, DOI 10.1155/2011/282745
   Martin Jeff W., 2012, Sarcoma, V2012, P627254, DOI 10.1155/2012/627254
   Mens MMJ, 2018, STEM CELL REV REP, V14, P309, DOI 10.1007/s12015-018-9808-y
   Min EY, 2014, INT J ONCOL, V45, P47, DOI 10.3892/ijo.2014.2426
   Mohseny AB, 2009, J PATHOL, V219, P294, DOI 10.1002/path.2603
   Molchadsky A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003707
   Mori T, 2014, ONCOGENE, V33, P4236, DOI 10.1038/onc.2013.545
   Moriarity BS, 2015, NAT GENET, V47, P615, DOI 10.1038/ng.3293
   Morrow James J., 2015, Critical Reviews in Oncogenesis, V20, P173, DOI 10.1615/CritRevOncog.2015013713
   Mutsaers AJ, 2014, BONE, V62, P56, DOI 10.1016/j.bone.2014.02.003
   Nie JH, 2019, NON-CODING RNA, V5, DOI 10.3390/ncrna5020036
   Nie ZG, 2018, ONCOL LETT, V16, P6502, DOI 10.3892/ol.2018.9453
   Nowacka-Zawisza M, 2017, ONCOL REP, V38, P2587, DOI 10.3892/or.2017.5972
   O'Brien J, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00402
   Ottaviani G, 2009, CANCER TREAT RES, V152, P3, DOI 10.1007/978-1-4419-0284-9_1
   Patil VS, 2014, CRIT REV BIOCHEM MOL, V49, P16, DOI 10.3109/10409238.2013.844092
   Perry JA, 2014, P NATL ACAD SCI USA, V111, pE5564, DOI 10.1073/pnas.1419260111
   Pfeifer GP, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19041166
   Qu Y, 2016, TUMOR BIOL, V37, P5275, DOI 10.1007/s13277-015-4389-8
   Rao-Bindal Krithi, 2011, Sarcoma, V2011, P679457, DOI 10.1155/2011/679457
   Ropero S, 2007, MOL ONCOL, V1, P19, DOI 10.1016/j.molonc.2007.01.001
   Rosenblum JM, 2015, EPIGENETICS-US, V10, P31, DOI 10.4161/15592294.2014.989084
   Rutkovskiy A, 2016, MED SCI MONIT BASIC, V22, P95, DOI 10.12659/MSMBR.901142
   Sachdeva M, 2015, CANCER LETT, V369, P202, DOI 10.1016/j.canlet.2015.08.016
   Sadikovic B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002834
   Segaliny AI, 2015, INT J CANCER, V137, P73, DOI 10.1002/ijc.29376
   Shanmugam M.K., 2018, ONCOTARGET, V9, P11414, DOI [10.18632/oncotarget.23356, DOI 10.18632/ONCOTARGET.23356]
   Sharma S, 2010, CARCINOGENESIS, V31, P27, DOI 10.1093/carcin/bgp220
   Shi Dingding, 2012, Genes Cancer, V3, P240, DOI 10.1177/1947601912455199
   Shin MH, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005884
   Song MS, 2008, EMBO J, V27, P1863, DOI 10.1038/emboj.2008.115
   Stiller CA, 2006, EUR J CANCER, V42, P2115, DOI 10.1016/j.ejca.2006.05.011
   Tang N, 2008, CLIN ORTHOP RELAT R, V466, P2114, DOI 10.1007/s11999-008-0335-z
   Techavichit P, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2909-6
   Tian W, 2018, GENE, V650, P7, DOI 10.1016/j.gene.2018.01.093
   Tu B, 2014, EXP CELL RES, V320, P164, DOI 10.1016/j.yexcr.2013.10.013
   Tu B, 2012, CANCER LETT, V325, P80, DOI 10.1016/j.canlet.2012.06.006
   Tung PY, 2015, ONCOGENE, V34, P2288, DOI 10.1038/onc.2014.172
   Turtle CJ, 2012, CURR OPIN IMMUNOL, V24, P633, DOI 10.1016/j.coi.2012.06.004
   Tzeng HE, 2013, BIOCHEM PHARMACOL, V85, P531, DOI 10.1016/j.bcp.2012.11.021
   Vaidya H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151392
   Varshney Jyotika, 2016, Vet Sci, V3, DOI 10.3390/vetsci3010003
   Velez AMA, 2015, N AM J MED SCI, V7, P176, DOI 10.4103/1947-2714.157476
   Velletri T, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2015.367
   Verrecchia F, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00133
   Vo JN, 2019, CELL, V176, P869, DOI 10.1016/j.cell.2018.12.021
   Wang CY, 2018, MED SCI MONITOR, V24, P7043, DOI 10.12659/MSM.912092
   Wang D, 2019, CANCER RES, V79, P7, DOI 10.1158/0008-5472.CAN-18-1086
   Wang MM, 2013, CANCER BIOL THER, V14, P155, DOI 10.4161/cbt.22955
   Wang Q, 2017, MOL MED REP, V16, P901, DOI 10.3892/mmr.2017.6635
   Wang QZ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180558
   Wang T, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-019-1195-y
   Wang YM, 2012, NAT IMMUNOL, V13, P753, DOI 10.1038/ni.2360
   Wu Q, 2017, CELL PHYSIOL BIOCHEM, V41, P1360, DOI 10.1159/000465455
   Wu Stephanie C, 2018, Oncotarget, V9, P32580, DOI 10.18632/oncotarget.25953
   Wu X, 2012, CANCER EPIDEMIOL, V36, P212, DOI 10.1016/j.canep.2011.08.002
   Wu YZ, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-1007-1
   Wu Z, 2017, ONCOTARGETS THER, V10, P5329, DOI 10.2147/OTT.S149905
   Xiao QR, 2017, ONCOL RES, V25, P267, DOI 10.3727/096504016X14732510786564
   Xu GX, 2017, SCI REP-UK, V7, DOI 10.1038/srep42411
   Xu HD, 2016, ONCOL LETT, V12, P5247, DOI 10.3892/ol.2016.5355
   Xu HD, 2014, CELL PHYSIOL BIOCHEM, V33, P1547, DOI 10.1159/000358718
   Xu J, 2017, J BONE ONCOL, V9, P34, DOI 10.1016/j.jbo.2017.05.001
   Yang Yi, 2017, Genes Cancer, V8, P484, DOI 10.18632/genesandcancer.133
   Yu Q, 2014, DIAGN PATHOL, V9, DOI 10.1186/1746-1596-9-71
   Yu X, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1509-1
   Zhang DY, 2017, J BUON, V22, P258
   Zhang HL, 2013, FASEB J, V27, P232, DOI 10.1096/fj.12-215491
   Zhang HX, 2013, STEM CELLS, V31, P433, DOI 10.1002/stem.1298
   Zhang HH, 2019, MED SCI MONITOR, V25, P1307, DOI 10.12659/MSM.915001
   Zhao YH, 2014, ACTA BIOCH BIOPH SIN, V46, P180, DOI 10.1093/abbs/gmt147
   Zheng Y, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-0780-x
   Zhou Y, 2019, CANCER BIOL THER, V20, P1141, DOI 10.1080/15384047.2019.1598766
   Zhu KP, 2018, INT J BIOL SCI, V14, P321, DOI 10.7150/ijbs.24360
NR 142
TC 8
Z9 8
U1 1
U2 3
PU SPANDIDOS PUBL LTD
PI ATHENS
PA POB 18179, ATHENS, 116 10, GREECE
SN 1792-1074
EI 1792-1082
J9 ONCOL LETT
JI Oncol. Lett.
PD FEB
PY 2020
VL 19
IS 2
BP 1099
EP 1116
DI 10.3892/ol.2019.11229
PG 18
WC Oncology
SC Oncology
GA KE9UD
UT WOS:000508895000001
PM 31966039
OA Other Gold, Green Published
DA 2020-11-30
ER

PT J
AU de Vega, FF
   Olague, G
   Lanza, D
   de la O, FC
   Banzhaf, W
   Goodman, E
   Menendez-Clavijo, J
   Martinez, A
AF de Vega, Francisco Fernandez
   Olague, Gustavo
   Lanza, Daniel
   de la O, Francisco Chavez
   Banzhaf, Wolfgang
   Goodman, Erik
   Menendez-Clavijo, Jose
   Martinez, Axel
TI Time and Individual Duration in Genetic Programming
SO IEEE ACCESS
LA English
DT Article
DE Complexity theory; Genetic programming; Computational modeling;
   Computers; Proposals; Analytical models; Standards; Bloat; computing
   time; genetic programming
ID OPERATOR EQUALIZATION; STATISTICAL TESTS; VISUAL-CORTEX; CODE GROWTH;
   BLOAT; SIZE; INTELLIGENCE; EVOLUTIONARY; ALGORITHMS; DIVERSITY
AB This paper presents a new way of measuring complexity in variable-size-chromosome-based evolutionary algorithms. Dealing with complexity is particularly useful when considering bloat in Genetic Programming. Instead of analyzing size growth, we focus on the time required for individuals& x2019; fitness evaluations, which correlates with size. This way, we consider time and space as two sides of a single coin when devising a more natural method for fighting bloat. We thus view the problem from a perspective that departs from traditional methods applied in Genetic Programming. We have analyzed first the behavior of individuals across generations, taking into account their fitness evaluation times, thus providing clues about the general practice of the evolutionary process when modern parallel and distributed computers are used to run the algorithm. This new perspective allows us to understand that new methods for bloat control can be derived. Moreover, we develop from this framework a first proposal to show the usefulness of the idea: to group individuals in classes according to computing time required for evaluation, automatically accomplished by parallel and distributed systems without any change in the underlying algorithm, when they are only allowed to breed within their classes. Experimental data confirms the strength of the approach: using computing time as a measure of individuals& x2019; complexity allows control of the natural size growth of genetic programming individuals while preserving the quality of solutions in both the parallel and sequential versions of the algorithm.
C1 [de Vega, Francisco Fernandez; de la O, Francisco Chavez] Univ Extremadura, Grp Evoluc Artificial, Merida 06800, Spain.
   [Olague, Gustavo; Menendez-Clavijo, Jose; Martinez, Axel] CICESE Res Ctr, EvoVis Lab, Ensenada 22860, Baja California, Mexico.
   [Lanza, Daniel] CERN, Informat Technol Dept, CH-1211 Geneva, Switzerland.
   [Banzhaf, Wolfgang; Goodman, Erik] Michigan State Univ, BEACON Ctr, E Lansing, MI 48824 USA.
RP Olague, G (corresponding author), CICESE Res Ctr, EvoVis Lab, Ensenada 22860, Baja California, Mexico.
EM olague@cicese.mx
RI de Vega, Francisco Fernandez/M-1385-2014; Olague, Gustavo/L-7795-2014;
   Chavez de la O, Francisco/H-3971-2011
OI Olague, Gustavo/0000-0001-5773-9517; Goodman, Erik/0000-0002-2419-0692;
   Chavez de la O, Francisco/0000-0002-9565-743X
FU Spanish Ministry of Economy and Competitiveness (Deep-Bio-Uex)
   [TIN2017-85727-C4-4-P]; Regional Government of Extremadura, Department
   of Commerce and Economy; European Regional Development Fund (a Way to
   Build Europe)European Union (EU) [G15068IB16035]; Center for Scientific
   Research and Higher Education at Ensenada (CICESE) through the
   Programacion Cerebral Aplicada al Estudio del Pensamiento y la Vision
   [634-128]
FX This work was supported in part by the Spanish Ministry of Economy and
   Competitiveness (Deep-Bio-Uex) under Project TIN2017-85727-C4-4-P, in
   part by the Regional Government of Extremadura, Department of Commerce
   and Economy, co-funded by the European Regional Development Fund (a Way
   to Build Europe) under Grant G15068IB16035, and in part by the Center
   for Scientific Research and Higher Education at Ensenada (CICESE)
   through the Programacion Cerebral Aplicada al Estudio del Pensamiento y
   la Vision under Project 634-128.
CR Alfaro-Cid E, 2010, EVOL COMPUT, V18, P305, DOI 10.1162/evco.2010.18.2.18206
   Altenberg L, 1994, ADV GENETIC PROGRAMM, V3, P47
   Banzhaf W., 2002, Genetic Programming and Evolvable Machines, V3, P81, DOI 10.1023/A:1014548204452
   Bleuler S, 2001, IEEE C EVOL COMPUTAT, P536, DOI 10.1109/CEC.2001.934438
   Cantu Paz E., 2001, EFFICIENT ACCURATE P, DOI [10.1007/978-1-4615-4369-5, DOI 10.1007/978-1-4615-4369-5]
   Clemente E, 2015, APPL SOFT COMPUT, V32, P250, DOI 10.1016/j.asoc.2015.03.011
   Cochran JK, 2003, COMPUT OPER RES, V30, P1087, DOI 10.1016/S0305-0548(02)00059-X
   Coffin M, 2000, INFORMS J COMPUT, V12, P24, DOI 10.1287/ijoc.12.1.24.11899
   de Vega FF, 2011, LECT NOTES COMPUT SC, V6692, P308, DOI 10.1007/978-3-642-21498-1_39
   de Vega FF, 2004, LECT NOTES COMPUT SC, V3242, P263
   Derrac J, 2011, SWARM EVOL COMPUT, V1, P3, DOI 10.1016/j.swevo.2011.02.002
   deVega F. F., 2001, THESIS
   Dignum S, 2008, LECT NOTES COMPUT SC, V4971, P110, DOI 10.1007/978-3-540-78671-9_10
   Dignum S, 2007, GECCO 2007: GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, VOL 1 AND 2, P1588
   Doerr B, 2017, PROCEEDINGS OF THE 2017 GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE (GECCO'17), P921, DOI 10.1145/3071178.3071271
   Estrada Trilce, 2008, Performance Evaluation Review, V36, P40, DOI 10.1145/1481506.1481515
   Fernandez de Vega F., 2019, GENETIC PROGRAMMING, P14, DOI [10.1007/978-3-030-39958-0, DOI 10.1007/978-3-030-39958-0]
   Fernandez F, 2002, IEEE IND ELEC, P2520
   Fernandez F., 2003, Genetic Programming and Evolvable Machines, V4, P21, DOI 10.1023/A:1021873026259
   Fernandez F, 2003, LECT NOTES COMPUT SC, V2610, P317
   Folino G, 1999, GECCO-99: PROCEEDINGS OF THE GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, P1015
   Galeano G, 2002, IEEE C EVOL COMPUTAT, P1727, DOI 10.1109/CEC.2002.1004503
   Garcia S, 2009, SOFT COMPUT, V13, P959, DOI 10.1007/s00500-008-0392-y
   Garcia S, 2010, INFORM SCIENCES, V180, P2044, DOI 10.1016/j.ins.2009.12.010
   Gardner MA, 2015, GENET PROGRAM EVOL M, V16, P455, DOI 10.1007/s10710-015-9242-8
   Greenwood G., 1994, P 7 ANN FLOR ART INT, P265
   Hernandez DE, 2018, NEURAL COMPUT APPL, V30, P3007, DOI 10.1007/s00521-017-2873-3
   Hernandez DE, 2016, J COMPUT SCI-NETH, V17, P216, DOI 10.1016/j.jocs.2015.10.011
   Koza J.R., 1992, GENETIC PROGRAMMING
   Langdon WB, 1999, FROM ANIM ANIMAT, P163
   Langdon WB, 1998, SOFT COMPUTING IN ENGINEERING DESIGN AND MANUFACTURING, P13
   Lei Z, 2008, INFORM SCIENCES, V178, P1836, DOI 10.1016/j.ins.2007.11.019
   Luengo J, 2009, EXPERT SYST APPL, V36, P7798, DOI 10.1016/j.eswa.2008.11.041
   Luke S., 2002, P GECCO 2002, P829
   Luke S, 2006, EVOL COMPUT, V14, P309, DOI 10.1162/evco.2006.14.3.309
   Mesghouni K., 2004, International Journal of Applied Mathematics and Computer Science, V14, P91
   Nesmachnow S, 2011, SOFT COMPUT, V15, P685, DOI 10.1007/s00500-010-0594-y
   Olague G, 2019, IEEE ACCESS, V7, P54054, DOI 10.1109/ACCESS.2019.2912792
   Olague G, 2019, MULTIMED TOOLS APPL, V78, P5881, DOI 10.1007/s11042-018-6634-9
   Olague G, 2018, IEEE ACCESS, V6, P26254, DOI 10.1109/ACCESS.2018.2831633
   Osman A., 2002, SCI ANN COMPUT SCI, V11, P110
   Oussaidene M, 1997, PARALLEL COMPUT, V23, P1183, DOI 10.1016/S0167-8191(97)00045-8
   Poli R, 2003, LECT NOTES COMPUT SC, V2610, P204
   Silva S., 2011, ACM SIGEVOLUTION, V5, P10, DOI DOI 10.1145/2043118
   Silva S, 2012, GENET PROGRAM EVOL M, V13, P197, DOI 10.1007/s10710-011-9150-5
   Silva S, 2009, GENET PROGRAM EVOL M, V10, P141, DOI 10.1007/s10710-008-9075-9
   Streeter MJ, 2003, LECT NOTES COMPUT SC, V2610, P443
   Tackett W. A., 1994, THESIS
   Tomassini M, 2004, LECT NOTES COMPUT SC, V2936, P243
   Tomassini Marco, 2005, NAT COMP SER, DOI 10.1007/3-540-29938-6
   Trujillo L, 2016, INFORM SCIENCES, V333, P21, DOI 10.1016/j.ins.2015.11.010
   Vanneschi L., 2010, P 12 ANN C GEN EV CO, P877, DOI DOI 10.1145/1830483.1830643
   Wagner Neal, 2001, C GEN EV COMP, V1, P458
   Whigham PA, 2010, IEEE T EVOLUT COMPUT, V14, P173, DOI 10.1109/TEVC.2009.2027314
   White DR, 2012, GENET PROGRAM EVOL M, V13, P65, DOI 10.1007/s10710-011-9148-z
   Zaki MJ, 1997, J PARALLEL DISTR COM, V43, P156, DOI 10.1006/jpdc.1997.1339
   Zomaya AY, 2001, IEEE T PARALL DISTR, V12, P899, DOI 10.1109/71.954620
NR 57
TC 0
Z9 0
U1 0
U2 0
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI PISCATAWAY
PA 445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA
SN 2169-3536
J9 IEEE ACCESS
JI IEEE Access
PY 2020
VL 8
BP 38692
EP 38713
DI 10.1109/ACCESS.2020.2975753
PG 22
WC Computer Science, Information Systems; Engineering, Electrical &
   Electronic; Telecommunications
SC Computer Science; Engineering; Telecommunications
GA LC7XF
UT WOS:000525545900102
OA DOAJ Gold
DA 2020-11-30
ER

PT J
AU Mendes, CD
   Teixeira, DG
   Lima, JPMS
   Lanza, DCF
AF Mendes, Cayro de Macedo
   Teixeira, Diego Gomes
   Matos Santos Lima, Joao Paulo
   Ferreira Lanza, Daniel Carlos
TI Characterization of putative proteins encoded by variable ORFs in white
   spot syndrome virus genome
SO BMC STRUCTURAL BIOLOGY
LA English
DT Article
DE ORF75; ORF94; ORF125; Uncharacterized proteins; VNTR regions
ID RNA RECOGNITION MOTIFS; STRUCTURE VALIDATION; ANKYRIN REPEAT; SEQUENCE;
   SHRIMP; BINDING; ORGANIZATION; GENERATION; NUCLEATION; STABILITY
AB BackgroundWhite Spot Syndrome Virus (WSSV) is an enveloped double-stranded DNA virus which causes mortality of several species of shrimp, being considered one of the main pathogens that affects global shrimp farming. This virus presents a complex genome of 300kb and viral isolates that present genomes with great identity. Despite this conservation, some variable regions in the WSSV genome occur in coding regions, and these putative proteins may have some relationship with viral adaptation and virulence mechanisms. Until now, the functions of these proteins were little studied. In this work, sequences and putative proteins encoded by WSSV variable regions were characterized in silico.ResultsThe in silico approach enabled determining the variability of some sequences, as well as the identification of some domains resembling the Formin homology 2, RNA recognition motif, Xeroderma pigmentosum group D repair helicase, Hemagglutinin and Ankyrin motif. The information obtained from the sequences and the analysis of secondary and tertiary structure models allow to infer that some of these proteins possibly have functions related to protein modulation/degradation, intracellular transport, recombination and endosome fusion events.ConclusionsThe bioinformatics approaches were efficient in generating three-dimensional models and to identify domains, thereby enabling to propose possible functions for the putative polypeptides produced by the ORFs wsv129, wsv178, wsv249, wsv463a, wsv477, wsv479, wsv492, and wsv497.
C1 [Mendes, Cayro de Macedo; Ferreira Lanza, Daniel Carlos] Univ Fed Rio Grande do Norte, Dept Biochem, Appl Mol Biol Lab LAPLIC, Natal, RN, Brazil.
   [Mendes, Cayro de Macedo; Matos Santos Lima, Joao Paulo; Ferreira Lanza, Daniel Carlos] Univ Fed Rio Grande do Norte, Postgrad Program Bioinformat, Natal, RN, Brazil.
   [Teixeira, Diego Gomes; Matos Santos Lima, Joao Paulo; Ferreira Lanza, Daniel Carlos] Univ Fed Rio Grande do Norte, Postgrad Program Biochem, Natal, RN, Brazil.
RP Lanza, DCF (corresponding author), Univ Fed Rio Grande do Norte, Dept Biochem, Appl Mol Biol Lab LAPLIC, Natal, RN, Brazil.; Lanza, DCF (corresponding author), Univ Fed Rio Grande do Norte, Postgrad Program Bioinformat, Natal, RN, Brazil.
EM danielclanza@gmail.com
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico -
   CNPqNational Council for Scientific and Technological Development (CNPq)
   [409378/2016-0]; Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior (CAPES)CAPES
FX This research received financial support from the Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico - CNPq (grant no:
   409378/2016-0), and the Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior (CAPES).
CR Abdollahi S, 2018, MICROB PATHOGENESIS, V118, P18, DOI 10.1016/j.micpath.2018.03.009
   Aggarwal A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002762
   Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389
   ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999
   Alvarez DE, 2013, J CELL BIOL, V202, P1075, DOI 10.1083/jcb.201303055
   Aspenstrom P, 2010, BBA-MOL CELL RES, V1803, P174, DOI 10.1016/j.bbamcr.2009.06.002
   Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340
   Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381
   Chen J, 1999, P NATL ACAD SCI USA, V96, P8967, DOI 10.1073/pnas.96.16.8967
   Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073
   Clery A, 2008, CURR OPIN STRUC BIOL, V18, P290, DOI 10.1016/j.sbi.2008.04.002
   Cokol M, 2000, EMBO REP, V1, P411, DOI 10.1093/embo-reports/kvd092
   Conte MR, 2000, EMBO J, V19, P3132, DOI 10.1093/emboj/19.12.3132
   Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004
   de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124
   Dieu BTM, 2004, J GEN VIROL, V85, P3607, DOI 10.1099/vir.0.80344-0
   Dinkel H, 2012, NUCLEIC ACIDS RES, V40, pD242, DOI 10.1093/nar/gkr1064
   Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195
   Eswar N, 2006, COMP PROTEIN STRUCTU
   Ferron F, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-255
   Fisher RD, 2003, J BIOL CHEM, V278, P28976, DOI 10.1074/jbc.M302596200
   Ganguly B, 2018, VIRUS RES, V247, P55, DOI 10.1016/j.virusres.2018.01.017
   Ganguly B, 2012, J ANIM SCI BIOTECHNO, V3, DOI 10.1186/2049-1891-3-13
   Gao ML, 2014, FISH SHELLFISH IMMUN, V39, P17, DOI 10.1016/j.fsi.2014.04.011
   Gudkovs N, 2014, DIS AQUAT ORGAN, V111, P249, DOI 10.3354/dao02780
   Han F, 2007, VIRUS GENES, V34, P193, DOI 10.1007/s11262-006-0053-0
   Herbert MH, 2015, VIRUSES-BASEL, V7, P709, DOI 10.3390/v7020709
   Hoa TT, 2005, DIS ASIAN AQUACULTUR, P339
   Hofmann K, 2001, TRENDS BIOCHEM SCI, V26, P347, DOI 10.1016/S0968-0004(01)01835-7
   Huang CH, 2002, MOL CELL PROTEOMICS, V1, P223, DOI 10.1074/mcp.M100035-MCP200
   Huang TZ, 2012, J VIROL, V86, P12997, DOI 10.1128/JVI.01702-12
   Huang TZ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-159
   Katoh K, 2019, BRIEF BIOINFORM, V20, P1160, DOI 10.1093/bib/bbx108
   Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199
   Kim CS, 2007, J VIROL, V81, P3852, DOI 10.1128/JVI.01311-06
   Kondo Y, 2015, ELIFE, V4, DOI 10.7554/eLife.04986
   Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315
   Krupovic M, 2015, BIOL DIRECT, V10, DOI 10.1186/s13062-015-0047-8
   Kuper J, 2012, EMBO J, V31, P494, DOI 10.1038/emboj.2011.374
   Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200
   Le Sage V, 2013, VIRUSES-BASEL, V5, P2019, DOI 10.3390/v5082019
   Letunic I, 2018, NUCLEIC ACIDS RES, V46, pD493, DOI 10.1093/nar/gkx922
   Li F, 2017, VIRUS GENES, V53, P249, DOI 10.1007/s11262-016-1421-z
   Li JN, 2006, BIOCHEMISTRY-US, V45, P15168, DOI 10.1021/bi062188q
   Lin FY, 2011, ARCH VIROL, V156, P1611, DOI 10.1007/s00705-011-1004-1
   Liu H, 2008, CELL, V133, P801, DOI 10.1016/j.cell.2008.04.029
   Liu Y, 2006, J VIROL, V80, P10419, DOI 10.1128/JVI.00698-06
   Lobley A, 2009, BIOINFORMATICS, V25, P1761, DOI 10.1093/bioinformatics/btp302
   Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286
   Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221
   Marfori M, 2011, BBA-MOL CELL RES, V1813, P1562, DOI 10.1016/j.bbamcr.2010.10.013
   Maris C, 2005, FEBS J, V272, P2118, DOI 10.1111/j.1742-4658.2005.04653.x
   Marks H, 2004, ARCH VIROL, V149, P673, DOI 10.1007/s00705-003-0248-9
   Martin-Tumasz S, 2011, NUCLEIC ACIDS RES, V39, P7837, DOI 10.1093/nar/gkr455
   Mirdita M, 2017, NUCLEIC ACIDS RES, V45, pD170, DOI 10.1093/nar/gkw1081
   Muller IC, 2010, DIS AQUAT ORGAN, V88, P91, DOI 10.3354/dao02142
   Nagarajan V, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S7-S5
   Noel EA, 2014, J VIROL, V88, P13798, DOI 10.1128/JVI.02109-14
   Otomo T, 2005, NATURE, V433, P488, DOI 10.1038/nature03251
   Otomo T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012896
   Parra RG, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004659
   Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701
   Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084
   Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537
   Ramos-Paredes J, 2012, AQUAC RES, V43, P339, DOI 10.1111/j.1365-2109.2011.02836.x
   Remmert M, 2012, NAT METHODS, V9, P173, DOI [10.1038/NMETH.1818, 10.1038/nmeth.1818]
   Riddick G, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100160
   Schonichen A, 2010, BBA-MOL CELL RES, V1803, P152, DOI 10.1016/j.bbamcr.2010.01.014
   Sedgwick SG, 1999, TRENDS BIOCHEM SCI, V24, P311, DOI 10.1016/S0968-0004(99)01426-7
   Shekar M, 2012, INDIAN J VIROL, V23, P175, DOI 10.1007/s13337-012-0078-z
   Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408
   Spear Mark, 2014, Virologica Sinica, V29, P139, DOI 10.1007/s12250-014-3476-0
   Thompson ME, 2013, NAT STRUCT MOL BIOL, V20, P111, DOI 10.1038/nsmb.2462
   van Hulten MCW, 2001, VIROLOGY, V286, P7, DOI 10.1006/viro.2001.1002
   Verbruggen B, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8010023
   Wang W, 2015, J VIROL, V89, P10602, DOI 10.1128/JVI.00939-15
   Wang ZL, 2005, J VIROL, V79, P8764, DOI 10.1128/JVI.79.14.8764-8772.2005
   Weber G, 2010, EMBO J, V29, P4172, DOI 10.1038/emboj.2010.295
   Xu YW, 2004, CELL, V116, P711, DOI 10.1016/S0092-8674(04)00210-7
   Yang F, 2001, J VIROL, V75, P11811, DOI 10.1128/JVI.75.23.11811-11820.2001
   ZAIDI AH, 2015, NAT PROTOC, V10, DOI DOI 10.1038/NPROT.2015-053
   Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40
   Zheng N, 2017, ANNU REV BIOCHEM, V86, P129, DOI 10.1146/annurev-biochem-060815-014922
   Zwart MP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013400
NR 84
TC 0
Z9 0
U1 1
U2 5
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1472-6807
J9 BMC STRUCT BIOL
JI BMC Struct. Biol.
PD APR 18
PY 2019
VL 19
AR 8
DI 10.1186/s12900-019-0106-y
PG 12
WC Biophysics
SC Biophysics
GA HU2VM
UT WOS:000465129800001
PM 30999895
OA Other Gold, Green Published
DA 2020-11-30
ER

PT J
AU Pereira, JMP
   de Souza, ENV
   Candido, JRB
   Dantas, MDA
   Nunes, ARD
   Ribeiro, K
   Teixeira, DIA
   Lanza, DCF
AF Pereira, Jessica M. P.
   de Souza, Emilia N. V.
   Candido, Jessica R. B.
   Dantas, Marcia D. A.
   Nunes, Allan R. D.
   Ribeiro, Karina
   Teixeira, Darlio I. A.
   Lanza, Daniel C. F.
TI Alternative PCR primers for genotyping of Brazilian WSSV isolates
SO JOURNAL OF INVERTEBRATE PATHOLOGY
LA English
DT Article
DE White spot syndrome virus; ORF94; ORF75; ORF125; Variable-number tandem
   repeats; Whispovirus
ID SPOT-SYNDROME-VIRUS; DISEASE OUTBREAKS; SHRIMP; GENOME; VIRULENCE;
   INFECTION; SEQUENCE; FITNESS; FARMS; GENE
AB White spot syndrome virus (WSSV) is one of the major challenges faced by global shrimp farming in recent decades. The characterization of WSSV genetic variability has been used to determine viral dispersion and is a promising method to determine the association between genotype and virulence. The major variable regions that have been used as markers to differentiate the WSSV genomes include the VNTR loci inside ORF94, ORF75, ORF125, and insertions/deletions interspersing ORF14/15 and ORF23/24. The primers used to amplify these regions were described at least 10 years ago, but some of them do not work efficiently to identify new WSSV variants. The objective of this work was to develop improved PCR primers for WSSV genotyping based on sequence alignments that include new sequences described in recent years. We validated these new primers in a pilot study to verify the genetic variability of the WSSV in Rio Grande do Norte state (northeast Brazil), and efficiency was compared to that of other previously described primers. We confirmed that the primers we developed were more efficient for genotype Brazilian WSSV isolates, enabling us to genotype a larger number of samples. In addition, our results also introduce new data about the genetic characterization of the WSSV isolates that occur in the northeastern region of Brazil.
C1 [Pereira, Jessica M. P.; de Souza, Emilia N. V.; Candido, Jessica R. B.; Dantas, Marcia D. A.; Nunes, Allan R. D.; Lanza, Daniel C. F.] Univ Fed Rio Grande do Norte, Lab Biol Mol Aplicada LAPLIC, Natal, RN, Brazil.
   [de Souza, Emilia N. V.; Candido, Jessica R. B.; Ribeiro, Karina; Teixeira, Darlio I. A.] Univ Fed Rio Grande do Norte, Escola Agr Jundiai, Macaiba, RN, Brazil.
   [Pereira, Jessica M. P.; Dantas, Marcia D. A.; Nunes, Allan R. D.; Lanza, Daniel C. F.] Univ Fed Rio Grande do Norte, Programa Posgrad Bioquim, Natal, RN, Brazil.
RP Lanza, DCF (corresponding author), Univ Fed Rio Grande do Norte, Ctr Biociencias, Dept Bioquim, Lab Biol Mol Aplicada LAPLIC, BR-59072970 Natal, RN, Brazil.
EM danielclanza@gmail.com
FU Coordenacdo de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES)CAPES; Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq)National Council for Scientific and Technological
   Development (CNPq)
FX The authors would like to thank the High Performance Computing Center
   (NPAD) of UFRN for provision of computational resources, the Coordenacdo
   de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), and the
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) for
   financial support. We are also grateful to the shrimp producers and
   associated entities who assisted us in providing samples.
CR Cannon RM, 2001, PREV VET MED, V49, P141, DOI 10.1016/S0167-5877(01)00184-2
   Chai CY, 2013, J MICROBIOL, V51, P695, DOI 10.1007/s12275-013-3171-0
   Dantas MDA, 2018, VIRUS RES, V245, P52, DOI 10.1016/j.virusres.2017.12.006
   Dieu BTM, 2004, J GEN VIROL, V85, P3607, DOI 10.1099/vir.0.80344-0
   Flegel TW, 2008, AQUACULTURE, V280, P1, DOI 10.1016/j.aquaculture.2008.04.029
   Holthuis L. B, 1980, FAO SPECIES CATALOGU, V125
   Lo CF, 1996, DIS AQUAT ORGAN, V25, P133, DOI 10.3354/dao025133
   Lo CF, 1999, DIS AQUAT ORGAN, V35, P175, DOI 10.3354/dao035175
   Marks H, 2005, J GEN VIROL, V86, P2081, DOI 10.1099/vir.0.80895-0
   Marks H, 2005, VIRUS RES, V110, P9, DOI 10.1016/j.virusres.2005.01.002
   Marks H, 2004, ARCH VIROL, V149, P673, DOI 10.1007/s00705-003-0248-9
   Mayo MA, 2002, ARCH VIROL, V147, P1655, DOI 10.1007/s007050200039
   Muller IC, 2010, DIS AQUAT ORGAN, V88, P91, DOI 10.3354/dao02142
   Musthaq SS, 2006, AQUACULTURE, V256, P34, DOI 10.1016/j.aquaculture.2006.01.036
   Oakey HJ, 2018, AQUACULTURE, V484, P152, DOI 10.1016/j.aquaculture.2017.11.009
   Pradeep B, 2008, DIS AQUAT ORGAN, V78, P189, DOI 10.3354/dao01878
   Pradeep B, 2009, J FISH DIS, V32, P801, DOI 10.1111/j.1365-2761.2009.01053.x
   Pradeep B, 2008, VIROLOGY, V376, P24, DOI 10.1016/j.virol.2008.02.037
   Ramos-Paredes J, 2017, J FISH DIS, V40, P425, DOI 10.1111/jfd.12598
   Rodriguez-Anaya L, 2016, GENOME ANNOUNC, V4, P4
   Tang KFJ, 2012, DIS AQUAT ORGAN, V99, P179, DOI 10.3354/dao02470
   Tran TTH, 2011, J GEN VIROL, V92, P675, DOI 10.1099/vir.0.026351-0
   van Hulten MCW, 2001, VIROLOGY, V286, P7, DOI 10.1006/viro.2001.1002
   van Hulten MCW, 2001, VIROLOGY, V285, P228, DOI 10.1006/viro.2001.0928
   Waikhom G, 2006, AQUACULTURE, V261, P54, DOI 10.1016/j.aquaculture.2006.07.031
   Walker PJ, 2011, AQUACULTURE, V318, P277, DOI 10.1016/j.aquaculture.2011.05.029
   Wang Q, 2000, DIS AQUAT ORGAN, V43, P175, DOI 10.3354/dao043175
   Wongteerasupaya C, 2003, DIS AQUAT ORGAN, V54, P253, DOI 10.3354/dao054253
   Yang F, 2001, J VIROL, V75, P11811, DOI 10.1128/JVI.75.23.11811-11820.2001
NR 29
TC 0
Z9 0
U1 0
U2 4
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0022-2011
EI 1096-0805
J9 J INVERTEBR PATHOL
JI J. Invertebr. Pathol.
PD MAR
PY 2019
VL 162
BP 55
EP 63
DI 10.1016/j.jip.2019.02.003
PG 9
WC Zoology
SC Zoology
GA HR2FX
UT WOS:000462952100006
PM 30738030
DA 2020-11-30
ER

PT J
AU de Lima, JGS
   Teixeira, DG
   Freitas, TT
   Lima, JPMS
   Lanza, DCF
AF de Lima, Juliana G. S.
   Teixeira, Diego G.
   Freitas, Tiago T.
   Lima, Joao P. M. S.
   Lanza, Daniel C. F.
TI Evolutionary origin of 2A-like sequences in Totiviridae genomes
SO VIRUS RESEARCH
LA English
DT Article
DE Pseudo 2A-site; Artivirus; Giardiavirus; 2A-like ranking; Arthropod
   totivirus; IMNV
ID INFECTIOUS MYONECROSIS VIRUS; DOUBLE-STRANDED RNAS; MOLECULAR
   CHARACTERIZATION; NUCLEOTIDE-SEQUENCE; PROTEIN-STRUCTURE; MYCOVIRUSES;
   IDENTIFICATION; MOSQUITOS; ALIGNMENT; VICTORIVIRUS
AB In recent years there has been a significant increase in the number of new species potentially belonging to the Totiviridae family. Most of these new viruses have not yet been covered by the Committee on Taxonomy of Viruses (ICTV) official classification. In this study, a phylogenetic analysis including new sequences of Totiviridae candidates revealed a clade including Giardiavirus and a great diversity of new totiviruses, which infect arthropods, protozoa and mollusc. This expanded Giardiavirus clade comprises two monophyletic groups, one of them including Giardia lamblia virus (GLV) grouped with viruses that infect arthropods and vertebrates (GLV-like group), and the other includes the previously proposed Artivirus group (IMNV-like group). A screening of the members of the GLV-like group in search of genomic elements already described in IMNV-like group revealed the existence of sites with a high propensity to become 2 A-like oligopeptides, mainly in a specific subgroup of arthropod viruses, suggesting that these viruses preserved ancestral characteristics. The existence of these "pseudo 2 A-sites" associated to phylogenetic reconstruction indicates that these sequences appear at a decisive stage for viral evolution. If they are changed to functional 2 A-like sequences, an irreversible route to increase the genome complexity will be initiated.
C1 [de Lima, Juliana G. S.; Freitas, Tiago T.; Lanza, Daniel C. F.] Univ Fed Rio Grande do Norte, Dept Biochem, Appl Mol Biol Lab LAPLIC, BR-59072970 Natal, RN, Brazil.
   [Teixeira, Diego G.; Lima, Joao P. M. S.] Univ Fed Rio Grande do Norte, Dept Biochem, Lab Metab Syst & Bioinformat LASIS, Natal, RN, Brazil.
   [de Lima, Juliana G. S.; Teixeira, Diego G.; Lima, Joao P. M. S.; Lanza, Daniel C. F.] Univ Fed Rio Grande do Norte, Postgrad Program Biochem, Natal, RN, Brazil.
   [Freitas, Tiago T.; Lanza, Daniel C. F.] Univ Fed Rio Grande do Norte, Postgrad Program Sci Technol & Innovat, Natal, RN, Brazil.
RP Lanza, DCF (corresponding author), Univ Fed Rio Grande do Norte, Dept Biochem, Appl Mol Biol Lab LAPLIC, BR-59072970 Natal, RN, Brazil.
EM danielclanza@gmail.com
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)CAPES
FX The authors would like to thank the High Performance Computing Center
   (NPAD) of UFRN for provision of computational resources and Coordenacao
   de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) for financial
   support. Juliana G. S. de Lima and Diego G. Teixeira received
   scholarships from CAPES.
CR Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770
   Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537
   Chen S, 2016, ARCH VIROL, V161, P487, DOI 10.1007/s00705-015-2657-y
   Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073
   Colmant AMG, 2017, MSPHERE, V2, DOI [10.1128/mSphere.00262-17, 10.1128/msphere.00262-17]
   Dantas MDA, 2016, VIRUS RES, V211, P159, DOI 10.1016/j.virusres.2015.10.020
   Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088
   Doherty M, 2007, J PHYTOPATHOL, V155, P188, DOI 10.1111/j.1439-0434.2007.01207.x
   Donnelly MLL, 2001, J GEN VIROL, V82, P1027, DOI 10.1099/0022-1317-82-5-1027
   Donnelly MLL, 2001, J GEN VIROL, V82, P1013, DOI 10.1099/0022-1317-82-5-1013
   Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075
   Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340
   Fauver JR, 2016, VIROLOGY, V498, P288, DOI 10.1016/j.virol.2016.07.031
   Galinier R, 2017, ACTA TROP, V167, P196, DOI 10.1016/j.actatropica.2016.12.021
   Guo LF, 2016, ARCH VIROL, V161, P731, DOI 10.1007/s00705-015-2716-4
   Hammond TM, 2008, EUKARYOT CELL, V7, P350, DOI 10.1128/EC.00356-07
   Haugland O, 2011, J VIROL, V85, P5275, DOI 10.1128/JVI.02154-10
   Isawa H, 2011, VIRUS RES, V155, P147, DOI 10.1016/j.virusres.2010.09.013
   Jiang YH, 2015, VIRUS RES, V195, P47, DOI 10.1016/j.virusres.2014.08.022
   Komatsu K, 2016, ARCH VIROL, V161, P1701, DOI 10.1007/s00705-016-2796-9
   Kondo H, 2016, VIRUS RES, V213, P353, DOI 10.1016/j.virusres.2015.11.015
   Koyama S, 2016, ARCH VIROL, V161, P2043, DOI 10.1007/s00705-016-2876-x
   Koyama S, 2015, J GEN VIROL, V96, P1930, DOI 10.1099/vir.0.000126
   Kozlakidis Z, 2006, J GEN VIROL, V87, P3113, DOI 10.1099/vir.0.82121-0
   Lachnit T, 2016, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01489
   Luke GA, 2008, J GEN VIROL, V89, P1036, DOI 10.1099/vir.0.83428-0
   Marchler-Bauer A, 2016, NUCLEIC ACIDS RES, V45, P1129
   Martinez J, 2016, J GEN VIROL, V97, P523, DOI 10.1099/jgv.0.000360
   Marzano S.-Y., 2016, J VIROL, V90
   Mor SK, 2016, ARCH VIROL, V161, P1925, DOI 10.1007/s00705-016-2873-0
   Mor SK, 2016, ARCH VIROL, V161, P2227, DOI 10.1007/s00705-016-2906-8
   Nerva L, 2016, VIRUS RES, V219, P22, DOI 10.1016/j.virusres.2015.10.028
   Nibert ML, 2007, J GEN VIROL, V88, P1315, DOI 10.1099/vir.0.82681-0
   Niu YH, 2016, VIROLOGY, V494, P15, DOI 10.1016/j.virol.2016.04.004
   Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042
   Ong JWL, 2018, VIRUS RES, V244, P276, DOI 10.1016/j.virusres.2017.11.026
   Osaki H, 2016, VIRUS GENES, V52, P835, DOI 10.1007/s11262-016-1379-x
   Poulos BT, 2006, J GEN VIROL, V87, P987, DOI 10.1099/vir.0.81127-0
   Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537
   Quito-Avila DF, 2016, EUR J PLANT PATHOL, V146, P705, DOI 10.1007/s10658-016-0943-5
   Rodriguez-Cousino N, 2017, TOXINS, V9, DOI 10.3390/toxins9100313
   Rowley PA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005890
   Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5
   Tang LH, 2015, ARCH VIROL, V160, P2907, DOI 10.1007/s00705-015-2562-4
   Tuomivirta TT, 2005, VIRUS RES, V110, P31, DOI 10.1016/j.virusres.2004.12.005
   Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033
   Wickner RB, 2012, VIRUS TAXONOMY CLASS, P639, DOI DOI 10.1016/B978-0-12-384684-6.00052-5
   Wu B, 2016, VIRUS GENES, V52, P244, DOI 10.1007/s11262-016-1295-0
   Wu MD, 2016, VIRUS RES, V223, P28, DOI 10.1016/j.virusres.2016.06.009
   Wu QF, 2010, P NATL ACAD SCI USA, V107, P1606, DOI 10.1073/pnas.0911353107
   Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371
   Xin CY, 2016, ARCH VIROL, V161, P3571, DOI 10.1007/s00705-016-3020-7
   Xu KW, 2016, 2016 PROGRESS IN ELECTROMAGNETICS RESEARCH SYMPOSIUM (PIERS), P156, DOI 10.1109/PIERS.2016.7734276
   Yamada KD, 2016, BIOINFORMATICS, V32, P3246, DOI 10.1093/bioinformatics/btw412
   Yang XY, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01373
   Yang XL, 2012, ARCH VIROL, V157, P1093, DOI 10.1007/s00705-012-1278-y
   Zangger H, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002836
   Zhai LF, 2015, ARCH VIROL, V160, P613, DOI 10.1007/s00705-014-2285-y
   Zhai Y, 2010, J GEN VIROL, V91, P2836, DOI 10.1099/vir.0.024794-0
   Zhang RJ, 2015, ARCH VIROL, V160, P1805, DOI 10.1007/s00705-015-2420-4
   Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40
   Zheng L, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01960
   Zhong J, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18050963
   Zhong J, 2014, ARCH VIROL, V159, P3063, DOI 10.1007/s00705-014-2144-x
   Zhong J, 2014, VIRUS GENES, V48, P570, DOI 10.1007/s11262-014-1050-3
NR 65
TC 5
Z9 6
U1 1
U2 5
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0168-1702
EI 1872-7492
J9 VIRUS RES
JI Virus Res.
PD JAN 2
PY 2019
VL 259
BP 1
EP 9
DI 10.1016/j.virusres.2018.10.011
PG 9
WC Virology
SC Virology
GA KQ7UD
UT WOS:000517124800001
PM 30339789
DA 2020-11-30
ER

PT J
AU Alves, JJP
   Fernandes, TAAD
   De Araujo, JMG
   Cobucci, RNO
   Lanza, DCF
   Bezerra, FL
   Andrade, VS
   Fernandes, JV
AF Paiva Alves, Jayra Juliana
   Araujo De Medeiros Fernandes, Thales Allyrio
   Galvao De Araujo, Joselio Maria
   Oliveira Cobucci, Ricardo Ney
   Ferreira Lanza, Daniel Carlos
   Bezerra, Fabiana Lima
   Andrade, Vania Sousa
   Fernandes, Jose Verissimo
TI Th17 response in patients with cervical cancer
SO ONCOLOGY LETTERS
LA English
DT Review
DE Th17 cells; uterine cervical cancer; carcinogenesis; immune system
ID HUMAN-PAPILLOMAVIRUS INFECTION; IL-17-PRODUCING T-CELLS;
   TUMOR-INFILTRATING LYMPHOCYTES; INFLAMMATORY-DISEASES; IMMUNE-RESPONSES;
   HOST-DEFENSE; ASSOCIATION ANALYSIS; EFFECTOR FUNCTIONS; INTERLEUKIN 17;
   MESSENGER-RNA
AB Persistent infection by high-risk human papillomavirus (HR-HPV) is the main risk factor for uterine cervical cancer (UCC). However, viral infection alone is not sufficient for the development and progression of premalignant cervical lesions for cancer. In previous years it has been suggested that the adaptive immune response triggered by the differentiation of naive helper T cells in Th17 cells may serve an important role in disease development. It has been hypothesized that Th17 cells may be involved in the promotion of UCC, as high levels of interleukin 17 (IL17) expression have been detected in the mucosa of the uterine cervix of patients affected by the disease. However, the role of Th17 cells in the tumor development and progression remains unclear. It is believed that the immune response of the Th17 type during persistent infection of the genital tract with HR-HPV triggers chronic inflammation with a long duration with the production of IL17 and other pro-inflammatory cytokines, creating a favorable environment for tumor development. These cytokines are produced by immune system cells in addition to tumor cells and appear to function by modulating the host immune system, resulting in an immunosuppressive response as opposed to inducing an effective protective immune response, thus contributing to the growth and progression of the tumor. In the present review, the latest advances are presented about the function of Th17 cells and the cytokines produced by them in the development and progression of UCC.
C1 [Paiva Alves, Jayra Juliana; Galvao De Araujo, Joselio Maria; Bezerra, Fabiana Lima; Andrade, Vania Sousa; Fernandes, Jose Verissimo] Univ Fed Rio Grande do Norte, Dept Microbiol & Parasitol, BR-59072970 Natal, RN, Brazil.
   [Araujo De Medeiros Fernandes, Thales Allyrio] Univ Rio Grande Norte State, Dept Biomed Sci, Rua Miguel Antonio da Silva Neto S-N, BR-59607360 Mossoro, RN, Brazil.
   [Oliveira Cobucci, Ricardo Ney] Univ Potiguar, Dept Gynecol & Obstet, BR-5905600 Natal, RN, Brazil.
   [Ferreira Lanza, Daniel Carlos] Univ Fed Rio Grande do Norte, Dept Biochem, BR-59072970 Natal, RN, Brazil.
RP Fernandes, TAAD (corresponding author), Univ Rio Grande Norte State, Dept Biomed Sci, Rua Miguel Antonio da Silva Neto S-N, BR-59607360 Mossoro, RN, Brazil.
EM thalesallyrio@yahoo.com.br
RI Cobucci, Ricardo Ney Oliveira/E-2907-2015; Araujo, Joselio M
   G/B-5502-2013; Andrade, Vania Sousa/AAR-3922-2020; Fernandes,
   Thales/F-4813-2010
OI Cobucci, Ricardo Ney Oliveira/0000-0002-0184-2061; Araujo, Joselio M
   G/0000-0003-3548-2786; Fernandes, Thales/0000-0003-4559-8918; Fernandes,
   Jose Verissimo/0000-0002-5169-6496
CR Annunziato F, 2015, IMMUNOLOGY, V144, P343, DOI 10.1111/imm.12399
   Arnold CE, 2015, IMMUNOBIOLOGY, V220, P10, DOI 10.1016/j.imbio.2014.09.022
   Asadzadeh Z, 2017, CELL IMMUNOL, V322, P15, DOI 10.1016/j.cellimm.2017.10.015
   Backert I, 2014, J IMMUNOL, V193, P3779, DOI 10.4049/jimmunol.1303076
   Barnes MJ, 2009, IMMUNITY, V31, P401, DOI 10.1016/j.immuni.2009.08.011
   Bettelli E, 2008, NATURE, V453, P1051, DOI 10.1038/nature07036
   Bie QL, 2017, MOL IMMUNOL, V90, P50, DOI 10.1016/j.molimm.2017.07.004
   Blaskewicz CD, 2011, BIOL REPROD, V85, P97, DOI 10.1095/biolreprod.110.090423
   Bodily J, 2011, TRENDS MICROBIOL, V19, P33, DOI 10.1016/j.tim.2010.10.002
   Bosch FX, 2007, DIS MARKERS, V23, P213, DOI 10.1155/2007/914823
   Castellsague X, 2008, GYNECOL ONCOL, V110, pS4, DOI 10.1016/j.ygyno.2008.07.045
   Catarino R, 2015, WORLD J CLIN ONCOL, V6, P281, DOI 10.5306/wjco.v6.i6.281
   Chen ZF, 2013, DIAGN PATHOL, V8, DOI 10.1186/1746-1596-8-61
   Cong JL, 2015, INT J CLIN EXP PATHO, V8, P9567
   Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800
   Damsker JM, 2010, ANN NY ACAD SCI, V1183, P211, DOI 10.1111/j.1749-6632.2009.05133.x
   Daud II, 2011, INT J CANCER, V128, P879, DOI 10.1002/ijc.25400
   Davidson MG, 2013, J IMMUNOL, V191, P1175, DOI 10.4049/jimmunol.1203201
   Dong C, 2014, CELL RES, V24, P901, DOI 10.1038/cr.2014.92
   Eyerich S, 2010, TRENDS IMMUNOL, V31, P354, DOI 10.1016/j.it.2010.06.004
   Eyerich S, 2009, J CLIN INVEST, V119, P3573, DOI 10.1172/JCI40202
   Feng MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108502
   Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210
   Forman D, 2012, VACCINE, V30, pF12, DOI 10.1016/j.vaccine.2012.07.055
   Fu BQ, 2014, CELL MOL IMMUNOL, V11, P564, DOI 10.1038/cmi.2014.54
   Gaffen SL, 2009, NAT REV IMMUNOL, V9, DOI 10.1038/nri2625
   Gaffen SL, 2008, CYTOKINE, V43, P402, DOI 10.1016/j.cyto.2008.07.017
   Gagliani N, 2015, NATURE, V523, P221, DOI 10.1038/nature14452
   Gagliani N, 2014, CELL, V157, P776, DOI 10.1016/j.cell.2014.03.006
   Galvez J, 2014, ISRN INFLAMM, V2014, P14, DOI DOI 10.1155/2014/928461
   Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543
   Goldszmid RS, 2014, CELL HOST MICROBE, V15, P295, DOI 10.1016/j.chom.2014.02.003
   Gosmann C, 2014, J IMMUNOL, V193, P2248, DOI 10.4049/jimmunol.1400216
   Guery L, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/314620
   Hardikar S, 2015, GYNECOL ONCOL, V139, P90, DOI 10.1016/j.ygyno.2015.07.110
   Hartupee J, 2009, J IMMUNOL, V182, P1660, DOI 10.4049/jimmunol.182.3.1660
   Hervouet C, 2010, J IMMUNOL, V184, P4842, DOI 10.4049/jimmunol.0901695
   Hou F, 2013, CLIN CHIM ACTA, V415, P337, DOI 10.1016/j.cca.2012.11.004
   Hou F, 2012, CLIN CHIM ACTA, V413, P1848, DOI 10.1016/j.cca.2012.07.012
   Hu Y, 2011, ANN NY ACAD SCI, V1217, P60, DOI 10.1111/j.1749-6632.2010.05825.x
   Huang F, 2007, J IMMUNOL, V179, P6504, DOI 10.4049/jimmunol.179.10.6504
   Huang Q, 2016, SCI REP-UK, V6, DOI 10.1038/srep36551
   Huber M, 2009, EUR J IMMUNOL, V39, P1716, DOI 10.1002/eji.200939412
   Iwasaki A, 2010, NAT REV IMMUNOL, V10, P699, DOI 10.1038/nri2836
   Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623
   Kaplan MH, 2013, IMMUNOL REV, V252, P104, DOI 10.1111/imr.12028
   Karczmarczyk A, 2014, ACTA HAEMATOL POL, V45, P155
   Kemp TJ, 2010, CANCER EPIDEM BIOMAR, V19, P1954, DOI 10.1158/1055-9965.EPI-10-0184
   Kim HS, 2017, J EXP MED, V214, P3381, DOI 10.1084/jem.20170523
   Komatsu N, 2014, NAT MED, V20, P62, DOI 10.1038/nm.3432
   Li L, 2015, GENET MOL RES, V14, P12178, DOI 10.4238/2015.October.9.6
   Li YX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118391
   Liang SC, 2007, J IMMUNOL, V179, P7791, DOI 10.4049/jimmunol.179.11.7791
   Liang W, 2016, CANCER IMMUNOL RES, V4, P83, DOI 10.1158/2326-6066.CIR-15-0313
   Lima Erika Galvao, 2013, ISRN Obstet Gynecol, V2013, P930479, DOI 10.1155/2013/930479
   Lin Y, 2014, SOUTH MED J, V107, P281, DOI 10.1097/SMJ.0000000000000100
   Lv QY, 2015, TUMOR BIOL, V36, P3979, DOI 10.1007/s13277-015-3041-y
   Maddur MS, 2012, AM J PATHOL, V181, P8, DOI 10.1016/j.ajpath.2012.03.044
   Mandic A, 2014, J BUON, V19, P958
   Mellett M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2127
   Mills KHG, 2008, EUR J IMMUNOL, V38, P2636, DOI 10.1002/eji.200838535
   Miyahara Y, 2008, P NATL ACAD SCI USA, V105, P15505, DOI 10.1073/pnas.0710686105
   Mora-Garcia Maria Lourdes, 2015, Rev Med Inst Mex Seguro Soc, V53 Suppl 2, pS206
   Morrison PJ, 2011, IMMUNOLOGY, V133, P397, DOI 10.1111/j.1365-2567.2011.03454.x
   MOSMANN TR, 1986, J IMMUNOL, V136, P2348
   Munoz N, 2006, VACCINE, V24, P1, DOI 10.1016/j.vaccine.2006.05.115
   Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954
   Nalbant Ayten, 2016, Front Biosci (Elite Ed), V8, P427
   Pappu R, 2011, IMMUNOLOGY, V134, P8, DOI 10.1111/j.1365-2567.2011.03465.x
   Paradkar PH, 2014, ASIAN PAC J CANCER P, V15, P3851, DOI 10.7314/APJCP.2014.15.9.3851
   Peters A, 2011, CURR OPIN IMMUNOL, V23, P702, DOI 10.1016/j.coi.2011.08.007
   Punt S, 2015, ONCOIMMUNOLOGY, V4, DOI 10.4161/2162402X.2014.984539
   Quan Y, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/258293
   Ron D, 2008, INT J BIOCHEM CELL B, V40, P2040, DOI 10.1016/j.biocel.2008.03.013
   Ruddy MJ, 2004, J BIOL CHEM, V279, P2559, DOI 10.1074/jbc.M308809200
   Saavedra K, 2012, CLIN EPIGENETICS, V4, DOI 10.1186/1868-7083-4-13
   Saleh A, 2009, J IMMUNOL, V182, P3357, DOI 10.4049/jimmunol.0801882
   Sasagawa T, 2012, J INFECT CHEMOTHER, V18, P807, DOI 10.1007/s10156-012-0485-5
   Schmitt E, 2014, TRENDS IMMUNOL, V35, P61, DOI 10.1016/j.it.2013.10.004
   Shabgah AG, 2014, POSTEP DERM ALERGOL, V31, P256, DOI 10.5114/pdia.2014.40954
   Shukla S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067849
   Song D, 2015, ONCOL LETT, V10, P600, DOI 10.3892/ol.2015.3295
   Stanley MA, 2009, INDIAN J MED RES, V130, P266
   Stanley M, 2008, GYNECOL ONCOL, V109, pS15, DOI 10.1016/j.ygyno.2008.02.003
   Sun DX, 2011, NAT IMMUNOL, V12, P853, DOI 10.1038/ni.2081
   Sun LX, 2015, GENET MOL RES, V14, P13612, DOI 10.4238/2015.October.28.22
   Tajima M, 2011, INT IMMUNOL, V23, P751, DOI 10.1093/intimm/dxr086
   Tartour E, 1999, CANCER RES, V59, P3698
   Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262
   Trajkovic V, 2001, J NEUROIMMUNOL, V119, P183, DOI 10.1016/S0165-5728(01)00391-5
   Vaccarella S, 2013, EUR J CANCER, V49, P3262, DOI 10.1016/j.ejca.2013.04.024
   van Hamburg JP, 2009, ARTHRITIS RHEUM-US, V60, P750, DOI 10.1002/art.24329
   Veldhoen M, 2008, NAT IMMUNOL, V9, P1341, DOI 10.1038/ni.1659
   Vidal AC, 2015, INFECT AGENTS CANCER, V10, DOI 10.1186/s13027-015-0005-1
   Walch-Ruckheim B, 2015, CANCER RES, V75, P5248, DOI 10.1158/0008-5472.CAN-15-0732
   Wei L, 2016, MOL MED REP, V13, P1673, DOI 10.3892/mmr.2015.4694
   Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497
   Wright JF, 2007, J BIOL CHEM, V282, P13447, DOI 10.1074/jbc.M700499200
   Wu MY, 2011, J FORMOS MED ASSOC, V110, P580, DOI 10.1016/j.jfma.2011.07.005
   Xue JS, 2018, CANCER MED-US, V7, P297, DOI 10.1002/cam4.1279
   Ye J, 2013, AM J PATHOL, V182, P10, DOI 10.1016/j.ajpath.2012.08.041
   Young MRI, 2016, INT J CANCER, V138, P2487, DOI 10.1002/ijc.29989
   Yu Q, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120855
   Zhang J, 2017, ONCOTARGET, V8, P24797, DOI 10.18632/oncotarget.15044
   Zhang S, 2017, NATURE, V551, P105, DOI 10.1038/nature24283
   Zhang Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086812
   Zhang Y, 2011, CLIN CHIM ACTA, V412, P894, DOI 10.1016/j.cca.2011.01.015
   Zhao M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02890-0
   Zhu S, 2012, CLIN SCI, V122, P487, DOI 10.1042/CS20110496
   Ziegler SF, 2009, MICROBES INFECT, V11, P594, DOI 10.1016/j.micinf.2009.04.002
NR 110
TC 7
Z9 8
U1 0
U2 4
PU SPANDIDOS PUBL LTD
PI ATHENS
PA POB 18179, ATHENS, 116 10, GREECE
SN 1792-1074
EI 1792-1082
J9 ONCOL LETT
JI Oncol. Lett.
PD NOV
PY 2018
VL 16
IS 5
BP 6215
EP 6227
DI 10.3892/ol.2018.9481
PG 13
WC Oncology
SC Oncology
GA GY3FG
UT WOS:000448433500092
PM 30405758
OA Green Published, Other Gold
DA 2020-11-30
ER

PT J
AU Chavez, F
   de Vega, FF
   Lanza, D
   Benavides, C
   Villegas, J
   Trujillo, L
   Olague, G
   Roman, G
AF Chavez, Francisco
   de Vega, Francisco Fernandez
   Lanza, Daniel
   Benavides, Cesar
   Villegas, Juan
   Trujillo, Leonardo
   Olague, Gustavo
   Roman, Graciela
TI Deploying massive runs of evolutionary algorithms with ECJ and Hadoop:
   Reducing interest points required for face recognition
SO INTERNATIONAL JOURNAL OF HIGH PERFORMANCE COMPUTING APPLICATIONS
LA English
DT Article
DE ECJ; face recognition; Hadoop; parallel evolutionary algorithm
ID MAPREDUCE
AB In this paper we present a new strategy for deploying massive runs of evolutionary algorithms with the well-known Evolutionary Computation Library (ECJ) tool, which we combine with the MapReduce model so as to allow the deployment of computing intensive runs of evolutionary algorithms on big data infrastructures. Moreover, by addressing a hard real life problem, we show how the new strategy allows us to address problems that cannot be solved with more traditional approaches. Thus, this paper shows that by using the Hadoop framework ECJ users can, by means of a new parameter, choose where the run will be launched, whether in a Hadoop based infrastructure or in a desktop computer. Moreover, together with the performed tests we address the well-known face recognition problem with a new purpose: to allow a genetic algorithm to decide which are the more relevant interest points within the human face. Massive runs have allowed us to reduce the set from about 60 to just 20 points. In this way, recognition tasks based on the solution provided by the genetic algorithm will work significantly quicker in the future, given that just 20 points will be required. Therefore, two goals have been achieved: (a) to allow ECJ users to launch massive runs of evolutionary algorithms on big data infrastructures and also (b) to demonstrate the capabilities of the tool to successfully improve results regarding the problem of face recognition.
C1 [Chavez, Francisco; de Vega, Francisco Fernandez] Univ Extremadura, Dept Comp Sci, Merida, Venezuela.
   [Lanza, Daniel] CERN European Org Nucl Res, Geneva, Switzerland.
   [Benavides, Cesar; Roman, Graciela] Univ Autonoma Metropolitana, Dept Ingn, Mexico City, DF, Mexico.
   [Villegas, Juan] Univ Autonoma Metropolitana, Dept Elect, Mexico City, DF, Mexico.
   [Trujillo, Leonardo] Inst Tecnol Tijuana, Calzada Tecnol S-N, Mexico City, DF, Mexico.
   [Olague, Gustavo] CICESE, Mexico City, DF, Mexico.
RP Chavez, F (corresponding author), Univ Extremadura, C Santa Teresa Jornet 38, Merida 06800, Spain.
EM fchavez@unex.es
RI de Vega, Francisco Fernandez/M-1385-2014; de la O, Francisco
   Chavez/H-3971-2011; Cortez, Juan Villegas/O-8143-2019; Olague,
   Gustavo/L-7795-2014; Trujillo, Leonardo/L-2939-2017
OI de la O, Francisco Chavez/0000-0002-9565-743X; Cortez, Juan
   Villegas/0000-0001-8918-1044; Olague, Gustavo/0000-0001-5773-9517;
   Trujillo, Leonardo/0000-0003-1812-5736
FU FP7-PEOPLE-2013-IRSES [612689]; Spanish Ministry of Economy, Project
   UEX:EPHEMEC [TIN2014-56494-C4-2-P]; Junta de Extremadura; FEDEREuropean
   Union (EU) [GR15068]; CONACyT MexicoConsejo Nacional de Ciencia y
   Tecnologia (CONACyT) [155045]; TESE [DIMI-MCIM-004/08]
FX The author(s) disclosed receipt of the following financial support for
   the research, authorship, and/or publication of this article: This work
   was supported by FP7-PEOPLE-2013-IRSES, Grant 612689 ACoBSEC, Spanish
   Ministry of Economy, Project UEX:EPHEMEC (TIN2014-56494-C4-2-P); Junta
   de Extremadura, and FEDER, project GR15068. It was also supported by
   CONACyT Mexico through (project number 155045, "Evolucion de Cerebros
   Artificiales en Vision por Computadora'') and TESE (project number
   DIMI-MCIM-004/08).
CR Benavides C., 2015, P MAEB 2015 MER SPAI, P733
   Cantu-Paz E, 2000, EFFICIENT ACCURATE P, V1
   Chavez F, 2016, LECT NOTES COMPUT SC, V9598, P91, DOI 10.1007/978-3-319-31153-1_7
   Dean J, 2004, USENIX ASSOCIATION PROCEEDINGS OF THE SIXTH SYMPOSIUM ON OPERATING SYSTEMS DESIGN AND IMPLEMENTATION (OSDE '04), P137
   Dean J, 2010, COMMUN ACM, V53, P72, DOI 10.1145/1629175.1629198
   Du X, 2013, INT J COMPUT APPL T, V46, P290, DOI 10.1504/IJCAT.2013.052807
   ECJ, 2015, ECJ JAVA BASED EVOLU
   Serrano-Talamantes JF, 2013, EXPERT SYST APPL, V40, P2398, DOI 10.1016/j.eswa.2012.10.064
   Fernandez F., 2003, Genetic Programming and Evolvable Machines, V4, P21, DOI 10.1023/A:1021873026259
   Fernandez F., 1999, Recent Advances in Parallel Virtual Machine and Message Passing Interface. 6th European PVM/MPI User's Group Meeting. Proceedings (Lecture Notes in Computer Science Vol.1697), P241
   Fernndez de Vega F., 2014, RES COMPUTING SCI, P120
   Garcia M., 2013, LNCS, P499, DOI DOI 10.1007/978-3-642-37192-9
   González Alejandro, 2010, Rev. ing. univ. Medellín, V9, P139
   Hsu RL, 2002, IEEE T PATTERN ANAL, V24, P696, DOI 10.1109/34.1000242
   Jain AK, 2010, HDB FACE RECOGNITION
   Koza JR, 1992, GENETIC PROGRAMMING, V1
   Laredo JLJ, 2010, GENET PROGRAM EVOL M, V11, P227, DOI 10.1007/s10710-009-9096-z
   Li FF, 2007, COMPUT VIS IMAGE UND, V106, P59, DOI 10.1016/j.cviu.2005.09.012
   Gonzalez DL, 2009, EUROMICRO WORKSHOP P, P419, DOI [10.1109/.24, 10.1109/PDP.2009.25]
   Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94
   Melab N, 2006, J PARALLEL DISTR COM, V66, P1052, DOI 10.1016/j.jpdc.2005.11.006
   O'Toole A, 2013, ENCY MIND, V2, P348
   Olague G, 2011, IMAGE VISION COMPUT, V29, P484, DOI 10.1016/j.imavis.2011.03.004
   Perez CB, 2013, INTELL DATA ANAL, V17, P561, DOI 10.3233/IDA-130594
   Sherry Dylan, 2012, Applications of Evolutionary Computation. Proceedings of EvoApplications 2012: EvoCOMNET, EvoCOMPLEX, EvoFIN, EvoGAMES, EvoHOT, EvoIASP, EvoNUM, EvoPAR, EvoRISK, EvoSTIM, and EvoSTOC, P477, DOI 10.1007/978-3-642-29178-4_48
   Shvachko K., 2010, SYMPOSIUM, P1, DOI DOI 10.1109/MSST.2010.5496972
   Srinivasan A, 2014, ICT CRITICAL INFRAST, VII, P155
   Stelzer D., 1998, Software Process Improvement and Practice, V4, P227, DOI 10.1002/(SICI)1099-1670(199812)4:4<227::AID-SPIP106>3.3.CO;2-T
   Sun K, 2015, OPTIK, V126, P3227, DOI 10.1016/j.ijleo.2015.07.080
   Tomassini M., 2013, P 2013 IEEE INT C CL, P209
   Trujillo L., 2005, IEEE COMP SOC C COMP, P14
   Trujillo L, 2008, EVOL COMPUT, V16, P483, DOI 10.1162/evco.2008.16.4.483
   Uwimana Epaphrodite, 2008, Proceedings of the Human Factors and Ergonomics Society. 52nd Annual Meeting, P788, DOI 10.1518/107118108X352265
   Wagner A, 2012, IEEE T PATTERN ANAL, V34, P372, DOI 10.1109/TPAMI.2011.112
   White T, 2012, HADOOP DEFINITIVE GU
   Yang MH, 2002, IEEE T PATTERN ANAL, V24, P34, DOI 10.1109/34.982883
   Zhang L, 2011, IEEE I CONF COMP VIS, P471, DOI 10.1109/ICCV.2011.6126277
   Zhang Z, 2014, INT SYM COMPUT INTEL, DOI 10.1109/ISCID.2014.195
   Zhao W, 2003, ACM COMPUT SURV, V35, P399, DOI 10.1145/954339.954342
   Zhu XX, 2012, PROC CVPR IEEE, P2879, DOI 10.1109/CVPR.2012.6248014
NR 40
TC 1
Z9 1
U1 0
U2 2
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1094-3420
EI 1741-2846
J9 INT J HIGH PERFORM C
JI Int. J. High Perform. Comput. Appl.
PD SEP
PY 2018
VL 32
IS 5
SI SI
BP 706
EP 720
DI 10.1177/1094342016678302
PG 15
WC Computer Science, Hardware & Architecture; Computer Science,
   Interdisciplinary Applications; Computer Science, Theory & Methods
SC Computer Science
GA GU4FG
UT WOS:000445237300010
DA 2020-11-30
ER

PT J
AU Cavalcante, GHO
   de Araujo, JMG
   Fernandes, JV
   Lanza, DCF
AF Cavalcante, Gustavo Henrique O.
   de Araujo, Joselio M. G.
   Fernandes, Jose Verissimo
   Lanza, Daniel C. F.
TI A seminested PCR assay for detection and typing of human papillomavirus
   based on E1 gene sequences
SO DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
LA English
DT Article
DE HPV; Cervical cancer; Genotyping; Molecular diagnosis; E1 protein
ID DNA-BINDING; REPLICATION PROTEIN; PHOSPHORYLATION; LOCALIZATION;
   DIMERIZATION; ALIGNMENT; HELICASE; DOMAIN; WOMEN
AB HPV infection is considered one of the leading causes of cervical cancer in the world. To date, more than 180 types of HPV have been described and viral typing is critical for defining the prognosis of cancer. In this work, a seminested PCR which allow fast and inexpensively detection and typing of HPV is presented. The system is based on the amplification of a variable length region within the viral gene E1, using three primers that potentially anneal in all HPV genomes. The amplicons produced in the first step can be identified by high resolution electrophoresis or direct sequencing. The seminested step includes nine specific primers which can be used in multiplex or individual reactions to discriminate the main types of HPV by amplicon size differentiation using agarose electrophoresis, reducing the time spent and cost per analysis. (C) 2017 Elsevier Inc. All rights reserved.
C1 [Cavalcante, Gustavo Henrique O.; Lanza, Daniel C. F.] Univ Fed Rio Grande do Norte, Dept Biochem, Appl Mol Biol Lab LAPLIC, Natal, RN, Brazil.
   [de Araujo, Joselio M. G.; Fernandes, Jose Verissimo] Univ Fed Rio Grande do Norte, Dept Microbiol & Parasitol, Lab Mol Biol Infect Dis & Canc LADIC, Natal, RN, Brazil.
   [Cavalcante, Gustavo Henrique O.] Univ Fed Rio Grande do Norte, Postgrad Program Biochem, Natal, RN, Brazil.
RP Lanza, DCF (corresponding author), Univ Fed Rio Grande do Norte, Dept Biochem, Appl Mol Biol Lab LAPLIC, Natal, RN, Brazil.
EM danielclanza@gmail.com
RI Araujo, Joselio M G/B-5502-2013
OI Araujo, Joselio M G/0000-0003-3548-2786; Fernandes, Jose
   Verissimo/0000-0002-5169-6496
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES,
   BrazilCAPES
FX This work was supported by Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior - CAPES, Brazil.
CR Auster AS, 2004, J BIOL CHEM, V279, P3733, DOI 10.1074/jbc.M311681200
   Bernard HU, 2010, VIROLOGY, V401, P70, DOI 10.1016/j.virol.2010.02.002
   Castle PE, 2008, J CLIN MICROBIOL, V46, P2595, DOI 10.1128/JCM.00824-08
   Costa MESM, 2016, ACTA TROP, V159, P120, DOI 10.1016/j.actatropica.2016.03.035
   de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033
   Deng WT, 2004, J VIROL, V78, P13954, DOI 10.1128/JVI.78.24.13954-13965.2004
   Doorbar J, 2015, REV MED VIROL, V25, P2, DOI 10.1002/rmv.1822
   Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340
   Forman D, 2012, VACCINE, V30, pF12, DOI 10.1016/j.vaccine.2012.07.055
   Forslund O, 1999, J GEN VIROL, V80, P2437, DOI 10.1099/0022-1317-80-9-2437
   Fradet-Turcotte A, 2010, J VIROL, V84, P11747, DOI 10.1128/JVI.01445-10
   Gravitt PE, 2000, J CLIN MICROBIOL, V38, P357
   Ho GYF, 1998, NEW ENGL J MED, V338, P423, DOI 10.1056/NEJM199802123380703
   HUSMAN AMDR, 1995, J GEN VIROL, V76, P1057
   IARC, 2007, IARC MON EV CARC RIS, P90, DOI 10.1094/PDIS-91-4-0467B
   Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199
   Kitchener HC, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13510
   Kleter B, 1998, AM J PATHOL, V153, P1731, DOI 10.1016/S0002-9440(10)65688-X
   Kurian EM, 2011, AM J CLIN PATHOL, V136, P808, DOI 10.1309/AJCPCQD7B7DPVHLH
   LENTZ MR, 1993, J VIROL, V67, P1414, DOI 10.1128/JVI.67.3.1414-1423.1993
   MANOS MM, 1989, CANCER CEL, V7, P209
   MINCHEVA A, 1987, MED MICROBIOL IMMUN, V176, P245, DOI 10.1007/bf00190531
   Naryshkin S, 2012, DRUG HEALTHC PATIENT, V4, P167, DOI 10.2147/DHPS.S37273
   SARAFI TR, 1995, VIROLOGY, V211, P385, DOI 10.1006/viro.1995.1421
   Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75
   Smith L, 2015, UROL CLIN N AM, V42, P507, DOI 10.1016/j.ucl.2015.06.004
   Thomer LK, 1993, J VIROL, V67, P6000
   Titolo S, 2003, J VIROL, V77, P5178, DOI 10.1128/JVI.77.9.5178-5191.2003
   Vallone PM, 2004, BIOTECHNIQUES, V37, P226, DOI 10.2144/04372ST03
   Van Doorslaer K, 2013, NUCLEIC ACIDS RES, V41, pD571, DOI 10.1093/nar/gks984
   VANDENBRULE AJC, 1990, J CLIN MICROBIOL, V28, P2739, DOI 10.1128/JCM.28.12.2739-2743.1990
   Veldhuijzen NJ, 2010, LANCET INFECT DIS, V10, P862, DOI 10.1016/S1473-3099(10)70190-0
   Walboomers JMM, 1992, DIAGNOSTIC MOL PATHO, VII, P153
   Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033
   Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134
NR 35
TC 1
Z9 1
U1 0
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0732-8893
EI 1879-0070
J9 DIAGN MICR INFEC DIS
JI Diagn. Microbiol. Infect. Dis.
PD MAY
PY 2018
VL 91
IS 1
BP 20
EP 26
DI 10.1016/j.diagmicrobio.2017.12.016
PG 7
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA GE3CK
UT WOS:000431091000004
PM 29370952
DA 2020-11-30
ER

PT J
AU Dantas, MDA
   Teixeira, DG
   Silva-Portela, RCB
   Soares, PET
   Lima, JPMS
   Agnez-Lima, LF
   Lanza, DCF
AF Dantas, Marcia Danielle A.
   Teixeira, Diego G.
   Silva-Portela, Rita Cassia B.
   Soares, Paulo Eduardo T.
   Lima, Joao Paulo M. S.
   Agnez-Lima, Lucymara F.
   Lanza, Daniel Carlos F.
TI Direct sequencing of the white spot syndrome virus from Brazil: Genome
   assembly and new insights on phylogeny
SO VIRUS RESEARCH
LA English
DT Article
DE WSSV; Shrimp farming; Homologous regions; Recombination
ID NUCLEAR POLYHEDROSIS-VIRUS; FUNCTIONAL-ANALYSIS; HISTORIC EMERGENCE;
   BACILLIFORM VIRUS; SHRIMP PATHOGENS; DNA-REPLICATION; VIRULENCE;
   ALIGNMENT; REGIONS; IDENTIFICATION
AB White spot syndrome virus (WSSV) has been the cause of great economic losses in world shrimp farming. In this work the genome of a Brazilian WSSV isolate was determined from direct sequencing of total DNA extracted from an infected whiteleg shrimp, and assembled based on a chimera template approach. Comparisons between WSSV-BR and other isolates revealed that the Brazilian virus has a relatively small genome, and is very similar to isolates from Thailand and Mexico. A phylogenetic relationship using different approaches has demonstrated that these isolates share a common evolutionary history. An analysis of conflicting phylogenetic signals also considering genomes of other isolates revealed that the evolutionary history of WSSV may be related to recombination events. We observed that these events can also be traced at some level by analyzing the homologous regions in the WSSV genome. The existence of recombination events introduces a new point of view that must be considered in the evolutionary history of WSSV.
C1 [Dantas, Marcia Danielle A.; Soares, Paulo Eduardo T.; Lanza, Daniel Carlos F.] Univ Fed Rio Grande do Norte, Dept Biochem, Appl Mol Biol Lab LAPLIC, Natal, RN, Brazil.
   [Dantas, Marcia Danielle A.; Teixeira, Diego G.; Lima, Joao Paulo M. S.; Agnez-Lima, Lucymara F.; Lanza, Daniel Carlos F.] Univ Fed Rio Grande do Norte, Postgrad Program Biochem, Natal, RN, Brazil.
   [Soares, Paulo Eduardo T.; Lima, Joao Paulo M. S.; Agnez-Lima, Lucymara F.; Lanza, Daniel Carlos F.] Univ Fed Rio Grande do Norte, Postgrad Program Bioinformat, Natal, RN, Brazil.
   [Silva-Portela, Rita Cassia B.; Agnez-Lima, Lucymara F.] Univ Fed Rio Grande do Norte, Dept Cellular Biol & Genet, Lab Mol Biol & Genom, Natal, RN, Brazil.
RP Lanza, DCF (corresponding author), Univ Fed Rio Grande do Norte, Ctr Biociencias, Dept Bioquim, Lab Biol Mol Aplicada LAPLIC, BR-59072970 Natal, RN, Brazil.
EM danielclanza@gmail.com
RI Agnez-Lima, Lucymara/F-9655-2012
OI Agnez-Lima, Lucymara/0000-0003-0642-3162
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES)CAPES; CAPESCAPES
FX We would like to thank the Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior (CAPES) for financial support. M.D.A. Dantas and D. G.
   Teixeira were received scholarships from CAPES.
CR Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537
   Buchfink B, 2015, NAT METHODS, V12, P59, DOI 10.1038/nmeth.3176
   Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109
   Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340
   Federhen S, 2012, NUCLEIC ACIDS RES, V40, pD136, DOI 10.1093/nar/gkr1178
   Filee J, 2008, RES MICROBIOL, V159, P325, DOI 10.1016/j.resmic.2008.04.012
   Flegel TW, 2012, J INVERTEBR PATHOL, V110, P166, DOI 10.1016/j.jip.2012.03.004
   Gao ML, 2014, FISH SHELLFISH IMMUN, V39, P17, DOI 10.1016/j.fsi.2014.04.011
   Giri L, 2012, J GEN VIROL, V93, P389, DOI 10.1099/vir.0.036566-0
   Hilton S, 2007, J GEN VIROL, V88, P1496, DOI 10.1099/vir.0.82760-0
   Hoa TTT, 2012, J FISH DIS, V35, P817, DOI 10.1111/j.1365-2761.2012.01406.x
   Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030
   Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199
   KOOL M, 1993, J GEN VIROL, V74, P2661, DOI 10.1099/0022-1317-74-12-2661
   Lan YS, 2002, VIRUS RES, V90, P269, DOI 10.1016/S0168-1702(02)00231-9
   Landais I, 2006, VIROLOGY, V344, P421, DOI 10.1016/j.virol.2005.08.036
   Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404
   Larsson A, 2014, BIOINFORMATICS, V30, P3276, DOI 10.1093/bioinformatics/btu531
   Lecuit M, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00025
   Leu JH, 2009, CURR TOP MICROBIOL, V328, P197
   Li DC, 2016, BIOL DIRECT, V11, DOI 10.1186/s13062-016-0105-x
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Lightner DV, 2012, J INVERTEBR PATHOL, V110, P174, DOI 10.1016/j.jip.2012.03.006
   Marks H, 2005, J GEN VIROL, V86, P2081, DOI 10.1099/vir.0.80895-0
   Marks H, 2005, VIRUS RES, V110, P9, DOI 10.1016/j.virusres.2005.01.002
   Marks H, 2004, ARCH VIROL, V149, P673, DOI 10.1007/s00705-003-0248-9
   Mayo MA, 2002, ARCH VIROL, V147, P1655, DOI 10.1007/s007050200039
   Morgulis A, 2008, BIOINFORMATICS, V24, P1757, DOI 10.1093/bioinformatics/btn322
   Pradeep B, 2009, J FISH DIS, V32, P801, DOI 10.1111/j.1365-2761.2009.01053.x
   Pradeep B, 2008, VIROLOGY, V376, P24, DOI 10.1016/j.virol.2008.02.037
   Rambaut A., 2013, TRACER VERSION 1 2 C
   Rasmussen C, 1996, VIROLOGY, V224, P235, DOI 10.1006/viro.1996.0525
   Schierup MH, 2000, GENETICS, V156, P879
   Stentiford GD, 2012, J INVERTEBR PATHOL, V110, P141, DOI 10.1016/j.jip.2012.03.013
   THEILMANN DA, 1992, VIROLOGY, V187, P97, DOI 10.1016/0042-6822(92)90298-4
   van Hulten MCW, 2000, J GEN VIROL, V81, P307, DOI 10.1099/0022-1317-81-2-307
   van Hulten MCW, 2001, VIROLOGY, V286, P7, DOI 10.1006/viro.2001.1002
   van Hulten MCW, 2001, VIROLOGY, V285, P228, DOI 10.1006/viro.2001.0928
   van Hulten MCW, 2002, J GEN VIROL, V83, P257, DOI 10.1099/0022-1317-83-1-257
   Waikhom G, 2006, AQUACULTURE, V261, P54, DOI 10.1016/j.aquaculture.2006.07.031
   Yang F, 2001, J VIROL, V75, P11811, DOI 10.1128/JVI.75.23.11811-11820.2001
   Yuan CW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175416
NR 42
TC 3
Z9 3
U1 1
U2 5
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-1702
EI 1872-7492
J9 VIRUS RES
JI Virus Res.
PD FEB 2
PY 2018
VL 245
BP 52
EP 61
DI 10.1016/j.virusres.2017.12.006
PG 10
WC Virology
SC Virology
GA FW3HG
UT WOS:000425196800006
PM 29258747
DA 2020-11-30
ER

PT J
AU Nunes, ARD
   Alves, BEB
   Pereira, HWB
   Nascimento, YM
   Morais, IC
   Fernandes, JV
   Araujo, JMG
   Lanza, DCF
AF Nunes, Allan R. D.
   Alves, Brenda Elen B.
   Pereira, Hannaly W. B.
   Nascimento, Yasmin M.
   Morais, Ingryd C.
   Fernandes, Jose Verissimo
   Araujo, Joselio M. G.
   Lanza, Daniel C. F.
TI Improved reverse transcription-polymerase chain reaction assay for the
   detection of flaviviruses with semi-nested primers for discrimination
   between dengue virus serotypes and Zika virus
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE arbovirus; Flaviviridae; West Nile virus; yellow fever virus
ID RIO-DE-JANEIRO; RAPID IDENTIFICATION; PCR; TRANSMISSION; COINFECTION
AB BACKGROUND The genus Flavivirus includes a variety of medically important viruses, including dengue virus (DENV) and Zika virus (ZIKV), which are most prevalent in Brazil. Because the clinical profile of patients affected by different DENV serotypes or ZIKV may be similar, the development of new methods that facilitate a rapid and accurate diagnosis is crucial.
   OBJECTIVES The current study aimed to develop an improved reverse transcription-polymerase chain reaction (RT-PCR) protocol for universal detection of flaviviruses by using semi-nested primers that discriminate between DENV serotypes and ZIKV.
   METHODS The bioinformatics workflow adopted for primer design included: (1) alignment of 1,442 flavivirus genome sequences, (2) characterisation of 27 conserved regions, (3) generation of a primer set comprising 77 universal primers, and (4) selection of primer pairs with greatest coverage and specificity. Following primer design, the reaction was validated in vitro. The same approach was applied to the design of primers specific for DENV and ZIKV, using a species-specific sequence database.
   FINDINGS The new assay amplified an 800-806 nt variable region of the NS5 gene and allowed discrimination of virtually all flavivirus species using reference-sequence comparison. The 800-806 nt fragment was validated as a template for a semi-nested multiplex PCR using five additional primers for the detection of DENV and ZIKV. These primers were designed to generate amplicons of different sizes, allowing differentiation of the four serotypes of DENV, and ZIKV using agarose gel electrophoresis.
   MAIN CONCLUSIONS The bioinformatics pipeline allowed efficient primer design, making it possible to identify the best targets within the coding region of the NS5 protein. The multiplex system proved effective in differentiation of DENV1-4 and ZIKV on a 2% agarose gel. The possibility of discriminating DENV serotypes and ZIKV in the same reaction provided a faster result consuming less sample. In addition, this simplified approach ensured the reduction of the cost per analysis.
C1 [Nunes, Allan R. D.; Lanza, Daniel C. F.] Univ Fed Rio Grande do Norte, Dept Bioquim, Lab Biol Mol Aplicada, Natal, RN, Brazil.
   [Alves, Brenda Elen B.; Pereira, Hannaly W. B.; Nascimento, Yasmin M.; Morais, Ingryd C.; Fernandes, Jose Verissimo; Araujo, Joselio M. G.] Univ Fed Rio Grande do Norte, Dept Microbiol & Parasitol, Lab Biol Mol Doencas Infecciosas & Canc, Natal, RN, Brazil.
   [Nunes, Allan R. D.; Morais, Ingryd C.; Lanza, Daniel C. F.] Univ Fed Rio Grande do Norte, Programa Posgrad Bioquim, Natal, RN, Brazil.
   [Alves, Brenda Elen B.; Pereira, Hannaly W. B.; Fernandes, Jose Verissimo; Araujo, Joselio M. G.] Univ Fed Rio Grande do Norte, Programa Posgrad Biol Parasitaria, Natal, RN, Brazil.
   [Alves, Brenda Elen B.; Pereira, Hannaly W. B.; Nascimento, Yasmin M.; Morais, Ingryd C.; Araujo, Joselio M. G.] Univ Fed Rio Grande do Norte, Inst Med Trop, Lab Virol, Natal, RN, Brazil.
RP Lanza, DCF (corresponding author), Univ Fed Rio Grande do Norte, Dept Bioquim, Lab Biol Mol Aplicada, Natal, RN, Brazil.; Lanza, DCF (corresponding author), Univ Fed Rio Grande do Norte, Programa Posgrad Bioquim, Natal, RN, Brazil.
EM danielclanza@gmail.com
RI Araujo, Joselio M G/B-5502-2013
OI Araujo, Joselio M G/0000-0003-3548-2786; Fernandes, Jose
   Verissimo/0000-0002-5169-6496
FU CAPESCAPES; CNPqNational Council for Scientific and Technological
   Development (CNPq)
FX CAPES, CNPq.
CR Calvet GA, 2016, J CLIN VIROL, V74, P1, DOI 10.1016/j.jcv.2015.11.014
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Chao DY, 2007, J CLIN MICROBIOL, V45, P584, DOI 10.1128/JCM.00842-06
   CHOW VTK, 1993, ARCH VIROL, V133, P157, DOI 10.1007/BF01309751
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Dyer J, 2007, J VIROL METHODS, V145, P9, DOI 10.1016/j.jviromet.2007.05.001
   ELDADAH ZA, 1991, J MED VIROL, V33, P260, DOI 10.1002/jmv.1890330410
   Figueiredo LTM, 1998, AM J TROP MED HYG, V59, P357, DOI 10.4269/ajtmh.1998.59.357
   FULOP L, 1993, J VIROL METHODS, V44, P179, DOI 10.1016/0166-0934(93)90053-T
   Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460
   Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]
   Kuno G, 1998, J VIROL METHODS, V72, P27, DOI 10.1016/S0166-0934(98)00003-2
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015
   Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144
   Maher-Sturgess SL, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-16
   Nogueira RMR, 2011, MEM I OSWALDO CRUZ, V106, P255, DOI 10.1590/S0074-02762011000300001
   PIERRE V, 1994, RES VIROLOGY, V145, P93, DOI 10.1016/S0923-2516(07)80011-2
   PURI B, 1994, ARCH VIROL, V134, P29, DOI 10.1007/BF01379104
   Nogueira RMR, 2007, REV PANAM SALUD PUBL, V22, P358, DOI 10.1590/S1020-49892007001000009
   SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454
   Sanchez-Seco MP, 2005, J VIROL METHODS, V126, P101, DOI 10.1016/j.jviromet.2005.01.025
   Scaramozzino N, 2001, J CLIN MICROBIOL, V39, P1922, DOI 10.1128/JCM.39.5.1922-1927.2001
   SCHATZMAYR H G, 1986, Memorias do Instituto Oswaldo Cruz, V81, P245, DOI 10.1590/S0074-02761986000200019
   Simmonds P, 2017, J GEN VIROL, V98, P2, DOI 10.1099/jgv.0.000672
   TAJIMA F, 1984, MOL BIOL EVOL, V1, P269
   TANAKA M, 1993, J VIROL METHODS, V41, P311, DOI 10.1016/0166-0934(93)90020-R
   Villamil-Gomez WE, 2016, INT J INFECT DIS, V51, P135, DOI 10.1016/j.ijid.2016.07.017
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 28
TC 2
Z9 2
U1 0
U2 2
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PY 2018
VL 113
IS 5
AR e170393
DI 10.1590/0074-02760170393
PG 9
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA GA9WT
UT WOS:000428693000003
PM 29513820
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Moizeis, RNC
   Fernandes, TAAD
   Guedes, PMD
   Pereira, HWB
   Lanza, DCF
   de Azevedo, JWV
   Galvao, JMD
   Fernandes, JV
AF Cunha Moizeis, Raiza Nara
   Araujo de Medeiros Fernandes, Thales Allyrio
   da Matta Guedes, Paulo Marcos
   Bezerra Pereira, Hannaly Wana
   Ferreira Lanza, Daniel Carlos
   Verissimo de Azevedo, Judson Welber
   de Araujo Galvao, Joselio Maria
   Fernandes, Jose Verissimo
TI Chikungunya fever: a threat to global public health
SO PATHOGENS AND GLOBAL HEALTH
LA English
DT Review
DE Chikungunya virus; chikungunya virus infection; chikungunya virus
   pathogenesis; chikungunya fever; arboviruses
ID VIRUS NONSTRUCTURAL PROTEIN-2; VERTICAL TRANSMISSION; REUNION ISLAND;
   INFECTION; ARTHRITIS; PATHOGENESIS; REPLICATION; DOMAINS;
   MANIFESTATIONS; COMPLICATIONS
AB Chikungunya fever is an emerging arbovirus infection, representing a serious public health problem. Its etiological agent is the Chikungunya virus (CHIKV). Transmission of this virus is mainly vector by mosquitoes of the genus Aedes, although transmission by blood transfusions and vertical transmission has also been reported. The disease presents high morbidity caused mainly by the arthralgia and arthritis generated. Cardiovascular and neurological manifestations have also been reported. The severity of the infection seems to be directly associated with the action of the virus, but also with the decompensation of preexisting comorbidities. Currently, there are no therapeutic products neither vaccines licensed to the infection CHIKV control, although several vaccine candidates are being evaluated and human polyvalent immunoglobulins anti-CHIKV had been tested. Antibodies can protect against the infection, but in sub-neutralizing concentrations can augment virus infection and exacerbate disease severity. So, the prevention still depends on the use of personal protection measures and vector control, which are only minimally effective.
C1 [Cunha Moizeis, Raiza Nara; da Matta Guedes, Paulo Marcos; Bezerra Pereira, Hannaly Wana; de Araujo Galvao, Joselio Maria; Fernandes, Jose Verissimo] Univ Fed Rio Grande do Norte, Programa Posgrad Biol Parasitaria, Natal, RN, Brazil.
   [Araujo de Medeiros Fernandes, Thales Allyrio] Univ Estado Rio Grande do Norte, Dept Ciencias Biomed, Mossoro, Brazil.
   [da Matta Guedes, Paulo Marcos; de Araujo Galvao, Joselio Maria; Fernandes, Jose Verissimo] Univ Fed Rio Grande do Norte, Dept Microbiol & Parasitol, Natal, RN, Brazil.
   [Ferreira Lanza, Daniel Carlos] Univ Fed Rio Grande do Norte, Dept Bioquim, Natal, RN, Brazil.
   [Verissimo de Azevedo, Judson Welber] Univ Fed Triangulo Mineiro, Dept Ortopedia, Uberaba, Brazil.
RP Fernandes, TAAD (corresponding author), Univ Estado Rio Grande do Norte, Dept Ciencias Biomed, Mossoro, Brazil.
EM thalesallyrio@yahoo.com.br
RI Fernandes, Thales/F-4813-2010; Araujo, Joselio M G/B-5502-2013; Guedes,
   Paulo/Y-2546-2018
OI Fernandes, Thales/0000-0003-4559-8918; Araujo, Joselio M
   G/0000-0003-3548-2786; Matta Guedes, Paulo Marcos/0000-0002-4564-6791;
   Fernandes, Jose Verissimo/0000-0002-5169-6496
CR Abdelnabi R, 2018, ANTIVIR RES, V149, P113, DOI 10.1016/j.antiviral.2017.09.016
   Akahata W, 2010, NAT MED, V16, P334, DOI 10.1038/nm.2105
   Akhrymuk I, 2012, J VIROL, V86, P7180, DOI 10.1128/JVI.00541-12
   Alvarez Maria Fernanda, 2017, F1000Res, V6, P390, DOI 10.12688/f1000research.11078.1
   [Anonymous], 2015, B EPIDEMIOLOGICO, V46, P1
   [Anonymous], 2017, GUI VIG SAUD
   de Brito CAA, 2016, REV SOC BRAS MED TRO, V49, P668, DOI 10.1590/0037-8682-0279-2016
   Bandeira AC, 2016, IDCases, V5, P57, DOI 10.1016/j.idcr.2016.07.008
   Brandler S, 2008, COMP IMMUNOL MICROB, V31, P271, DOI 10.1016/j.cimid.2007.07.012
   Brizzi K, 2017, CURR INFECT DIS REP, V19, DOI 10.1007/s11908-017-0561-1
   Broeckel R, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005637
   Brouard C, 2008, TRANSFUSION, V48, P1333, DOI 10.1111/j.1537-2995.2008.01646.x
   Burt FJ, 2017, LANCET INFECT DIS, V17, pE107, DOI 10.1016/S1473-3099(16)30385-1
   Burt FJ, 2012, LANCET, V379, P662, DOI 10.1016/S0140-6736(11)60281-X
   Cardona-Correa SE, 2017, REV CHIL PEDIATR-CHI, V88, P285, DOI 10.4067/S0370-41062017000200015
   Cassadou S, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.13.20752
   Cerny T, 2017, NEUROCRIT CARE, V27, P447, DOI 10.1007/s12028-017-0413-8
   Chaaithanya IK, 2014, INDIAN J MED RES, V140, P142
   Chang LJ, 2014, LANCET, V384, P2046, DOI 10.1016/S0140-6736(14)61185-5
   Chen MW, 2017, ANTIVIR RES, V143, P38, DOI 10.1016/j.antiviral.2017.04.001
   Chen RB, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003591
   Chen WQ, 2015, TRENDS MICROBIOL, V23, P35, DOI 10.1016/j.tim.2014.09.005
   Chiam CW, 2015, J GEN VIROL, V96, P3243, DOI 10.1099/jgv.0.000263
   Chow A, 2011, J INFECT DIS, V203, P149, DOI 10.1093/infdis/jiq042
   Couderc T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040029
   Couderc T, 2012, J INFECT DIS, V206, P851, DOI 10.1093/infdis/jis296
   Couderc T, 2009, J INFECT DIS, V200, P516, DOI 10.1086/600381
   da Cunha RV, 2017, MEM I OSWALDO CRUZ, V112, P523, DOI 10.1590/0074-02760170044
   Das PK, 2014, J BIOL CHEM, V289, P5635, DOI 10.1074/jbc.M113.503433
   Das T, 2010, PROG NEUROBIOL, V91, P121, DOI 10.1016/j.pneurobio.2009.12.006
   Sa PKD, 2017, REV SOC BRAS MED TRO, V50, P265, DOI 10.1590/0037-8682-0375-2016
   Fares RCG, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/321873
   Fros JJ, 2013, J VIROL, V87, P10394, DOI 10.1128/JVI.00884-13
   Fros JJ, 2010, J VIROL, V84, P10877, DOI 10.1128/JVI.00949-10
   Gasque P, 2015, VECTOR-BORNE ZOONOT, V15, P241, DOI 10.1089/vbz.2014.1710
   Gerardin P, 2016, NEUROLOGY, V86, P94, DOI 10.1212/WNL.0000000000002234
   Gerardin P, 2008, PLOS MED, V5, P413, DOI 10.1371/journal.pmed.0050060
   Goo L, 2016, J INFECT DIS, V214, P1487, DOI 10.1093/infdis/jiw431
   Goupil Brad A, 2016, Open Rheumatol J, V10, P129, DOI 10.2174/1874312901610010129
   Halstead SB, 2015, EMERG INFECT DIS, V21, P557, DOI 10.3201/eid2104.141723
   Hawman DW, 2013, J VIROL, V87, P13878, DOI 10.1128/JVI.02666-13
   Her ZS, 2010, J IMMUNOL, V184, P5903, DOI 10.4049/jimmunol.0904181
   Hoarau JJ, 2010, J IMMUNOL, V184, P5914, DOI 10.4049/jimmunol.0900255
   Hochedez P, 2006, EMERG INFECT DIS, V12, P1565, DOI 10.3201/eid1210.060495
   Honorio NA, 2015, CAD SAUDE PUBLICA, V31, P906, DOI 10.1590/0102-311XPE020515
   Inglis FM, 2016, J NEUROVIROL, V22, P140, DOI 10.1007/s13365-015-0378-3
   Johnson BW, 2016, J INFECT DIS, V214, pS471, DOI 10.1093/infdis/jiw274
   Joob B, 2017, ARQ NEURO-PSIQUIAT, V75, P326, DOI 10.1590/0004-282X20170029
   Judith D, 2013, EMBO REP, V14, P534, DOI 10.1038/embor.2013.51
   Kam YW, 2009, MICROBES INFECT, V11, P1186, DOI 10.1016/j.micinf.2009.09.003
   Karpe YA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022336
   Kelvin AA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001279
   Kosasih H, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002483
   Lemant J, 2008, CRIT CARE MED, V36, P2536, DOI 10.1097/CCM.0b013e318183f2d2
   Leung JYS, 2011, ADV VIROL, V2011, DOI 10.1155/2011/249640
   Lo Presti A, 2014, ASIAN PAC J TROP MED, V7, P925, DOI 10.1016/S1995-7645(14)60164-4
   Lourenco-de-Oliveira R, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005698
   Lum FM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20305-4
   Lum FM, 2015, ANTIVIR RES, V120, P165, DOI 10.1016/j.antiviral.2015.06.009
   Mahendradas P, 2013, J OPHTHALMIC INFLAMM, V3, DOI 10.1186/1869-5760-3-35
   Malet H, 2009, J VIROL, V83, P6534, DOI 10.1128/JVI.00189-09
   Marimoutou C, 2012, MEDICINE, V91, P212, DOI 10.1097/MD.0b013e318260b604
   Marques CDL, 2017, REV BRAS REUMATOL, V57, P421, DOI DOI 10.1016/J.RBR.2017.05.004
   Martinez-Pulgarin DF, 2016, TRAVEL MED INFECT DI, V14, P451, DOI 10.1016/j.tmaid.2016.05.008
   Miner JJ, 2015, ARTHRITIS RHEUMATOL, V67, P1214, DOI 10.1002/art.39027
   Miossec P, 2009, NEW ENGL J MED, V361, P888, DOI 10.1056/NEJMra0707449
   Mohan Alladi, 2010, Indian J Dermatol, V55, P54, DOI 10.4103/0019-5154.60355
   Neuvonen M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002383
   Ng LFP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004261
   Nhan T-X, 2016, J CLIN CASE REP, V6
   Pakran J, 2011, INT J DERMATOL, V50, P61, DOI 10.1111/j.1365-4632.2010.04644.x
   Panas MD, 2014, J VIROL, V88, P5888, DOI 10.1128/JVI.00439-14
   Parashar D, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/631642
   PEIRIS JSM, 1979, NATURE, V282, P509, DOI 10.1038/282509a0
   Petersen LR, 2010, VOX SANG, V98, P495, DOI 10.1111/j.1423-0410.2009.01286.x
   Phuklia W, 2013, VIRUS RES, V177, P179, DOI 10.1016/j.virusres.2013.08.011
   Rodrigues NCP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165945
   Plante K, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002142
   Powers AM, 2000, J GEN VIROL, V81, P471, DOI 10.1099/0022-1317-81-2-471
   Powers AM, 2007, J GEN VIROL, V88, P2363, DOI 10.1099/vir.0.82858-0
   Powers AM, 2018, CLIN MICROBIOL REV, V31, DOI 10.1128/CMR.00104-16
   Prashant Soma, 2009, Indian J Dermatol, V54, P128, DOI 10.4103/0019-5154.53186
   Puiprom O, 2013, INFECT GENET EVOL, V17, P210, DOI 10.1016/j.meegid.2013.04.005
   Rajapakse S, 2010, T ROY SOC TROP MED H, V104, P89, DOI 10.1016/j.trstmh.2009.07.031
   Ramful D, 2007, PEDIATR INFECT DIS J, V26, P811, DOI 10.1097/INF.0b013e3180616d4f
   Reddy V, 2014, J MED VIROL, V86, P1393, DOI 10.1002/jmv.23875
   Robillard PY, 2006, PRESSE MED, V35, P785, DOI 10.1016/S0755-4982(06)74690-5
   ROSS R. W., 1956, JOUR HYG, V54, P177
   Rothan HA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126360
   Schilte C, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002137
   Schilte C, 2010, J EXP MED, V207, P429, DOI 10.1084/jem.20090851
   Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263
   Schwartz O, 2010, NAT REV MICROBIOL, V8, P491, DOI 10.1038/nrmicro2368
   Simon Fabrice, 2011, Curr Infect Dis Rep, V13, P218, DOI 10.1007/s11908-011-0180-1
   Singh SK, 2011, REV MED VIROL, V21, P78, DOI 10.1002/rmv.681
   Sourisseau M, 2007, PLOS PATHOG, V3, P804, DOI 10.1371/journal.ppat.0030089
   Staples JE, 2009, CLIN INFECT DIS, V49, P942, DOI 10.1086/605496
   Sudeep AB, 2015, TRENDS MICROBIOL, V23, P35
   Tandale BV, 2009, J CLIN VIROL, V46, P145, DOI 10.1016/j.jcv.2009.06.027
   Tang BL, 2012, CELL MICROBIOL, V14, P1354, DOI 10.1111/j.1462-5822.2012.01825.x
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Teng TS, 2015, J INFECT DIS, V211, P1925, DOI 10.1093/infdis/jiv049
   Teng TS, 2011, FUTURE VIROL, V6, P975, DOI 10.2217/FVL.11.67
   Teo TH, 2013, J IMMUNOL, V190, P259, DOI 10.4049/jimmunol.1202177
   Thangamani S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012137
   Thiberville SD, 2013, ANTIVIR RES, V99, P345, DOI 10.1016/j.antiviral.2013.06.009
   Thiboutot MM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000623
   Thon-Hon VG, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-213
   Torres JR, 2016, INT J INFECT DIS, V51, P85, DOI 10.1016/j.ijid.2016.09.009
   Torres JR, 2015, IDCases, V2, P6, DOI 10.1016/j.idcr.2014.12.002
   Utt A, 2015, J VIROL, V89, P3145, DOI 10.1128/JVI.03213-14
   van Duijl-Richter MKS, 2015, VIRUSES-BASEL, V7, P3647, DOI 10.3390/v7072792
   van Genderen FT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004625
   Vega-Rua A, 2015, VIRUSES-BASEL, V7, P5902, DOI 10.3390/v7112917
   Vega-Rua A, 2014, J VIROL, V88, P6294, DOI 10.1128/JVI.00370-14
   Versteeg L, 2016, CURR TROP MED REP, V3, P60, DOI [10.1007/s40475-016-0074-2, DOI 10.1007/S40475-016-0074-2]
   Volk SM, 2010, J VIROL, V84, P6497, DOI 10.1128/JVI.01603-09
   Wahid B, 2017, INT J INFECT DIS, V58, P69, DOI 10.1016/j.ijid.2017.03.006
   Wauquier N, 2011, J INFECT DIS, V204, P115, DOI 10.1093/infdis/jiq006
   Waymouth HE, 2013, SEMIN ARTHRITIS RHEU, V43, P273, DOI 10.1016/j.semarthrit.2013.03.003
   Weaver SC, 2015, ANTIVIR RES, V120, P32, DOI 10.1016/j.antiviral.2015.04.016
   WHO, CHIK
NR 122
TC 5
Z9 6
U1 1
U2 5
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 2047-7724
EI 2047-7732
J9 PATHOG GLOB HEALTH
JI Pathog. Glob. Health
PY 2018
VL 112
IS 4
BP 182
EP 194
DI 10.1080/20477724.2018.1478777
PG 13
WC Public, Environmental & Occupational Health; Parasitology; Tropical
   Medicine
SC Public, Environmental & Occupational Health; Parasitology; Tropical
   Medicine
GA GT5TC
UT WOS:000444571800003
PM 29806537
OA Green Published
DA 2020-11-30
ER

PT J
AU Nunes, ARD
   Chavante, SF
   Rocha, HAO
   Lanza, DCF
AF Nunes, Allan R. D.
   Chavante, Suely F.
   Rocha, Hugo A. O.
   Lanza, Daniel C. F.
TI "In-House'' Production of Single Stranded Oligodeoxyribonucleotides
SO NUCLEIC ACID THERAPEUTICS
LA English
DT Article
DE rolling circle amplification; anticoagulant aptamer; oligonucleotide
   production; G-quadruplex; enzymatic synthesis
ID ENZYMATIC PRODUCTION; HUMAN THROMBIN; DNA; OLIGONUCLEOTIDES; APTAMERS;
   ALGORITHM
AB The most widely used technique for the production of DNA aptamers/oligonucleotides is chemical synthesis. Despite its effectiveness, this technique cannot be performed "in house'', making the user fully dependent on a supplier. In this work, we present a simplified method by which it is possible to enzymatically produce DNA aptamers "in house''. This new method uses the rolling circle replication followed by a unique cleavage step using the SchI endonuclease. Potentially, any oligonucleotide can be produced by the enzymatic method proposed in this study. To illustrate, we present the production of three variations of the 31- TBA aptamer, a single stranded DNA which has anticoagulant action.
C1 [Nunes, Allan R. D.; Lanza, Daniel C. F.] Univ Fed Rio Grande do Norte, Ctr Biociencias, Dept Bioquim, Lab Biol Mol Aplicada LAPLIC, BR-59072970 Natal, RN, Brazil.
   [Nunes, Allan R. D.; Chavante, Suely F.; Rocha, Hugo A. O.; Lanza, Daniel C. F.] Univ Fed Rio Grande do Norte, Ctr Biociencias, Dept Bioquim, Programa Posgrad Bioquim, Natal, RN, Brazil.
RP Lanza, DCF (corresponding author), Univ Fed Rio Grande do Norte, Ctr Biociencias, Dept Bioquim, Lab Biol Mol Aplicada LAPLIC, BR-59072970 Natal, RN, Brazil.
EM danielclanza@gmail.com
RI Rocha, Hugo Alexandre Oliveira/X-6410-2019; de Oliveira Rocha, Hugo
   Alexandre/I-5130-2019; Rocha, Hugo Alexandre Oliveira/X-6411-2019
OI Rocha, Hugo Alexandre Oliveira/0000-0003-2252-1221; 
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)CAPES
FX The authors thank the Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior (CAPES) for the financial support.
CR BOCK LC, 1992, NATURE, V355, P564, DOI 10.1038/355564a0
   Ducani C, 2013, NAT METHODS, V10, P647, DOI [10.1038/NMETH.2503, 10.1038/nmeth.2503]
   Gragoudas ES, 2004, NEW ENGL J MED, V351, P2805, DOI 10.1056/NEJMoa042760
   Ikebukuro K, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni108
   Keefe AD, 2010, NAT REV DRUG DISCOV, V9, P537, DOI 10.1038/nrd3141
   Kikin O, 2008, NUCLEIC ACIDS RES, V36, pD141, DOI 10.1093/nar/gkm982
   Lohmann JS, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-49
   Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26
   Mathews DH, 2004, P NATL ACAD SCI USA, V101, P7287, DOI 10.1073/pnas.0401799101
   Nelissen FHT, 2015, ANAL BIOCHEM, V475, P68, DOI 10.1016/j.ab.2015.01.014
   Suh SH, 2013, J BIOTECHNOL, V167, P454, DOI 10.1016/j.jbiotec.2013.07.027
   Umekage S, 2009, J BIOTECHNOL, V139, P265, DOI 10.1016/j.jbiotec.2008.12.012
   Wang XL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008430
   Zavyalova E, 2011, CURR MED CHEM, V18, P3343, DOI 10.2174/092986711796504727
NR 14
TC 0
Z9 0
U1 2
U2 19
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 2159-3337
EI 2159-3345
J9 NUCLEIC ACID THER
JI Nucl. Acid Ther.
PD APR
PY 2017
VL 27
IS 2
BP 115
EP 120
PG 6
WC Biochemistry & Molecular Biology; Chemistry, Medicinal; Medicine,
   Research & Experimental
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Research &
   Experimental Medicine
GA EQ9KB
UT WOS:000398402300007
PM 28051347
DA 2020-11-30
ER

PT J
AU Nobre, CCG
   de Araujo, JMG
   Fernandes, TAAD
   Cobucci, RNO
   Lanza, DCF
   Andrade, VS
   Fernandes, JV
AF Guimaraes Nobre, Camila Cristina
   Galvao de Araujo, Joselio Maria
   Araujo de Medeiros Fernandes, Thales Allyrio
   Oliveira Cobucci, Ricardo Ney
   Ferreira Lanza, Daniel Carlos
   Andrade, Vania Sousa
   Fernandes, Jose Verissimo
TI Macrophage Migration Inhibitory Factor (MIF): Biological Activities and
   Relation with Cancer
SO PATHOLOGY & ONCOLOGY RESEARCH
LA English
DT Review
DE Macrophage migration inhibitory factor; Neoplasms; Tumorigenesis;
   Inflammation
ID HUMAN BREAST-CANCER; SQUAMOUS-CELL CARCINOMA; SUPPRESSOR-CELLS;
   TUMOR-GROWTH; PROMOTER POLYMORPHISMS; THERAPEUTIC TARGET; ANGIOGENIC
   FACTORS; FACTOR EXPRESSION; RECEPTOR COMPLEX; IMMUNE-RESPONSE
AB Macrophage migration inhibitory factor (MIF) emerged in recent years as an important inflammation mediator, playing a prominent role in the pathogenesis of various types of malignant neoplasm. MIF is a glycoprotein that presents a wide spectrum of biological activities and exerts a complex interaction with various cellular signaling pathways, causing imbalance of homeostasis. Experimental and clinical studies show that high levels of MIF are found in almost all types of human cancers and are implicated in seemingly all stages of development of the tumors. The production of MIF is triggered through an autocrine signal emitted by tumor cells, and stimulates the production of cytokines, chemokines, and growth as well as angiogenic factors that lead to growth of the tumor, increasing its aggressiveness and metastatic potential. MIF is produced by virtually all types of human body cells, in response to stress caused by different factors, leading to pathological conditions such as chronic inflammation and immunomodulation with suppression of immune surveillance and of immune response against tumors, angiogenesis, and carcinogenesis. In this review, we present recent advances on the biological activity of MIF, the signaling pathways with which it is involved and their role in tumorigenesis.
C1 [Guimaraes Nobre, Camila Cristina; Galvao de Araujo, Joselio Maria; Oliveira Cobucci, Ricardo Ney; Andrade, Vania Sousa; Fernandes, Jose Verissimo] Univ Fed Rio Grande do Norte, Dept Microbiol & Parasitol, Postgrad Program Parasite Biol, BR-59072970 Natal, RN, Brazil.
   [Araujo de Medeiros Fernandes, Thales Allyrio] Univ Rio Grande Norte State, Dept Biomed Sci, BR-59607360 Mossoro, RN, Brazil.
   [Araujo de Medeiros Fernandes, Thales Allyrio] Univ Rio Grande Norte Stat, Postgrad Program Hlth & Soc, Mossoro, RN, Brazil.
   [Oliveira Cobucci, Ricardo Ney] Univ Potiguar, Dept Gynecol & Obstet, BR-5905600 Natal, RN, Brazil.
   [Ferreira Lanza, Daniel Carlos] Univ Fed Rio Grande do Norte, Dept Biochemisty, BR-59072970 Natal, RN, Brazil.
RP Fernandes, JV (corresponding author), Univ Fed Rio Grande do Norte, Dept Microbiol & Parasitol, Postgrad Program Parasite Biol, BR-59072970 Natal, RN, Brazil.; Fernandes, TAAD (corresponding author), Univ Rio Grande Norte State, Dept Biomed Sci, BR-59607360 Mossoro, RN, Brazil.; Fernandes, TAAD (corresponding author), Univ Rio Grande Norte Stat, Postgrad Program Hlth & Soc, Mossoro, RN, Brazil.
EM thalesallyrio@yahoo.com.br; veris@cb.ufrn.br
RI Cobucci, Ricardo N/J-8134-2017; Araujo, Joselio M G/B-5502-2013;
   Fernandes, Thales/F-4813-2010; Andrade, Vania Sousa/AAR-3922-2020;
   Cobucci, Ricardo Ney Oliveira/E-2907-2015
OI Cobucci, Ricardo N/0000-0002-0184-2061; Araujo, Joselio M
   G/0000-0003-3548-2786; Fernandes, Thales/0000-0003-4559-8918; Cobucci,
   Ricardo Ney Oliveira/0000-0002-0184-2061; Fernandes, Jose
   Verissimo/0000-0002-5169-6496
CR Arisawa T, 2008, ONCOL REP, V19, P223
   Babu SN, 2012, ASIAN PAC J CANCER P, V13, P1737, DOI 10.7314/APJCP.2012.13.5.1737
   Bando H, 2002, JPN J CANCER RES, V93, P389, DOI 10.1111/j.1349-7006.2002.tb01269.x
   Benigni F, 2000, J CLIN INVEST, V106, P1291, DOI 10.1172/JCI9900
   BERNHAGEN J, 1993, NATURE, V365, P756, DOI 10.1038/365756a0
   Bernhagen J, 1998, J MOL MED-JMM, V76, P151, DOI 10.1007/s001090050204
   Bernhagen J, 2007, NAT MED, V13, P587, DOI 10.1038/nm1567
   Bifulco C, 2008, CURR PHARM DESIGN, V14, P3790, DOI 10.2174/138161208786898608
   Binsky I, 2007, P NATL ACAD SCI USA, V104, P13408, DOI 10.1073/pnas.0701553104
   BLOOM BR, 1966, SCIENCE, V153, P80, DOI 10.1126/science.153.3731.80
   Patrick KBA, 2008, J REPROD IMMUNOL, V77, P142, DOI 10.1016/j.jri.2007.07.004
   Bucala R, 1996, FASEB J, V10, P1607
   Cheng RJ, 2011, INT J GYNECOL CANCER, V21, P1004, DOI 10.1097/IGC.0b013e31821c45b7
   Cohen NA, 2012, CHEM BIOL, V19, P1175, DOI 10.1016/j.chembiol.2012.07.018
   Conroy H, 2010, QJM-INT J MED, V103, P831, DOI 10.1093/qjmed/hcq148
   Cooke G, 2009, BIOFACTORS, V35, P165, DOI 10.1002/biof.27
   Dambacher J, 2007, INFLAMM BOWEL DIS, V13, P71, DOI 10.1002/ibd.20008
   Rosado JD, 2011, INT J BIOL SCI, V7, P1239
   Dietlin TA, 2007, J LEUKOCYTE BIOL, V81, P1205, DOI 10.1189/jlb.1006640
   El-Turk F, 2008, BIOCHEMISTRY-US, V47, P10740, DOI 10.1021/bi800603x
   Elinav E, 2013, NAT REV CANCER, V13, P759, DOI 10.1038/nrc3611
   Fernandes JV, 2015, PATHOL ONCOL RES, V21, P527, DOI 10.1007/s12253-015-9913-z
   Fernandes JV, 2015, ONCOL LETT, V9, P1015, DOI 10.3892/ol.2015.2884
   Fingerle-Rowson G, 2003, AM J PATHOL, V162, P47, DOI 10.1016/S0002-9440(10)63797-2
   Fingerle-Rowson GR, 2001, IMMUNOL CELL BIOL, V79, P368, DOI 10.1046/j.1440-1711.2001.01024.x
   Funamizu N, 2013, INT J CANCER, V132, P785, DOI 10.1002/ijc.27736
   Gabitass RF, 2011, CANCER IMMUNOL IMMUN, V60, P1419, DOI 10.1007/s00262-011-1028-0
   Gasser S, 2005, NATURE, V436, P1186, DOI 10.1038/nature03884
   Gordon-Weeks AN, 2015, CYTOKINE GROWTH F R, V26, P451, DOI 10.1016/j.cytogfr.2015.03.002
   Gore Y, 2008, J BIOL CHEM, V283, P2784, DOI 10.1074/jbc.M703265200
   Gregory JL, 2004, ARTHRITIS RHEUM-US, V50, P3023, DOI 10.1002/art.20470
   Grieb G, 2010, DRUG NEWS PERSPECT, V23, P257, DOI 10.1358/dnp.2010.23.4.1453629
   Guo CQ, 2013, VASC CELL, V5, DOI 10.1186/2045-824X-5-20
   Guo Yong-Shun, 2011, Zhonghua Zhong Liu Za Zhi, V33, P28
   Hagemann T, 2007, MOL CANCER THER, V6, P1993, DOI 10.1158/1535-7163.MCT-07-0118
   Hanel W, 2012, J CELL BIOCHEM, V113, P433, DOI 10.1002/jcb.23400
   Hoi Alberta Y., 2007, Inflammation & Allergy Drug Targets, V6, P183, DOI 10.2174/187152807781696455
   Ichihara E, 2011, ACTA MED OKAYAMA, V65, P353
   Jung HY, 2008, J BIOL CHEM, V283, P20383, DOI 10.1074/jbc.M800050200
   Kleemann R, 1998, J MOL BIOL, V280, P85, DOI 10.1006/jmbi.1998.1864
   Krockenberger M, 2008, J IMMUNOL, V180, P7338, DOI 10.4049/jimmunol.180.11.7338
   Krockenberger M, 2010, J CANCER RES CLIN, V136, P651, DOI 10.1007/s00432-009-0702-5
   Landskron G, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/149185
   Lehmann LE, 2008, BIOFACTORS, V33, P281, DOI 10.1002/biof.5520330404
   Lerch JK, 2014, SEMIN IMMUNOL, V26, P409, DOI 10.1016/j.smim.2014.03.004
   Lolis E, 2003, EXPERT OPIN THER TAR, V7, P153, DOI 10.1517/14728222.7.2.153
   Lue H, 2007, ONCOGENE, V26, P5046, DOI 10.1038/sj.onc.1210318
   Lue HQ, 2002, MICROBES INFECT, V4, P449, DOI 10.1016/S1286-4579(02)01560-5
   Massirer KB, 2011, WIRES SYST BIOL MED, V3, P107, DOI 10.1002/wsbm.100
   Matsunaga J, 1999, CELL MOL BIOL, V45, P1035
   Mawhinney L, 2014, MOL MED, V20, P729, DOI 10.2119/molmed.2014.00136
   McClelland M, 2009, AM J PATHOL, V174, P638, DOI 10.2353/ajpath.2009.080463
   Meyer-Siegler KL, 2007, GENES IMMUN, V8, P646, DOI 10.1038/sj.gene.6364427
   Mitchell RA, 2004, CELL SIGNAL, V16, P13, DOI 10.1016/j.cellsig.2003.07.002
   Mittelbronn M, 2011, ACTA NEUROPATHOL, V122, P353, DOI 10.1007/s00401-011-0858-3
   Movahedi K, 2008, BLOOD, V111, P4233, DOI 10.1182/blood-2007-07-099226
   Nakaya K, 2012, ASIAN PAC J CANCER P, V13, P607, DOI 10.7314/APJCP.2012.13.2.607
   NISHINO T, 1995, MOL MED, V1, P781, DOI 10.1007/BF03401892
   Oda S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002215
   Onodera S, 2004, ARTHRITIS RHEUM-US, V50, P1437, DOI 10.1002/art.20190
   Pende D, 2002, CANCER RES, V62, P6178
   Ren Y, 2006, ONCOGENE, V25, P3501, DOI 10.1038/sj.onc.1209395
   Ren Y, 2005, ANN SURG, V242, P55, DOI 10.1097/01.sla.0000168555.97710.bb
   Ren Y, 2003, INT J CANCER, V107, P22, DOI 10.1002/ijc.11287
   Rendon BE, 2009, EXP MOL PATHOL, V86, P180, DOI 10.1016/j.yexmp.2009.01.001
   Richard V, 2015, INT J ONCOL, V47, P1627, DOI 10.3892/ijo.2015.3185
   Richard V, 2014, ONCOL REP, V32, P523, DOI 10.3892/or.2014.3272
   Rosengren E, 1996, MOL MED, V2, P143, DOI 10.1007/BF03402210
   Rosengren E, 1997, FEBS LETT, V417, P85, DOI 10.1016/S0014-5793(97)01261-1
   Santos LL, 2006, WIEN MED WOCHENSCHR, V156, P11, DOI 10.1007/s10354-005-0243-8
   Shen YC, 2012, DEV BIOL, V363, P84, DOI 10.1016/j.ydbio.2011.12.023
   Shi XR, 2006, IMMUNITY, V25, P595, DOI 10.1016/j.immuni.2006.08.020
   Siegler KLM, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-73
   Simpson KD, 2012, J IMMUNOL, V189, P5533, DOI 10.4049/jimmunol.1201161
   Sinha P, 2007, CANCER RES, V67, P4507, DOI 10.1158/0008-5472.CAN-06-4174
   SUZUKI M, 1994, J MOL BIOL, V235, P1141, DOI 10.1006/jmbi.1994.1063
   Takahashi N, 1998, MOL MED, V4, P707, DOI 10.1007/BF03401765
   Tanese K, 2015, J INVEST DERMATOL, V135, P2901, DOI 10.1038/jid.2015.259
   Tang Wei-min, 2011, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V27, P97
   Tarnowski M, 2010, MOL CANCER RES, V8, P1328, DOI 10.1158/1541-7786.MCR-10-0288
   Tillmann S, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00115
   Tong X, 2015, INT J CLIN EXP MED, V8, P15949
   Veillat V, 2010, J CLIN ENDOCR METAB, V95, pE403, DOI 10.1210/jc.2010-0417
   Verjans E, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-230
   Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147
   White ES, 2003, CLIN CANCER RES, V9, P853
   Wu SP, 2006, ARTHRITIS RHEUM-US, V54, P3661, DOI 10.1002/art.22179
   Wu SH, 2011, ONCOL LETT, V2, P1261, DOI 10.3892/ol.2011.409
   Yaddanapudi K, 2016, CANCER IMMUNOL RES, V4, P101, DOI 10.1158/2326-6066.CIR-15-0070-T
   Yaddanapudi K, 2013, J IMMUNOL, V190, P2984, DOI 10.4049/jimmunol.1201650
   Youn JI, 2008, J IMMUNOL, V181, P5791, DOI 10.4049/jimmunol.181.8.5791
   Zea AH, 2005, CANCER RES, V65, P3044, DOI 10.1158/0008-5472.CAN-04-4505
   Zhang XJ, 2013, INT J BIOL SCI, V9, P1108, DOI 10.7150/ijbs.7232
NR 93
TC 48
Z9 52
U1 1
U2 9
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1219-4956
EI 1532-2807
J9 PATHOL ONCOL RES
JI Pathol. Oncol. Res.
PD APR
PY 2017
VL 23
IS 2
BP 235
EP 244
DI 10.1007/s12253-016-0138-6
PG 10
WC Oncology; Pathology
SC Oncology; Pathology
GA ER7NQ
UT WOS:000399000200002
PM 27771887
DA 2020-11-30
ER

PT J
AU Cavalcante, GHO
   Araujo, CRD
   de Lima, FS
   Costa, MS
   Pereira, HWB
   de Souza, ID
   da Fonseca, JT
   Costa, SED
   Lanza, DCF
AF Oliveira Cavalcante, Gustavo Henrique
   de Freitas Araujo, Carla Rhuama
   de Lima, Felipe Sales
   Costa, Marcel Setubal
   Bezerra Pereira, Hannaly Wana
   de Souza, Iara Dantas
   da Fonseca, Jessyca Tamires
   de Lima Costa, Sara Ester
   Ferreira Lanza, Daniel Carlos
TI Medical Biochemistry - Clinical Cases
SO REVISTA DE ENSINO DE BIOQUIMICA
LA Portuguese
DT Article
DE Biomedicine; human health; application
AB The presentation of situations that exemplifies the practical application of the biochemical concepts is one of the main challenges in the development of didactic materials for the teaching of biochemistry. So far, there are a small number of materials, especially in Portuguese language, that present practical situations exemplifying the application of the several biochemical concepts in the area of human health. The Medical Biochemistry-Clinical Cases app/ebook is intended to enable the integrated vision of the basic knowledge in biochemistry and its practical application in day-to-day situations of human health professionals. The biochemical concepts are presented as clinical cases, making possible the exercise of the analytical attitude and decision-making to solve problems based on real situations. The app is available on the internet for free, facilitating both, the access and the use of the material as a supplementary source.
C1 [de Freitas Araujo, Carla Rhuama; de Lima, Felipe Sales; Costa, Marcel Setubal] Univ Fed Rio Grande do Norte, Biomed Sci, Natal, RN, Brazil.
   [Oliveira Cavalcante, Gustavo Henrique; Ferreira Lanza, Daniel Carlos] Univ Fed Rio Grande do Norte, Dept Biochem, Appl Mol Biol Lab, Natal, RN, Brazil.
   [Oliveira Cavalcante, Gustavo Henrique; da Fonseca, Jessyca Tamires; Ferreira Lanza, Daniel Carlos] Univ Fed Rio Grande do Norte, Grad Program Biochem, Natal, RN, Brazil.
   [Bezerra Pereira, Hannaly Wana; de Lima Costa, Sara Ester] Univ Fed Rio Grande do Norte, Grad Program Parasite Biol, Natal, RN, Brazil.
   [de Souza, Iara Dantas; Ferreira Lanza, Daniel Carlos] Univ Fed Rio Grande do Norte, Grad Program Bioinformat, Natal, RN, Brazil.
RP Cavalcante, GHO (corresponding author), Univ Fed Rio Grande do Norte, Dept Biochem, Appl Mol Biol Lab, Natal, RN, Brazil.; Cavalcante, GHO (corresponding author), Univ Fed Rio Grande do Norte, Grad Program Biochem, Natal, RN, Brazil.
EM gugahenriqe@gmail.com
CR Andrade PF, 2003, FORMACAO EDUCADORES
   Beckhauser PF, 2006, REV ENSINO BIOQUIM, V4, pB1
   Amaral CLC, 2006, REV ENSINO BIOQUIM, V4, pA1
   HAYDT Regina Celia, 2011, CURSO DIDATICA GERAL
   Yokaichiya DK, 2002, REV ENSINO BIOQUIMIC, V1, P12
NR 5
TC 0
Z9 0
U1 0
U2 0
PU SOC BRASILEIRA BIOQUIMICA & BIOLOGIA MOLECULAR
PI SAO PAULO
PA AV PROF LINEU PRESTES 748, BLOCO 3 SUPERIOR, SALA 0367, SAO PAULO,
   05513-970, BRAZIL
SN 2318-8790
J9 REV ENSINO BIOQUIM
JI Rev. Ensino Bioquim.
PY 2017
VL 15
SI SI
BP 31
EP 39
DI 10.16923/reb.v15i0.708
PG 9
WC Education, Scientific Disciplines
SC Education & Educational Research
GA FJ5CP
UT WOS:000412763300003
OA DOAJ Gold
DA 2020-11-30
ER

PT S
AU Lanza, D
   Chavez, F
   Fernandez, F
   Garcia-Valdez, M
   Trujillo, L
   Olague, G
AF Lanza, Daniel
   Chavez, F.
   Fernandez, Francisco
   Garcia-Valdez, M.
   Trujillo, Leonardo
   Olague, Gustavo
BE Schutze, O
   Trujillo, L
   Legrand, P
   Maldonado, Y
TI Profiting from Several Recommendation Algorithms Using a Scalable
   Approach
SO NEO 2015
SE Studies in Computational Intelligence
LA English
DT Proceedings Paper
CT Results of the Numerical and Evolutionary Optimization Workshop (NEO)
CY SEP 23-25, 2015
CL Instituto Tecnologico Tijuana, Tijuana, MEXICO
SP CINVESTAV IPN
HO Instituto Tecnologico Tijuana
ID FUZZY-SYSTEMS
AB This chapter proposes the use of a scalable platform to run a complex recommendation system. We focus on a system made up of several recommendation algorithms which are run as an offline process. This offline process generates user profiles that represent which algorithm should provide the recommendations to a given user and item, and will be combined with a fuzzy decision system to generate every recommendation. Yet, given the amount of data that will be processed and the need to run that offline process frequently, we propose to reduce execution time by using Hadoop, a scalable, distributed and fault-tolerant platform. Obtained results shows how the main goal pursued here is achieved: the efficient use of computer resources which allows for a significant reduction in computing time.
C1 [Lanza, Daniel] CERN, European Org Nucl Res, Geneva, Switzerland.
   [Chavez, F.; Fernandez, Francisco] Univ Extremadura, Badajoz, Spain.
   [Garcia-Valdez, M.; Trujillo, Leonardo] Inst Tecnol Tijuana, Tijuana, Baja California, Mexico.
   [Olague, Gustavo] Ctr Invest Cient & Educ Super Ensenada, Ensenada, Baja California, Mexico.
RP Lanza, D (corresponding author), CERN, European Org Nucl Res, Geneva, Switzerland.
EM daniel.lanza@cern.ch; fchavez@unex.es; fcofdez@unex.es;
   mario@tectijuana.edu.mx; leo@tectijuana.edu.mx; olague@cicese.mx
RI Trujillo, Leonardo/L-2939-2017; Garcia-Valdez, Mario/AAH-3864-2019;
   Olague, Gustavo/L-7795-2014; Garcia-Valdez, Mario/A-6738-2013; de la O,
   Francisco Chavez/H-3971-2011; de Vega, Francisco Fernandez/M-1385-2014
OI Trujillo, Leonardo/0000-0003-1812-5736; Garcia-Valdez,
   Mario/0000-0002-2593-1114; Olague, Gustavo/0000-0001-5773-9517;
   Garcia-Valdez, Mario/0000-0002-2593-1114; de la O, Francisco
   Chavez/0000-0002-9565-743X; 
FU ACoBSEC [612689]; Spanish Ministry of Economy [TIN2014-56494-C4-2-P];
   CDTI project Smart Cities & Mobile Technologies; Junta de Extremadura;
   FEDEREuropean Union (EU) [GR15068]; CONACyT MexicoConsejo Nacional de
   Ciencia y Tecnologia (CONACyT) [155045];  [DIMI-MCIM-004/08]
FX This work has been supported by FP7-PEOPLE-2013-IRSES, Grant 612689
   ACoBSEC, Spanish Ministry of Economy, Project UEX:EPHEMEC
   (TIN2014-56494-C4-2-P) and CDTI project Smart Cities & Mobile
   Technologies; Junta de Extremadura, and FEDER, project GR15068. It has
   also been supported by CONACyT Mexico by the project 155045 - "Evolucion
   de Cerebros Artificiales en Vision por Computadora" and TESE by the
   project DIMI-MCIM-004/08.
CR Aksel F., 2010, WORKSH PRACT US REC, P11
   Al-Shamri MYH, 2008, EXPERT SYST APPL, V35, P1386, DOI 10.1016/j.eswa.2007.08.016
   [Anonymous], 2015, DISTR SCAL FAULT TOL
   [Anonymous], 2000, ENCY LIB INFORM S32, V69, P180
   [Anonymous], AP TOMC IS OP SOURC
   [Anonymous], 2015, MAH MACH LEARN LIB B
   [Anonymous], 2015, HBASE DISTR SCAL DAT
   Bagchi S, 2015, PROCEDIA COMPUT SCI, V50, P229, DOI 10.1016/j.procs.2015.04.055
   Balabanovic M, 1997, COMMUN ACM, V40, P66, DOI 10.1145/245108.245124
   Bao X., 2009, RECSYS 09, P109
   Bell R.M., 2007, ASA STAT COMPUTING G, V18, P4
   Bellogin A., 2011, P 34 INT ACM SIGIR C, P1147, DOI DOI 10.1145/2009916.2010092
   Bennett J., 2007, P KDD CUP WORKSH, V2007, P35
   Billsus D, 2000, USER MODEL USER-ADAP, V10, P147, DOI 10.1023/A:1026501525781
   Bobadilla J, 2013, KNOWL-BASED SYST, V46, P109, DOI 10.1016/j.knosys.2013.03.012
   Burke R., 2007, The Adaptive Web. Methods and Strategies of Web Personalization, P377
   Burke R, 2002, USER MODEL USER-ADAP, V12, P331, DOI 10.1023/A:1021240730564
   Clemente E, 2015, APPL SOFT COMPUT, V32, P250, DOI 10.1016/j.asoc.2015.03.011
   Cordon O, 2001, JOINT 9TH IFSA WORLD CONGRESS AND 20TH NAFIPS INTERNATIONAL CONFERENCE, PROCEEDINGS, VOLS. 1-5, P1241, DOI 10.1109/NAFIPS.2001.943725
   CORDON O, 2001, EVOLUTIONARY TUNING
   de Campos LM, 2010, INT J APPROX REASON, V51, P785, DOI 10.1016/j.ijar.2010.04.001
   Dean J, 2004, USENIX ASSOCIATION PROCEEDINGS OF THE SIXTH SYMPOSIUM ON OPERATING SYSTEMS DESIGN AND IMPLEMENTATION (OSDE '04), P137
   Eyjolfsdottir EA, 2010, TECHNICAL REPORT
   Gacto MJ, 2014, INFORM SCIENCES, V276, P63, DOI 10.1016/j.ins.2014.02.047
   Garcia-Valdez M., 2010, IEEE INT C FUZZ SYST, P1, DOI DOI 10.1049/IET-C0M.2010.0654
   Girase S., 2015, ARXIV150306562
   Herrera F, 2008, EVOL INTELL, V1, P27, DOI 10.1007/s12065-007-0001-5
   Jing Jiang, 2011, Proceedings of the 2011 IEEE World Congress on Services (SERVICES 2011), P490, DOI 10.1109/SERVICES.2011.66
   Koren Y., 2009, NETFLIX PRIZE DOC, V81
   Leung CWK, 2008, KNOWL-BASED SYST, V21, P515, DOI 10.1016/j.knosys.2008.03.012
   Lu J, 2013, COMPUT INTELL-US, V29, P37, DOI 10.1111/j.1467-8640.2012.00427.x
   Owen S., 2011, MAHOUT ACTION
   Pandey S., 2014, INT J RES ENG TECHNO, V3, P39
   Pazzani M. J., 2007, The Adaptive Web. Methods and Strategies of Web Personalization, P325
   Pazzani MJ, 1999, ARTIF INTELL REV, V13, P393, DOI 10.1023/A:1006544522159
   Porcel C., SISTEMA RECOMENDACIO
   Sarwar Badrul, 2001, P 10 INT C WORLD WID, P285, DOI DOI 10.1145/371920.372071
   Schelter Sebastian, 2013, P 7 ACM C REC SYST R, P281, DOI DOI 10.1145/2507157.2507195
   Seminario C. E., 2012, WORKSH REC UT EV RMS
   Shih, 2005, P 38 ANN HAW INT C S, p217b
   Shvachko K., 2010, SYMPOSIUM, P1, DOI DOI 10.1109/MSST.2010.5496972
   Stigler SM, 1989, STAT SCI, V4, P73, DOI DOI 10.1214/SS/1177012580
   Su X., 2009, ADV ARTIF INTELL, V2009, P1, DOI DOI 10.1155/2009/421425
   VanSetten M., 2005, SUPPORTING PEOPLE FI
   Vinodhini S., 2014, INT J ENG RES TECHNO, V3
   Walunj S. G., 2013, P 2013 ANN C COMP PE, P153, DOI DOI 10.1145/2487294.2487328
   Wang L., 2010, CAMRA 2010
   Xu RZ, 2014, J SYST SOFTWARE, V95, P231, DOI 10.1016/j.jss.2014.04.045
   Zhang Z, 2013, INFORM SCIENCES, V235, P117, DOI 10.1016/j.ins.2013.01.025
NR 49
TC 1
Z9 1
U1 0
U2 0
PU SPRINGER INTERNATIONAL PUBLISHING AG
PI CHAM
PA GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND
SN 1860-949X
EI 1860-9503
BN 978-3-319-44003-3; 978-3-319-44002-6
J9 STUD COMPUT INTELL
PY 2017
VL 663
BP 357
EP 375
DI 10.1007/978-3-319-44003-3_14
PG 19
WC Computer Science, Artificial Intelligence; Computer Science, Theory &
   Methods
SC Computer Science
GA BI2AG
UT WOS:000407614300014
DA 2020-11-30
ER

PT J
AU Costa, MESM
   Oliveira, CBS
   Andrade, JMD
   Medeiros, TA
   Neto, VFA
   Lanza, DCF
AF Costa, Maria Eduarda S. M.
   Oliveira, Claudio Bruno S.
   Andrade, Joelma Maria de A.
   Medeiros, Thatiany A.
   Andrade Neto, Valter F.
   Lanza, Daniel C. F.
TI An alternative nested-PCR assay for the detection of Toxoplasma gondii
   strains based on GRA7 gene sequences
SO ACTA TROPICA
LA English
DT Article
DE Apicomplexa; Rhoptry; Dense granule protein 7; Toxoplasmosis; B1 gene;
   529 bp region
ID MOLECULAR DIAGNOSIS; HAMMONDIA-HAMMONDI; POLYMERASE; CHILDREN; MUSCLE
AB Toxoplasma gondii is a widespread parasite able to infect virtually any nucleated cells of warm-blooded hosts. In some cases, T. gondii detection using already developed PCR primers can be inefficient in routine laboratory tests, especially to detect atypical strains. Here we report a new nested-PCR protocol able to detect virtually all T. gondii isolates. Analyzing 685 sequences available in GenBank, we determine that GRA7 is one of the most conserved genes of T. gondii genome. Based on an alignment of 85 GRA7 sequences new primer sets that anneal in the highly conserved regions of this gene were designed. The new GRA7 nested-PCR assay providing sensitivity and specificity equal to or greater than the gold standard PCR assays for T. gondii detection, that amplify the B1 sequence or the repetitive 529 bp element. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Costa, Maria Eduarda S. M.; Lanza, Daniel C. F.] Univ Fed Rio Grande do Norte, Dept Bioquim, Lab Biol Mol Aplicada LAPLIC, BR-59072970 Natal, RN, Brazil.
   [Oliveira, Claudio Bruno S.; Andrade, Joelma Maria de A.; Medeiros, Thatiany A.; Andrade Neto, Valter F.] Univ Fed Rio Grande do Norte, Dept Microbiol & Parasitol, Lab Biol Malaria & Toxoplasmose, BR-59072970 Natal, RN, Brazil.
   [Costa, Maria Eduarda S. M.; Andrade Neto, Valter F.; Lanza, Daniel C. F.] Univ Fed Rio Grande do Norte, Programa Posgrad Biol Parasitaria, BR-59072970 Natal, RN, Brazil.
RP Lanza, DCF (corresponding author), Univ Fed Rio Grande do Norte, Dept Bioquim, Lab Biol Mol Aplicada LAPLIC, Ctr Biociencias, BR-59072970 Natal, RN, Brazil.
EM danielclanza@gmail.com
OI ANDRADE, JOELMA/0000-0001-7017-2420
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)CAPES
FX We would like to thank the Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior (CAPES) for financial support.
CR Carneiro ACAV, 2013, J CLIN MICROBIOL, V51, P901, DOI 10.1128/JCM.02502-12
   Ajioka JW, 1998, GENOME RES, V8, P18, DOI 10.1101/gr.8.1.18
   Canon-Franco WA, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-427
   Bastien P, 2002, T R SOC TROP MED HYG, V96, P205
   Benson DA, 2005, NUCLEIC ACIDS RES, V33, pD34, DOI 10.1093/nar/gki063
   Blackman MJ, 2001, MOL BIOCHEM PARASIT, V117, P11, DOI 10.1016/S0166-6851(01)00328-0
   BURG JL, 1989, J CLIN MICROBIOL, V27, P1787, DOI 10.1128/JCM.27.8.1787-1792.1989
   Cassaing S, 2006, J CLIN MICROBIOL, V44, P720, DOI 10.1128/JCM.44.3.720-724.2006
   Chatterton JMW, 2011, J MED MICROBIOL, V60, P1762, DOI 10.1099/jmm.0.032813-0
   Andrade MMC, 2013, RES VET SCI, V94, P587, DOI 10.1016/j.rvsc.2013.01.006
   Coppens I, 2006, CELL, V125, P261, DOI 10.1016/j.cell.2006.01.056
   DARDE ML, 1992, J PARASITOL, V78, P786, DOI 10.2307/3283305
   Delair E, 2011, OCUL IMMUNOL INFLAMM, V19, P91, DOI 10.3109/09273948.2011.564068
   Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340
   Fallahi S, 2014, PARASITOL INT, V63, P37, DOI 10.1016/j.parint.2013.08.005
   Ferguson DJP, 1999, PARASITOLOGY, V119, P259, DOI 10.1017/S0031182099004692
   FRENKEL JK, 1975, SCIENCE, V189, P222, DOI 10.1126/science.806116
   Homan WL, 2000, INT J PARASITOL, V30, P69, DOI 10.1016/S0020-7519(99)00170-8
   HOWE DK, 1995, J INFECT DIS, V172, P1561, DOI 10.1093/infdis/172.6.1561
   HUANG MM, 1992, NUCLEIC ACIDS RES, V20, P4567, DOI 10.1093/nar/20.17.4567
   Kompalic-Cristo A, 2004, T ROY SOC TROP MED H, V98, P92, DOI 10.1016/S0035-9203(03)00012-9
   Kong QM, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-2
   Lewis JM, 2015, RHEUMATOLOGY, V54, P1939, DOI 10.1093/rheumatology/kev115
   Rajendran C, 2012, INFECT GENET EVOL, V12, P359, DOI 10.1016/j.meegid.2011.12.010
   Reischl U, 2003, BMC INFECT DIS, V3, DOI 10.1186/1471-2334-3-7
   Robert-Gangneux F, 2012, CLIN MICROBIOL REV, V25, P264, DOI 10.1128/CMR.05013-11
   Silva LA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090237
   Stillwaggon E, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001333
   TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]
   Vallone PM, 2004, BIOTECHNIQUES, V37, P226, DOI 10.2144/04372ST03
   Wahab T, 2010, J CLIN MICROBIOL, V48, P591, DOI 10.1128/JCM.01113-09
   Wallon M, 2004, PEDIATRICS, V113, P1567, DOI 10.1542/peds.113.6.1567
   Walzer KA, 2013, P NATL ACAD SCI USA, V110, P7446, DOI 10.1073/pnas.1304322110
   Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134
NR 34
TC 6
Z9 6
U1 0
U2 7
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0001-706X
EI 1873-6254
J9 ACTA TROP
JI Acta Trop.
PD JUL
PY 2016
VL 159
BP 120
EP 124
DI 10.1016/j.actatropica.2016.03.035
PG 5
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA DN8DM
UT WOS:000377309400015
PM 27036222
OA Bronze
DA 2020-11-30
ER

PT J
AU Oliveira, CBS
   Meurer, YSR
   Andrade, JMA
   Costa, MESM
   Andrade, MMC
   Silva, LA
   Lanza, DCF
   Vitor, RWA
   Andrade-Neto, VF
AF Oliveira, Claudio B. S.
   Meurer, Ywlliane S. R.
   Andrade, Joelma M. A.
   Costa, Maria E. S. M.
   Andrade, Milena M. C.
   Silva, Leticia A.
   Lanza, Daniel C. F.
   Vitor, Ricardo W. A.
   Andrade-Neto, Valter F.
TI Pathogenicity and phenotypic sulfadiazine resistance of Toxoplasma
   gondii isolates obtained from livestock in northeastern Brazil
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE atypical profiles; pathogenicity; sulfadiazine-resistance; Toxoplasma
   gondii
ID CONGENITAL TOXOPLASMOSIS; GENETIC-CHARACTERIZATION; OCULAR
   TOXOPLASMOSIS; STRAINS; ANIMALS; IDENTIFICATION; DIVERSITY; INFECTION;
   GENOTYPES; CHICKENS
AB Toxoplasma gondii is the causative protozoan agent of toxoplasmosis, which is a common infection that is widely distributed worldwide. Studies revealed stronger clonal strains in North America and Europe and genetic diversity in South American strains. Our study aimed to differentiate the pathogenicity and sulfadiazine resistance of three T. gondii isolates obtained from livestock intended for human consumption. The cytopathic effects of the T. gondii isolates were evaluated. The pathogenicity was determined by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) using a CS3 marker and in a rodent model in vivo. Phenotypic sulfadiazine resistance was measured using a kinetic curve of drug activity in Swiss mice. IgM and IgG were measured by ELISA, and the dihydropteroate synthase (DHPS) gene sequence was analysed. The cytopathic effects and the PCR-RFLP profiles from chickens indicated a different infection source. The Ck3 isolate displayed more cytopathic effects in vitro than the Ck2 and ME49 strains. Additionally, the Ck2 isolate induced a differential humoral immune response compared to ME49. The Ck3 and Pg1 isolates, but not the Ck2 isolate, showed sulfadiazine resistance in the sensitivity assay. We did not find any DHPS gene polymorphisms in the mouse samples. These atypical pathogenicity and sulfadiazine resistance profiles were not previously reported and served as a warning to local health authorities.
C1 [Oliveira, Claudio B. S.; Meurer, Ywlliane S. R.; Andrade, Joelma M. A.; Andrade, Milena M. C.; Andrade-Neto, Valter F.] Univ Fed Rio Grande do Norte, Ctr Biociencias, Dept Microbiol & Parasitol, Lab Biol Malaria & Toxoplasmose, Natal, RN, Brazil.
   [Meurer, Ywlliane S. R.] Univ Fed Rio Grande do Norte, Ctr Biociencias, Dept Fisiol, Lab Estudos Memoria, Natal, RN, Brazil.
   [Andrade, Milena M. C.; Silva, Leticia A.; Vitor, Ricardo W. A.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Belo Horizonte, MG, Brazil.
   [Costa, Maria E. S. M.; Lanza, Daniel C. F.] Univ Fed Rio Grande do Norte, Ctr Biociencias, Dept Bioquim, Lab Biol Mol Aplicada, Natal, RN, Brazil.
RP Andrade-Neto, VF (corresponding author), Univ Fed Rio Grande do Norte, Ctr Biociencias, Dept Microbiol & Parasitol, Lab Biol Malaria & Toxoplasmose, Natal, RN, Brazil.
EM aneto@cb.ufrn.br
RI Meurer, Ywlliane/F-8112-2017; Vitor, Ricardo/B-8924-2013
OI Meurer, Ywlliane/0000-0003-0141-0880; Andrade Neto,
   Valter/0000-0002-9986-0865; ANDRADE, JOELMA/0000-0001-7017-2420
FU CNPqNational Council for Scientific and Technological Development (CNPq)
   [301837/2012-0, 471448/2013-3]; FAPEMIGMinas Gerais State Research
   Foundation (FAPEMIG) [APQ-00104-13]
FX CNPq (301837/2012-0 and 471448/2013-3), FAPEMIG (APQ-00104-13).
CR Carneiro ACAV, 2013, J CLIN MICROBIOL, V51, P901, DOI 10.1128/JCM.02502-12
   Alvarado-Esquivel C, 2011, EUR J MICROBIOL IMMU, V1, P249, DOI 10.1556/EuJMI.1.2011.3.9
   Alves CF, 2005, PARASITE, V12, P171, DOI 10.1051/parasite/2005122171
   Andrade HM, 2008, J PROTEOME RES, V7, P2357, DOI 10.1021/pr700659m
   Andrade RM, 2006, J CLIN INVEST, V116, P2366, DOI 10.1172/JCI28796
   Aspinall TV, 2002, INT J PARASITOL, V32, P1193, DOI 10.1016/S0020-7519(02)00070-X
   Aspinall TV, 2002, J INFECT DIS, V185, P1637, DOI 10.1086/340577
   Barbosa IR, 2009, T ROY SOC TROP MED H, V103, P377, DOI 10.1016/j.trstmh.2008.11.025
   Boughattas S, 2011, TROP BIOMED, V28, P615
   Andrade MMC, 2013, RES VET SCI, V94, P587, DOI 10.1016/j.rvsc.2013.01.006
   Cook AJC, 2000, BRIT MED J, V321, P142, DOI 10.1136/bmj.321.7254.142
   Doliwa C, 2013, INT J PARASITOL-DRUG, V3, P35, DOI 10.1016/j.ijpddr.2012.12.002
   Doliwa C, 2013, PARASITE, V20, DOI 10.1051/parasite/2013020
   Dubey JP, 2008, VET PARASITOL, V157, P299, DOI 10.1016/j.vetpar.2008.07.036
   Dubey J.P., 2010, TOXOPLASMOSIS ANIMAL
   Dubey JP, 2002, INT J PARASITOL, V32, P99, DOI 10.1016/S0020-7519(01)00364-2
   Dubey JP, 1998, CLIN MICROBIOL REV, V11, P267, DOI 10.1128/CMR.11.2.267
   Ferreira AD, 2006, INFECT GENET EVOL, V6, P22, DOI 10.1016/j.meegid.2004.12.004
   Halos L, 2010, INT J PARASITOL, V40, P193, DOI 10.1016/j.ijpara.2009.06.009
   HOWE DK, 1995, J INFECT DIS, V172, P1561, DOI 10.1093/infdis/172.6.1561
   Kaye A, 2011, J PEDIATR HEALTH CAR, V25, P355, DOI 10.1016/j.pedhc.2010.04.008
   Khan A, 2006, EMERG INFECT DIS, V12, P942, DOI 10.3201/eid1206.060025
   Khan A, 2011, INT J PARASITOL, V41, P645, DOI 10.1016/j.ijpara.2011.01.005
   Kijlstra A, 2008, INT J PARASITOL, V38, P1359, DOI 10.1016/j.ijpara.2008.06.002
   Kumar A, 2010, BRIT J CLIN PHARMACO, V70, P609, DOI 10.1111/j.1365-2125.2010.03716.x
   Lang C, 2006, MICROBES INFECT, V8, P1994, DOI 10.1016/j.micinf.2006.02.031
   Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502
   Mendes NHD, 2014, T ROY SOC TROP MED H, V108, P656, DOI 10.1093/trstmh/tru113
   Meneceur P, 2008, ANTIMICROB AGENTS CH, V52, P1269, DOI 10.1128/AAC.01203-07
   Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X
   Oliveira CBS, 2014, MOLECULES, V19, P5898, DOI 10.3390/molecules19055898
   Pena HFJ, 2008, INT J PARASITOL, V38, P561, DOI 10.1016/j.ijpara.2007.09.004
   Ragozo AMA, 2010, VET PARASITOL, V170, P307, DOI 10.1016/j.vetpar.2010.02.024
   Silva LA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090237
   Su C, 2003, SCIENCE, V299, P414, DOI 10.1126/science.1078035
   Su C, 2010, PARASITOLOGY, V137, P1, DOI 10.1017/S0031182009991065
   Sukthana Y, 2006, TRENDS PARASITOL, V22, P137, DOI 10.1016/j.pt.2006.01.007
   Tenter AM, 2000, INT J PARASITOL, V30, P1217, DOI 10.1016/S0020-7519(00)00124-7
   Vaillant V, 2005, FOODBORNE PATHOG DIS, V2, P221, DOI 10.1089/fpd.2005.2.221
   Wang T, 2011, EXP PARASITOL, V127, P107, DOI 10.1016/j.exppara.2010.07.003
NR 40
TC 10
Z9 12
U1 0
U2 9
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PD JUN
PY 2016
VL 111
IS 6
BP 391
EP 398
DI 10.1590/0074-02760150459
PG 8
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA DQ0LC
UT WOS:000378889800006
PM 27276184
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Dantas, MDA
   Cavacante, GHO
   Oliveira, RAC
   Lanza, DCF
AF Dantas, Marcia Danielle A.
   Cavacante, Gustavo Henrique O.
   Oliveira, Raffael A. C.
   Lanza, Daniel C. F.
TI New insights about ORF1 coding regions support the proposition of a new
   genus comprising arthropod viruses in the family Totiviridae
SO VIRUS RESEARCH
LA English
DT Article
DE Infectious myonecrosis virus; Giardia lamblia virus; Drosophila
   melanogaster virus; Armigeres subalbatus virus; Double strand RNA
   viruses
ID INFECTIOUS MYONECROSIS VIRUS; MULTIPLE SEQUENCE ALIGNMENT;
   PROTEIN-STRUCTURE; CRYSTAL-STRUCTURE; RNA-BINDING; I-TASSER; REVEALS;
   MOSQUITOS; HOMOLOGY; CLEAVAGE
AB Analyzing the positions of 2A-like polypeptide cleavage sites in all available genomes of arthropod totiviruses we propose the limits of all ORF1 coding sequences and observed that two proteins previously predicted in infectious myonecrosis virus genome are unique in the arthropod totiviruses group. A putative protein cleavage site upstream the major capsid protein was also identified only in these genomes. In addition, protein models generated using ab initio and threading approaches revealed conserved structures possibly related to formation of viral protrusions and RNA packaging, clarifying the mechanisms involved in the extracellular transmission. These data appoints that the group formed by arthropod totiviruses are sufficient distinctive to be clustered in new genus belonging to the Totiviridae family, in agreement with previous phylogenetic analysis. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Dantas, Marcia Danielle A.; Cavacante, Gustavo Henrique O.; Lanza, Daniel C. F.] Univ Fed Rio Grande do Norte, Lab Biol Mol Aplicada, Dept Bioquim, BR-59072970 Natal, RN, Brazil.
   [Dantas, Marcia Danielle A.; Oliveira, Raffael A. C.; Lanza, Daniel C. F.] Univ Fed Rio Grande do Norte, Programa Posgrad Bioquim, BR-59072970 Natal, RN, Brazil.
RP Lanza, DCF (corresponding author), Univ Fed Rio Grande do Norte, Ctr Biociencias, Dept Bioquim, Lab Biol Mol Aplicada LAPLIC, BR-59072970 Natal, RN, Brazil.
EM danielclanza@gmail.com
RI Oliveira, Raffael AC/C-9624-2016
OI Oliveira, Raffael AC/0000-0001-9353-4113
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES)CAPES; CAPESCAPES
FX We would like to thank Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior (CAPES) for financial support. M.D.A. Dantas was
   supported by a scholarship from CAPES.
CR Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770
   BYCROFT M, 1995, EMBO J, V14, P3563, DOI 10.1002/j.1460-2075.1995.tb07362.x
   Chandran K, 2001, J VIROL, V75, P5335, DOI 10.1128/JVI.75.11.5335-5342.2001
   Chappell JD, 2002, EMBO J, V21, P1, DOI 10.1093/emboj/21.1.1
   Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073
   Dantas MDA, 2015, VIRUS RES, V203, P66, DOI 10.1016/j.virusres.2015.03.015
   Dong JH, 2011, P NATL ACAD SCI USA, V108, P12681, DOI 10.1073/pnas.1104834108
   Donnelly MLL, 2001, J GEN VIROL, V82, P1027, DOI 10.1099/0022-1317-82-5-1027
   Doronina VA, 2008, MOL CELL BIOL, V28, P4227, DOI 10.1128/MCB.00421-08
   Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340
   Fauquet CM, 2005, VIRUS TAXONOMY CLASS, P571
   Haugland O, 2011, J VIROL, V85, P5275, DOI 10.1128/JVI.02154-10
   Isawa H, 2011, VIRUS RES, V155, P147, DOI 10.1016/j.virusres.2010.09.013
   King AMQ, 2012, VIRUS TAXONOMY, V9
   Luke G.A., 2014, RECENT RES DEV VIROL, V9, P25
   Merckel MC, 2005, MOL CELL, V18, P161, DOI 10.1016/j.molcel.2005.03.019
   Nagata T, 2012, PROTEINS, V80, P1699, DOI 10.1002/prot.24059
   Nanduri S, 1998, EMBO J, V17, P5458, DOI 10.1093/emboj/17.18.5458
   Nibert ML, 2007, J GEN VIROL, V88, P1315, DOI 10.1099/vir.0.82681-0
   Nibert ML, 2013, CURR OPIN VIROL, V3, P20, DOI 10.1016/j.coviro.2012.10.006
   Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042
   Oliveira RAC, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-243
   PALMENBERG AC, 1992, VIROLOGY, V190, P754, DOI 10.1016/0042-6822(92)90913-A
   PERSSON R, 1991, J CELL BIOL, V112, P257, DOI 10.1083/jcb.112.2.257
   Poulos BT, 2006, J GEN VIROL, V87, P987, DOI 10.1099/vir.0.81127-0
   Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537
   Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5
   SCHEFFTER SM, 1995, VIROLOGY, V212, P84, DOI 10.1006/viro.1995.1456
   Settembre EC, 2011, EMBO J, V30, P408, DOI 10.1038/emboj.2010.322
   Stefl R, 2006, STRUCTURE, V14, P345, DOI 10.1016/j.str.2005.11.013
   Tang JH, 2008, P NATL ACAD SCI USA, V105, P17526, DOI 10.1073/pnas.0806724105
   Tang KFJ, 2005, DIS AQUAT ORGAN, V63, P261, DOI 10.3354/dao063261
   van Raaij MJ, 1999, NATURE, V401, P935, DOI 10.1038/44880
   Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033
   Wu QF, 2010, P NATL ACAD SCI USA, V107, P1606, DOI 10.1073/pnas.0911353107
   Xing L, 2014, BBA-GEN SUBJECTS, V1840, P2234, DOI 10.1016/j.bbagen.2014.04.003
   Yang XL, 2012, ARCH VIROL, V157, P1093, DOI 10.1007/s00705-012-1278-y
   YEAGER M, 1994, EMBO J, V13, P1011, DOI 10.1002/j.1460-2075.1994.tb06349.x
   Zhai Y, 2010, J GEN VIROL, V91, P2836, DOI 10.1099/vir.0.024794-0
   Zhang X, 2005, VIROLOGY, V343, P25, DOI 10.1016/j.virol.2005.08.002
   Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40
NR 41
TC 10
Z9 10
U1 0
U2 10
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0168-1702
EI 1872-7492
J9 VIRUS RES
JI Virus Res.
PD JAN 4
PY 2016
VL 211
BP 159
EP 164
DI 10.1016/j.virusres.2015.10.020
PG 6
WC Virology
SC Virology
GA CY5JI
UT WOS:000366443500022
PM 26497779
OA Bronze
DA 2020-11-30
ER

PT S
AU Chavez, F
   Fernandez, F
   Benavides, C
   Lanza, D
   Villegas, J
   Trujillo, L
   Olague, G
   Roman, G
AF Chavez, Francisco
   Fernandez, Francisco
   Benavides, Cesar
   Lanza, Daniel
   Villegas, Juan
   Trujillo, Leonardo
   Olague, Gustavo
   Roman, Graciela
BE Squillero, G
   Burelli, P
TI ECJ plus HADOOP: An Easy Way to Deploy Massive Runs of Evolutionary
   Algorithms
SO APPLICATIONS OF EVOLUTIONARY COMPUTATION, EVOAPPLICATIONS 2016, PT II
SE Lecture Notes in Computer Science
LA English
DT Proceedings Paper
CT 19th European Conference on the Applications of Evolutionary Computation
   (EvoApplications)
CY MAR 30-APR 01, 2016
CL Porto, PORTUGAL
SP Edinburgh Napier Univ, Inst Informat & Digital Innovat, EvoCOMNET Track, World Federat Soft Comp, Camara Municipal Porto, Turismo Porto, Univ Coimbra
DE Multi-objective evolutionary algorithm; Face recognition; Hadoop; ECJ
ID FACE DETECTION; MAPREDUCE
AB This paper describes initial steps towards allowing Evolutionary Algorithms (EAs) researchers to easily deploy computing intensive runs of EAs on Big Data infrastructures. Although many proposals have already been described in the literature, and a number of new software tools have been implemented embodying parallel versions of EAs, we present here a different approach. Given traditional resistance to change when adopting new software, we try instead to endow the well known ECJ tool with the MapReduce model. By using the Hadoop framework, we introduce changes in ECJ that allow researchers to launch any EA problem on a big data infrastructure similarly as when a single computer is used to run the algorithm. By means of a new parameter, researchers can choose where the run will be launched, whether in a Hadoop based infrastructure or in a desktop computer. This paper shows the tests performed, how the whole system has been tuned to optimize the running time for ECJ experiments, and finally a realworld problem is shown to describe how the MapReduce model can automatically deploy the tasks generated by ECJ without additional intervention.
C1 [Chavez, Francisco; Fernandez, Francisco] Univ Extremadura, Dept Comp Sci, C Santa Teresa Jornet 38, Merida 06800, Spain.
   [Benavides, Cesar; Roman, Graciela] Univ Autonoma Metropolitana, Dept Ingn Elect, San Rafael Atlixco 186, Mexico City 09340, DF, Mexico.
   [Lanza, Daniel] European Org Nucl Res, CERN, Meyrin, Switzerland.
   [Villegas, Juan] Univ Autonoma Metropolitana, Dept Elect, Av San Pablo Xalpa 180, Mexico City 02200, DF, Mexico.
   [Trujillo, Leonardo] Inst Tecnol Tijuana, Calzada Tecnol S-N, Tijuana 22414, BC, Mexico.
   [Olague, Gustavo] CICESE, Carretera Ensenada Tijuana 3918, Ensenada 22860, BC, Mexico.
RP Chavez, F (corresponding author), Univ Extremadura, Dept Comp Sci, C Santa Teresa Jornet 38, Merida 06800, Spain.
EM Chavez.fchavez@unex.es
RI de Vega, Francisco Fernandez/M-1385-2014; Cortez, Juan
   Villegas/O-8143-2019; Olague, Gustavo/L-7795-2014; Trujillo,
   Leonardo/L-2939-2017
OI Cortez, Juan Villegas/0000-0001-8918-1044; Olague,
   Gustavo/0000-0001-5773-9517; Trujillo, Leonardo/0000-0003-1812-5736
FU FP7-PEOPLE-2013-IRSES [612689 ACoBSEC]; Spanish Ministry of Economy,
   Project UEX:EPHEMEC [TIN2014-56494-C4-2-P]; Junta de Extremadura;
   FEDEREuropean Union (EU) [GR15068]; CONACyT MexicoConsejo Nacional de
   Ciencia y Tecnologia (CONACyT) [155045]; TESE [DIMI-MCIM-004/08]
FX This work has been supported by FP7-PEOPLE-2013-IRSES, Grant 612689
   ACoBSEC, Spanish Ministry of Economy, Project UEX:EPHEMEC
   (TIN2014-56494-C4-2-P); Junta de Extremadura, and FEDER, project
   GR15068. Also it has been supported by CONACyT Mexico by the project
   155045 - "Evolucion de Cerebros Artificiales en Vision por Computadora"
   and TESE by the project DIMI-MCIM-004/08.
CR Benavides C., 2015, P MAEB 2015 MER SPAI, P733
   Cantu-Paz E., 2011, GENETIC ALGORITHMS E, V1
   Dean J, 2004, USENIX ASSOCIATION PROCEEDINGS OF THE SIXTH SYMPOSIUM ON OPERATING SYSTEMS DESIGN AND IMPLEMENTATION (OSDE '04), P137
   Dean J, 2010, COMMUN ACM, V53, P72, DOI 10.1145/1629175.1629198
   Du X, 2013, INT J COMPUT APPL T, V46, P290, DOI 10.1504/IJCAT.2013.052807
   Fernandez F., 1999, Recent Advances in Parallel Virtual Machine and Message Passing Interface. 6th European PVM/MPI User's Group Meeting. Proceedings (Lecture Notes in Computer Science Vol.1697), P241
   Fernandez F., GENET PROGRAM EVOLVA, V4, P21
   Fernndez de Vega F., 2014, RES COMPUTING SCI, P120
   Garcia M., 2013, LNCS, P499, DOI DOI 10.1007/978-3-642-37192-9
   González Alejandro, 2010, Rev. ing. univ. Medellín, V9, P139
   Hsu RL, 2002, IEEE T PATTERN ANAL, V24, P696, DOI 10.1109/34.1000242
   Jain A. K., 2010, DISTINGUISHED LECT S
   Koza JR, 1992, GENETIC PROGRAMMING, V1
   Laredo JLJ, 2010, GENET PROGRAM EVOL M, V11, P227, DOI 10.1007/s10710-009-9096-z
   Li FF, 2007, COMPUT VIS IMAGE UND, V106, P59, DOI 10.1016/j.cviu.2005.09.012
   Gonzalez DL, 2009, EUROMICRO WORKSHOP P, P419, DOI [10.1109/.24, 10.1109/PDP.2009.25]
   Melab N., J PARALLEL DISTRIB C, V66, P1052
   Sherry Dylan, 2012, Applications of Evolutionary Computation. Proceedings of EvoApplications 2012: EvoCOMNET, EvoCOMPLEX, EvoFIN, EvoGAMES, EvoHOT, EvoIASP, EvoNUM, EvoPAR, EvoRISK, EvoSTIM, and EvoSTOC, P477, DOI 10.1007/978-3-642-29178-4_48
   Shvachko K, 2010, IEEE S MASS STOR SYS
   Stelzer D., 1998, Software Process Improvement and Practice, V4, P227, DOI 10.1002/(SICI)1099-1670(199812)4:4<227::AID-SPIP106>3.3.CO;2-T
   Tomassini M., 2013, P 2013 IEEE INT C CL, P209
   Wagner A, 2012, IEEE T PATTERN ANAL, V34, P372, DOI 10.1109/TPAMI.2011.112
   White T., 2009, HADOOP DEFINITIVE GU
   Yang MH, 2002, IEEE T PATTERN ANAL, V24, P34, DOI 10.1109/34.982883
   Zhang L, 2011, IEEE I CONF COMP VIS, P471, DOI 10.1109/ICCV.2011.6126277
   Zhang Z, 2014, INT SYM COMPUT INTEL, DOI 10.1109/ISCID.2014.195
   Zhao W, 2003, ACM COMPUT SURV, V35, P399, DOI 10.1145/954339.954342
   Zhu XX, 2012, PROC CVPR IEEE, P2879, DOI 10.1109/CVPR.2012.6248014
   2015, OPTIK INT J LIGHT EL, V126, P3227, DOI DOI 10.1016/J.IJLEO.2015.07.080
NR 29
TC 2
Z9 2
U1 0
U2 0
PU SPRINGER INTERNATIONAL PUBLISHING AG
PI CHAM
PA GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND
SN 0302-9743
EI 1611-3349
BN 978-3-319-31153-1
J9 LECT NOTES COMPUT SC
PY 2016
VL 9598
BP 91
EP 106
DI 10.1007/978-3-319-31153-1_7
PG 16
WC Computer Science, Artificial Intelligence; Computer Science,
   Interdisciplinary Applications; Computer Science, Theory & Methods
SC Computer Science
GA BM6WQ
UT WOS:000467438600007
DA 2020-11-30
ER

PT J
AU Dantas, MDA
   Chavante, SF
   Teixeira, DIA
   Lima, JPMS
   Lanza, DCF
AF Dantas, Marcia Danielle A.
   Chavante, Suely F.
   Teixeira, Darlio Inacio A.
   Lima, Joao Paulo M. S.
   Lanza, Daniel C. F.
TI Analysis of new isolates reveals new genome organization and a
   hypervariable region in infectious myonecrosis virus (IMNV)
SO VIRUS RESEARCH
LA English
DT Article
DE IMNV Brazil; Hypervariable region; dsRNA virus; Shrimp diseases; IRES
ID RIBOSOME ENTRY SITE; SPIKE PROTEIN; AMINO-ACIDS; GIARDIAVIRUS;
   IDENTIFICATION; TRANSLATION; SHRIMP; ATTACHMENT; PREDICTION; SEQUENCES
AB Infectious myonecrosis virus (IMNV) has been the cause of many losses in shrimp farming since 2002, when the first myonecrosis outbreak was reported at Brazilian's northeast coast. Two additional genomes of Brazilian IMNV isolates collected in 2009 and 2013 were sequenced and analyzed in the present study. The sequencing revealed extra 643 bp and 22 bp, at 5' and 3' ends of IMNV genome respectively, confirming that its actual size is at least 8226 bp long. Considering these additional sequences in genome extremities, ORF1 can starts at nt 470, encoding a 1708 aa polyprotein. Computational predictions reveal two stem loops and two pseudoknots in the 5' end and a putative stem loop and a slippery motif located at 3' end, indicating that these regions can be involved in the start and termination of translation. Through a careful phylogenetic analysis, a higher genetic variability among Brazilian isolates could be observed, comparing with Indonesian IMNV isolates. It was also observed that the most variable region of IMNV genome is located in the first half of ORF1, coinciding with a region which probably encodes the capsid protrusions. The results presented here are a starting point to elucidate the viral's translational regulation and the mechanisms involved in virulence. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Dantas, Marcia Danielle A.; Lanza, Daniel C. F.] Univ Fed Rio Grande do Norte, Lab Biol Mol Aplicada, BR-59072970 Natal, RN, Brazil.
   [Dantas, Marcia Danielle A.; Chavante, Suely F.; Lima, Joao Paulo M. S.; Lanza, Daniel C. F.] Univ Fed Rio Grande do Norte, Programa Posgrad Bioquim, BR-59072970 Natal, RN, Brazil.
   [Teixeira, Darlio Inacio A.] Univ Fed Rio Grande do Norte, Escola Agr Jundiai, Macaiba, RN, Brazil.
   [Lima, Joao Paulo M. S.] Univ Fed Rio Grande do Norte, Lab Sistemas Metab & Bioinformat, BR-59072970 Natal, RN, Brazil.
RP Lanza, DCF (corresponding author), Univ Fed Rio Grande do Norte, Ctr Biociencias, Dept Bioquim, Lab Biol Mol Aplicada LAPLIC, BR-59072970 Natal, RN, Brazil.
EM danielclanza@gmail.com
CR Andrade TPD, 2007, AQUACULTURE, V264, P9, DOI 10.1016/j.aquaculture.2006.11.030
   Anjum S, 2013, J INFECT DIS, V208, P1888, DOI 10.1093/infdis/jit376
   Baird SD, 2006, RNA, V12, P1755, DOI 10.1261/rna.157806
   BAYLISS CD, 1990, J GEN VIROL, V71, P1303, DOI 10.1099/0022-1317-71-6-1303
   BRIERLEY I, 1989, CELL, V57, P537, DOI 10.1016/0092-8674(89)90124-4
   CARPENTER S, 1991, J VIROL, V65, P1605, DOI 10.1128/JVI.65.3.1605-1610.1991
   CAVANAGH D, 1988, VIRUS RES, V11, P141, DOI 10.1016/0168-1702(88)90039-1
   Chappell JD, 2002, EMBO J, V21, P1, DOI 10.1093/emboj/21.1.1
   Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214
   Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075
   Garlapati S, 2005, EUKARYOT CELL, V4, P742, DOI 10.1128/EC.4.4.742-754.2005
   Garlapati S, 2004, J BIOL CHEM, V279, P3389, DOI 10.1074/jbc.M307565200
   Garlapati S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007435
   Gonzalez-Candelas F, 2013, BRENNERS ENCY GENETI, P603
   Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188
   Hellen CUT, 2001, GENE DEV, V15, P1593, DOI 10.1101/gad.891101
   Huang CH, 2005, BIOINFORMATICS, V21, P3501, DOI 10.1093/bioinformatics/bti568
   Katoh K, 2012, BIOINFORMATICS, V28, P3144, DOI 10.1093/bioinformatics/bts578
   Katoh K, 2010, BIOINFORMATICS, V26, P1899, DOI 10.1093/bioinformatics/btq224
   Lanza D.C.F., 2008, PROTEINS, P104
   Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404
   Lee DK, 2010, VIRUS RES, V149, P175, DOI 10.1016/j.virusres.2010.01.015
   Lightner DV, 2011, J INVERTEBR PATHOL, V106, P110, DOI 10.1016/j.jip.2010.09.012
   Lightner D.V., 2004, GLOB AQUAC ADVOCATE, V7, P85
   Liu HQ, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-91
   Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26
   Ma MX, 2013, VIRUS RES, V176, P78, DOI 10.1016/j.virusres.2013.04.018
   Mitraki A, 1999, EUR J BIOCHEM, V264, P599, DOI 10.1046/j.1432-1327.1999.00683.x
   Naim S, 2014, VIRUS RES, V189, P97, DOI 10.1016/j.virusres.2014.05.013
   Nibert ML, 2007, J GEN VIROL, V88, P1315, DOI 10.1099/vir.0.82681-0
   Nunes A.J. P., 2004, PANORAMA AQUICULT, V83, P37
   Oliveira RAC, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-243
   Poulos BT, 2006, J GEN VIROL, V87, P987, DOI 10.1099/vir.0.81127-0
   Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537
   Promkuntod N, 2014, VIROLOGY, V448, P26, DOI 10.1016/j.virol.2013.09.018
   Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377
   Sato K, 2011, BIOINFORMATICS, V27, pI85, DOI 10.1093/bioinformatics/btr215
   Senapin S, 2007, AQUACULTURE, V266, P32, DOI 10.1016/j.aquaculture.2007.02.026
   SOMOGYI P, 1993, MOL CELL BIOL, V13, P6931, DOI 10.1128/MCB.13.11.6931
   Sperschneider J, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq021
   Stoneley M, 2004, ONCOGENE, V23, P3200, DOI 10.1038/sj.onc.1207551
   TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]
   Tang JH, 2008, P NATL ACAD SCI USA, V105, P17526, DOI 10.1073/pnas.0806724105
   WANG AL, 1993, P NATL ACAD SCI USA, V90, P8595, DOI 10.1073/pnas.90.18.8595
   Yu DC, 1996, RNA, V2, P824
   Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595
NR 46
TC 6
Z9 6
U1 0
U2 13
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0168-1702
EI 1872-7492
J9 VIRUS RES
JI Virus Res.
PD MAY 4
PY 2015
VL 203
BP 66
EP 71
DI 10.1016/j.virusres.2015.03.015
PG 6
WC Virology
SC Virology
GA CL2AO
UT WOS:000356746200010
PM 25849112
DA 2020-11-30
ER

PT J
AU Silva, DCD
   Nunes, ARD
   Teixeira, DIA
   Lima, JPMS
   Lanza, DCF
AF Silva, Douglas C. D.
   Nunes, Allan R. D.
   Teixeira, Darlio I. A.
   Lima, Joao Paulo M. S.
   Lanza, Daniel C. F.
TI Infectious hypodermal and hematopoietic necrosis virus from Brazil:
   Sequencing, comparative analysis and PCR detection
SO VIRUS RESEARCH
LA English
DT Article
DE Shrimp nanism; White Spot Syndrome; Penaeus stitlirostris densovirus;
   Brevidensovirus
ID PENAEUS-STYLIROSTRIS DENSOVIRUS; GENOMIC ORGANIZATION;
   NUCLEOTIDE-SEQUENCE; IHHN VIRUS; SHRIMP; PARVOVIRUS; PREVALENCE;
   ALIGNMENT; VANNAMEI; MONODON
AB A 3739 nucleotide fragment of Infectious hypodermal and hematopoietic necrosis virus (IHHNV) from Brazil was amplified and sequenced. This fragment contains the entire coding sequences of viral proteins, the full 3' untranslated region (3'UTR) and a partial sequence of 5' untranslated region (5'UTR). The genome organization of IHHNV revealed the three typical major coding domains: a left ORF1 of 2001 bp that codes NS1, a left ORF2 (NS2) of 1091 bp that codes NS2 and a right ORF3 of 990 bp that codes VP. Nucleotide and amino acid sequences of the three viral proteins were compared with putative amino acid sequences of viruses reported from different regions. Comparisons among genomes from different geographic locations reveal 31 nucleotide regions that are 100% similar, distributed throughout the genome. An analysis of secondary structure of UTR regions, revealed regions with high probability to form hairpins, that may be involved in mechanisms of viral replication. Additionally, a maximum likelihood analysis indicates that Brazilian IHHNV belongs to lineage III, in the infectious IHHNV group, and is clustered with IHHNV isolates from Hawaii, China, Taiwan, Vietnam and South Korea. A new nested PCR targeting conserved nucleotide regions is proposed to detect IHHNV. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Silva, Douglas C. D.; Nunes, Allan R. D.; Lanza, Daniel C. F.] Univ Fed Rio Grande do Norte, Ctr Biociencias, Dept Bioquim, Lab Biol Mol Aplicada LAPLIC, BR-59072970 Natal, RN, Brazil.
   [Lima, Joao Paulo M. S.] Univ Fed Rio Grande do Norte, Dept Bioquim, Lab Glicobiol Mol, BR-59072970 Natal, RN, Brazil.
   [Teixeira, Darlio I. A.] Univ Fed Rio Grande do Norte, Escola Agr Jundiai, BR-59072970 Natal, RN, Brazil.
   [Lima, Joao Paulo M. S.] Univ Fed Rio Grande do Norte, Programa Posgrad Bioquim, BR-59072970 Natal, RN, Brazil.
RP Lanza, DCF (corresponding author), Univ Fed Rio Grande do Norte, Ctr Biociencias, Dept Bioquim, Lab Biol Mol Aplicada LAPLIC, BR-59072970 Natal, RN, Brazil.
EM danielclanza@gmail.com
RI Lima, Joao Paulo/G-4023-2014
OI Lima, Joao Paulo/0000-0002-6113-8834
FU CAPESCAPES; FAPERN
FX We would like to thank CAPES and FAPERN for financial support and the
   company Camanor for providing shrimp samples used in this study.
CR AFANASIEV BN, 1991, VIROLOGY, V185, P323, DOI 10.1016/0042-6822(91)90780-F
   Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389
   BELL TA, 1984, AQUACULTURE, V38, P185, DOI 10.1016/0044-8486(84)90142-X
   BOUBLIK Y, 1994, VIROLOGY, V200, P752, DOI 10.1006/viro.1994.1239
   Brock J.A., 1983, P 71 INT COUNC EXPL
   BROWDY CL, 1993, J CRUSTACEAN BIOL, V13, P87, DOI 10.2307/1549124
   Cotmore Susan F., 2006, V47, P593
   Dhar AK, 2001, J CLIN MICROBIOL, V39, P2835, DOI 10.1128/JCM.39.8.2835-2845.2001
   Braz RDD, 2009, AQUACULTURE, V288, P143, DOI 10.1016/j.aquaculture.2008.11.021
   Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340
   Fauquet C. M., 2005, 8 INT COMM TAX VIR
   Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188
   HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694
   Kalagayan G., 1991, J WORLD AQUACULT SOC, V22, P235, DOI DOI 10.1111/J.1749-7345.1991.TB00740.X
   Kaufmann B, 2010, J VIROL, V84, P11289, DOI 10.1128/JVI.01240-10
   Kim JH, 2012, ARCH VIROL, V157, P369, DOI 10.1007/s00705-011-1155-0
   Kim JH, 2011, AQUACULTURE, V313, P161, DOI 10.1016/j.aquaculture.2011.01.019
   Krabsetsve K, 2004, DIS AQUAT ORGAN, V61, P153, DOI 10.3354/dao061153
   Kraft JJ, 2013, NUCLEIC ACIDS RES, V41, P3398, DOI 10.1093/nar/gkt026
   Li L, 2013, J VIROL, V87, P10501, DOI 10.1128/JVI.01393-13
   Lightner DV, 2011, J INVERTEBR PATHOL, V106, P110, DOI 10.1016/j.jip.2010.09.012
   Lightner D.V., 1983, CRC HDB MARICULTURE, V1, P289
   Lightner D.V., 1988, DIS DIAGNOSIS CONTRO, P8
   MARI J, 1993, J GEN VIROL, V74, P2637, DOI 10.1099/0022-1317-74-12-2637
   Morales-Covarrubias MS, 1999, J AQUAT ANIM HEALTH, V11, P296, DOI 10.1577/1548-8667(1999)011&lt;0296:POIHAH&gt;2.0.CO;2
   Nunan LM, 2000, MAR BIOTECHNOL, V2, P319
   OIE, 2000, DIAGN MAN AQ AN DIS
   OIE (Office International des Epizooties), 2003, MAN DIAGN TESTS AQ A, P4
   Pollom E, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003294
   Primavera JH, 2000, J CRUSTACEAN BIOL, V20, P796, DOI 10.1651/0278-0372(2000)020[0796:RDSICG]2.0.CO;2
   Rai P, 2011, VIRUS RES, V158, P37, DOI 10.1016/j.virusres.2011.03.005
   Rai P, 2009, AQUACULTURE, V295, P168, DOI 10.1016/j.aquaculture.2009.07.015
   Robles-Sikisaka R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011799
   Shike H, 2000, VIROLOGY, V277, P167, DOI 10.1006/viro.2000.0589
   TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]
   Tang KFJ, 2007, DIS AQUAT ORGAN, V74, P165, DOI 10.3354/dao074165
   Tang KFJ, 2006, VIRUS RES, V118, P185, DOI 10.1016/j.virusres.2006.01.003
   Tang KFJ, 2000, AQUACULTURE, V190, P203, DOI 10.1016/S0044-8486(00)00407-5
   Tang KFJ, 2003, DIS AQUAT ORGAN, V53, P91, DOI 10.3354/dao053091
   Tang KFJ, 2002, DIS AQUAT ORGAN, V49, P93, DOI 10.3354/dao049093
   TATTERSALL P, 1976, NATURE, V263, P106, DOI 10.1038/263106a0
   Teixeira-Lopes MA, 2011, AQUACULTURE, V312, P212, DOI 10.1016/j.aquaculture.2011.01.005
   Trindade I.M.S., 2009, PRIMEIRO REGISTRO OF
   Vega-Heredia S, 2012, TRANSBOUND EMERG DIS, V59, P95, DOI 10.1111/j.1865-1682.2011.01249.x
   Wang YYE, 2009, J VIROL, V83, P1845, DOI 10.1128/JVI.01061-08
   Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033
   Yang B, 2007, VET MICROBIOL, V120, P63, DOI 10.1016/j.vetmic.2006.10.011
NR 47
TC 5
Z9 9
U1 0
U2 11
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0168-1702
EI 1872-7492
J9 VIRUS RES
JI Virus Res.
PD AUG 30
PY 2014
VL 189
BP 136
EP 146
DI 10.1016/j.virusres.2014.05.008
PG 11
WC Virology
SC Virology
GA AO7UI
UT WOS:000341557700021
PM 24867614
DA 2020-11-30
ER

PT J
AU Oliveira, RAC
   Almeida, RVM
   Dantas, MDA
   Castro, FN
   Lima, JPMS
   Lanza, DCF
AF Oliveira, Raffael A. C.
   Almeida, Ricardo V. M.
   Dantas, Marcia D. A.
   Castro, Felipe N.
   Lima, Joao Paulo M. S.
   Lanza, Daniel C. F.
TI In silico single strand melting curve: a new approach to identify
   nucleic acid polymorphisms in Totiviridae
SO BMC BIOINFORMATICS
LA English
DT Article
DE RNA secondary structure; Infectious Myonecrosis Virus; high resolution
   melting curve; Virus detection; IHHNV; WSSV; Trichomonas
ID REAL-TIME PCR; BAYESIAN PHYLOGENETIC INFERENCE; SECONDARY STRUCTURE
   PREDICTION; BLOOD-CULTURE BOTTLES; RESOLUTION; SEQUENCE; VIRUS; ASSAY;
   IDENTIFICATION; SIMULATION
AB Background: The PCR technique and its variations have been increasingly used in the clinical laboratory and recent advances in this field generated new higher resolution techniques based on nucleic acid denaturation dynamics. The principle of these new molecular tools is based on the comparison of melting profiles, after denaturation of a DNA double strand. Until now, the secondary structure of single-stranded nucleic acids has not been exploited to develop identification systems based on PCR. To test the potential of single-strand RNA denaturation as a new alternative to detect specific nucleic acid variations, sequences from viruses of the Totiviridae family were compared using a new in silico melting curve approach. This family comprises double-stranded RNA virus, with a genome constituted by two ORFs, ORF1 and ORF2, which encodes the capsid/RNA binding proteins and an RNA-dependent RNA polymerase (RdRp), respectively.
   Results: A phylogenetic tree based on RdRp amino acid sequences was constructed, and eight monophyletic groups were defined. Alignments of RdRp RNA sequences from each group were screened to identify RNA regions with conserved secondary structure. One region in the second half of ORF2 was identified and individually modeled using the RNAfold tool. Afterwards, each DNA or RNA sequence was denatured in silico using the softwares MELTSIM and RNAheat that generate melting curves considering the denaturation of a double stranded DNA and single stranded RNA, respectively. The same groups identified in the RdRp phylogenetic tree were retrieved by a clustering analysis of the melting curves data obtained from RNAheat. Moreover, the same approach was used to successfully discriminate different variants of Trichomonas vaginalis virus, which was not possible by the visual comparison of the double stranded melting curves generated by MELTSIM.
   Conclusion: In silico analysis indicate that ssRNA melting curves are more informative than dsDNA melting curves. Furthermore, conserved RNA structures may be determined from analysis of individuals that are phylogenetically related, and these regions may be used to support the reconstitution of their phylogenetic groups. These findings are a robust basis for the development of in vitro systems to ssRNA melting curves detection.
C1 [Oliveira, Raffael A. C.; Dantas, Marcia D. A.; Castro, Felipe N.; Lanza, Daniel C. F.] Univ Fed Rio Grande do Norte, Ctr Biociencias, Dept Bioquim, Lab Biol Mol Aplicada LAPLIC, BR-59072970 Natal, RN, Brazil.
   [Almeida, Ricardo V. M.; Lima, Joao Paulo M. S.] Univ Fed Rio Grande do Norte, Dept Bioquim, Lab Glicobiol Mol, BR-59072970 Natal, RN, Brazil.
   [Almeida, Ricardo V. M.] Univ Fed Rio Grande do Norte, Programa Posgrad Sistemt Evol, BR-59072970 Natal, RN, Brazil.
   [Dantas, Marcia D. A.] Univ Fed Rio Grande do Norte, Programa Posgrad Bioquim, BR-59072970 Natal, RN, Brazil.
   [Lima, Joao Paulo M. S.; Lanza, Daniel C. F.] Univ Fed Rio Grande do Norte, Inst Trop Med Rio Grande Norte IMT RN, BR-59072970 Natal, RN, Brazil.
RP Lanza, DCF (corresponding author), Univ Fed Rio Grande do Norte, Ctr Biociencias, Dept Bioquim, Lab Biol Mol Aplicada LAPLIC, BR-59072970 Natal, RN, Brazil.
EM danielclanza@gmail.com
RI Castro, Felipe/AAL-9749-2020; Oliveira, Raffael AC/C-9624-2016; Lima,
   Joao Paulo/G-4023-2014
OI Oliveira, Raffael AC/0000-0001-9353-4113; Lima, Joao
   Paulo/0000-0002-6113-8834
FU Coordenacao de Aperfeicoamento Pessoal de Nivel Superior (CAPES)CAPES;
   Fundacao Apoio a Pesquisa do RN (FAPERN)
FX The authors wish to thank Coordenacao de Aperfeicoamento Pessoal de
   Nivel Superior (CAPES) and Fundacao Apoio a Pesquisa do RN (FAPERN) for
   financial support. R. V. M. Almeida and M. D. A. Dantas have master's
   scholarship from (CAPES). The authors are also grateful to two anonymous
   reviewers for valuable comments and suggestions that helped to improve
   the manuscript.
CR Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263
   Bellaousov S, 2013, NUCLEIC ACIDS RES, V41, pW471, DOI 10.1093/nar/gkt290
   Bergeron E, 2012, J VIROL, V86, P10759, DOI 10.1128/JVI.01144-12
   Bessarab IN, 2011, ARCH VIROL, V156, P285, DOI 10.1007/s00705-010-0858-y
   Blake RD, 1999, BIOINFORMATICS, V15, P370, DOI 10.1093/bioinformatics/15.5.370
   Bruenn JA, 2003, NUCLEIC ACIDS RES, V31, P1821, DOI 10.1093/nar/gkg277
   Cousins MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051359
   Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214
   Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075
   Dwight Z, 2011, BIOINFORMATICS, V27, P1019, DOI 10.1093/bioinformatics/btr065
   Dwight ZL, 2012, IEEE ACM T COMPUT BI, V9, P1805, DOI 10.1109/TCBB.2012.112
   Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113
   Erali M, 2010, METHODS, V50, P250, DOI 10.1016/j.ymeth.2010.01.013
   Espy MJ, 2006, CLIN MICROBIOL REV, V19, P165, DOI 10.1128/CMR.19.1.165-256.2006
   Esteban DJ, 2014, VIRUS GENES, V48, P38, DOI 10.1007/s11262-013-0983-2
   Flores R, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00217
   Ghabrial SA, 2009, ARCH VIROL, V154, P373, DOI 10.1007/s00705-008-0272-x
   Gundry CN, 2008, NUCLEIC ACIDS RES, V36, P3401, DOI 10.1093/nar/gkn204
   Hill T., 1956, STAT MECH
   HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163
   Hofacker IL, 2002, J MOL BIOL, V319, P1059, DOI 10.1016/S0022-2836(02)00308-X
   Ising E, 1925, Z PHYS, V31, P253, DOI 10.1007/BF02980577
   Jeng K, 2012, J CLIN MICROBIOL, V50, P3287, DOI 10.1128/JCM.00677-12
   Katoh K, 2012, BIOINFORMATICS, V28, P3144, DOI 10.1093/bioinformatics/bts578
   Katoh K, 2010, BIOINFORMATICS, V26, P1899, DOI 10.1093/bioinformatics/btq224
   Katsanis SH, 2013, NAT REV GENET, V14, P415, DOI 10.1038/nrg3493
   King AMQ, 2012, MOST RECENT REPORT I
   Li BS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028078
   Liew M, 2004, CLIN CHEM, V50, P1156, DOI 10.1373/clinchem.2004.032136
   Liu HQ, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-91
   LOK ASF, 1994, P NATL ACAD SCI USA, V91, P4077, DOI 10.1073/pnas.91.9.4077
   Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26
   Lusvarghi S, 2013, NUCLEIC ACIDS RES, V41, P6637, DOI 10.1093/nar/gkt353
   Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189
   Mathews DH, 2004, P NATL ACAD SCI USA, V101, P7287, DOI 10.1073/pnas.0401799101
   MCCASKILL JS, 1990, BIOPOLYMERS, V29, P1105, DOI 10.1002/bip.360290621
   Mercer TR, 2013, NAT STRUCT MOL BIOL, V20, P300, DOI 10.1038/nsmb.2480
   Montgomery J, 2007, CLIN CHEM, V53, P1891, DOI 10.1373/clinchem.2007.092361
   Munro SB, 2013, J CLIN MICROBIOL, V51, P1124, DOI 10.1128/JCM.03113-12
   Nguyen-Dumont T, 2009, HUM MUTAT, V30, P884, DOI 10.1002/humu.20949
   Porcellato D, 2012, LETT APPL MICROBIOL, V54, P344, DOI 10.1111/j.1472-765X.2012.03210.x
   Poulos BT, 2006, J GEN VIROL, V87, P987, DOI 10.1099/vir.0.81127-0
   R. Development Core Team, 2008, R LANG ENV STAT COMP
   Rasmussen JP, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-107
   Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180
   Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029
   Rouleau E, 2009, HUM MUTAT, V30, P867, DOI 10.1002/humu.20947
   Shao Y, 2007, RNA, V13, P1631, DOI 10.1261/rna.546207
   Smith BL, 2010, MOL ECOL RESOUR, V10, P193, DOI 10.1111/j.1755-0998.2009.02726.x
   TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]
   Tan X, 2012, P NATL ACAD SCI USA, V109, P869, DOI 10.1073/pnas.1119873109
   Turner DH, 2010, NUCLEIC ACIDS RES, V38, pD280, DOI 10.1093/nar/gkp892
   Tycowski KT, 2012, CELL REP, V2, P26, DOI 10.1016/j.celrep.2012.05.020
   WARTELL RM, 1985, PHYS REP, V126, P67, DOI 10.1016/0370-1573(85)90060-2
   Washietl S, 2005, P NATL ACAD SCI USA, V102, P2454, DOI 10.1073/pnas.0409169102
   Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033
   Wittwer CT, 2003, CLIN CHEM, V49, P853, DOI 10.1373/49.6.853
   Wittwer CT, 1997, BIOTECHNIQUES, V22, P130, DOI 10.2144/97221bi01
   Won H, 2010, J CLIN MICROBIOL, V48, P3410, DOI 10.1128/JCM.00718-10
   Zhai Y, 2010, J GEN VIROL, V91, P2836, DOI 10.1099/vir.0.024794-0
   ZUKER M, 1999, RNA BIOCH BIOTECHNOL
NR 61
TC 4
Z9 4
U1 0
U2 9
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2105
J9 BMC BIOINFORMATICS
JI BMC Bioinformatics
PD JUL 16
PY 2014
VL 15
AR 243
DI 10.1186/1471-2105-15-243
PG 14
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Mathematical & Computational Biology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Mathematical & Computational Biology
GA AM0IN
UT WOS:000339528100001
PM 25030031
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Lanza, LNM
   Lanza, DCF
   Sodek, L
AF Menolli Lanza, Luciana Nunes
   Ferreira Lanza, Daniel Carlos
   Sodek, Ladaslav
TI Utilization of (NO3)-N-15 (-) by nodulated soybean plants under
   conditions of root hypoxia
SO PHYSIOLOGY AND MOLECULAR BIOLOGY OF PLANTS
LA English
DT Article
ID NITRATE REDUCTION; OXYGEN DEFICIENCY; BARLEY ROOTS; NITROGEN
   ASSIMILATION; ANAEROBIC GERMINATION; TOMATO ROOTS; AMINO-ACIDS; XYLEM
   SAP; NITRITE; METABOLISM
AB Waterlogging of soils is common in nature. The low availability of oxygen under these conditions leads to hypoxia of the root system impairing the development and productivity of the plant. The presence of nitrate under flooding conditions is regarded as being beneficial towards tolerance to this stress. However, it is not known how nodulated soybean plants, cultivated in the absence of nitrate and therefore not metabolically adapted to this compound, would respond to nitrate under root hypoxia in comparison with non-nodulated plants grown on nitrate. A study was conducted with N-15 labelled nitrate supplied on waterlogging for a period of 48 h using both nodulated and non-nodulated plants of different physiological ages. Enrichment of N was found in roots and leaves with incorporation of the isotope in amino acids, although to a much smaller degree under hypoxia than normoxia. This demonstrates that nitrate is taken up under hypoxic conditions and assimilated into amino acids, although to a much lesser extent than for normoxia. The similar response obtained with nodulated and non-nodulated plants indicates the rapid metabolic adaptation of nodulated plants to the presence of nitrate under hypoxia. Enrichment of N in nodules was very much weaker with a distinct enrichment pattern of amino acids (especially asparagine) suggesting that labelling arose from a tissue source external to the nodule rather than through assimilation in the nodule itself.
RP Sodek, L (corresponding author), Univ Estadual Campinas, Dept Biol Vegetal, BR-13083862 Campinas, SP, Brazil.
EM lsodek@unicamp.br
RI Sodek, Ladaslav/J-7621-2012
OI Sodek, Ladaslav/0000-0003-2908-2954
CR Allegre A, 2004, J EXP BOT, V55, P2625, DOI 10.1093/jxb/erh258
   Amarante L, 2006, BIOL PLANTARUM, V50, P405, DOI 10.1007/s10535-006-0057-6
   ARMSTRONG W, 1994, ACTA BOT NEERL, V43, P307
   ATKINS CA, 1990, PLANTA, V182, P565, DOI 10.1007/BF02341033
   ATKINS CA, 1988, PLANT PHYSIOL, V86, P204, DOI 10.1104/pp.86.1.204
   Bailey-Serres J, 2008, ANNU REV PLANT BIOL, V59, P313, DOI 10.1146/annurev.arplant.59.032607.092752
   Barrie A., 1996, MASS SPECTROMETRY SO, P1
   BECANA M, 1989, PLANTA, V180, P40, DOI 10.1007/BF02411408
   Botrel A, 1996, PLANT PHYSIOL BIOCH, V34, P645
   Brandão Andrea D., 2009, Braz. J. Plant Physiol., V21, P13, DOI 10.1590/S1677-04202009000100003
   BUWALDA F, 1989, NEW PHYTOL, V111, P161, DOI 10.1111/j.1469-8137.1989.tb00677.x
   de Sousa C. A. F., 2002, Physiology and Molecular Biology of Plants, V8, P97
   GARCIANOVO F, 1973, NEW PHYTOL, V72, P1031, DOI 10.1111/j.1469-8137.1973.tb02079.x
   GLAAB J, 1993, PLANTA, V191, P173, DOI 10.1007/BF00199747
   Godber IM, 1998, PLANT CELL ENVIRON, V21, P1089, DOI 10.1046/j.1365-3040.1998.00346.x
   Gupta KJ, 2011, PLANT SCI, V181, P520, DOI 10.1016/j.plantsci.2011.03.018
   Hoagland D. R, 1938, CALIFORNIA AGR EXP S, V347, P1, DOI DOI 10.1017/CBO9781107415324.004
   Horchani F, 2010, ACTA PHYSIOL PLANT, V32, P1113, DOI 10.1007/s11738-010-0503-0
   Igamberdiev AU, 2004, J EXP BOT, V55, P2473, DOI 10.1093/jxb/erh272
   Izmailov SF, 2003, BIOL BULL+, V30, P140, DOI 10.1023/A:1023237205432
   LEE RB, 1978, J EXP BOT, V29, P693, DOI 10.1093/jxb/29.3.693
   LEE RB, 1979, J EXP BOT, V30, P119, DOI 10.1093/jxb/30.1.119
   Libourel IGL, 2006, PLANT PHYSIOL, V142, P1710, DOI 10.1104/pp.106.088898
   Lima JD, 2003, PLANT SCI, V165, P649, DOI 10.1016/S0168-9452(03)00251-6
   MALAVOLTA E, 1954, PLANT PHYSIOL, V29, P98, DOI 10.1104/pp.29.1.98
   Lanza LNM, 2013, BRAGANTIA, V72, P2, DOI 10.1590/S0006-87052013005000011
   Morard P, 2004, J PLANT PHYSIOL, V161, P855, DOI 10.1016/j.jplph.2003.11.003
   Norris D. O., 1976, Tropical Pasture Research. Principles and Methods. (Shaw, N.H.; Bryan, W.W.; Editors)., P134
   Oliveira HC, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.23578
   Oliveira HC, 2013, PLANT PHYSIOL BIOCH, V66, P141, DOI 10.1016/j.plaphy.2013.02.015
   Oliveira HC, 2013, PLANTA, V237, P255, DOI 10.1007/s00425-012-1773-0
   Oliveira HC, 2013, AMINO ACIDS, V44, P743, DOI 10.1007/s00726-012-1399-3
   REGGIANI R, 1993, PLANT CELL PHYSIOL, V34, P379
   Reggiani R, 1997, AMINO ACIDS, V13, P183, DOI 10.1007/BF01373216
   Reggiani R, 1995, AMINO ACIDS, V9, P385, DOI 10.1007/BF00807275
   RITCHIE S, 1982, 53 IOW STAT U SCI TE
   SPRENT JI, 1987, J EXP BOT, V38, P1121, DOI 10.1093/jxb/38.7.1121
   Stoimenova M, 2007, PLANTA, V226, P465, DOI 10.1007/s00425-007-0496-0
   Thomas André Luís, 2005, Braz. J. Plant Physiol., V17, P291, DOI 10.1590/S1677-04202005000300003
   TROUGHT MCT, 1981, J EXP BOT, V32, P509, DOI 10.1093/jxb/32.3.509
NR 40
TC 6
Z9 6
U1 0
U2 6
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0971-5894
EI 0974-0430
J9 PHYSIOL MOL BIOL PLA
JI Physiol. Mol. Biol. Plants
PD JUL
PY 2014
VL 20
IS 3
BP 287
EP 293
DI 10.1007/s12298-014-0241-7
PG 7
WC Plant Sciences
SC Plant Sciences
GA AM5KB
UT WOS:000339895700002
PM 25049455
OA Green Published
DA 2020-11-30
ER

PT J
AU Meirelles, GV
   Lanza, DCF
   da Silva, JC
   Bernachi, JS
   Leme, AFP
   Kobarg, J
AF Meirelles, Gabriela Vaz
   Ferreira Lanza, Daniel Carlos
   da Silva, Julio Cesar
   Bernachi, Jessica Santana
   Paes Leme, Adriana Franco
   Kobarg, Jorg
TI Characterization of hNek6 Interactome Reveals an Important Role for Its
   Short N-Terminal Domain and Colocalization with Proteins at the
   Centrosome
SO JOURNAL OF PROTEOME RESEARCH
LA English
DT Article
DE Nek6; N-terminal domain; kinome network; hubs; centrosome; signal
   transduction; carcinogenesis
ID NIMA-RELATED KINASES; COILED-COIL REGION; INTERACTION NETWORK; FAMILY
   KINASE; SUBSTRATE-SPECIFICITY; MITOTIC PROGRESSION; INTRINSIC DISORDER;
   BREAST-CARCINOMA; COMPLEX NETWORKS; 2-HYBRID SYSTEM
AB Physical protein protein interactions are fundamental to all biological processes and are organized in complex networks One branch of the kinome network is the evolutionarily conserved NIMA-related serine/threonine kinases (Neks) Most of the 11 mammalian Neks studied so far are related to cell cycle regulation and due to association with diverse human pathologies, Neks are promising chemotherapeutic targets Human Nek6 was associated to carcinogenesis but its interacting partners and signaling pathways remain elusive Here we introduce hNek6 as a highly connected member in the human kinase interactome In a more global context, we performed a broad data bank comparison based on degree distribution analysis and found that the human kinome is enriched in hubs Our networks include a broad set of novel hNek6 interactors as identified by our yeast two hybrid screens classified into 18 functional categories All of the tested interactions were confirmed and the majority of tested substrates were phosphorylated in vitro by hNek6 Notably, we found that hNek6 N-terminal is important to mediate the interactions with its partners Some novel interactors also colocalized with hNek6 and gamma-tubulin in human cells, pointing to a possible centrosomal interaction The interacting proteins link hNek6 to novel pathways, for example, Notch signaling and actin cytoskeleton regulation, or give new insights on how hNek6 may regulate previously proposed pathways such as cell cycle regulation, DNA repair response, and NF-kappa B signaling Our findings open new perspectives in the study of hNek6 role in cancer by analyzing its novel interactions in specific pathways in tumor cells which may provide important implications for drug design and cancer therapy
C1 [Kobarg, Jorg] Ctr Nacl Pesquisa Energia & Mat, Lab Nacl Biociencias, BR-13084971 Campinas, SP, Brazil.
   [Meirelles, Gabriela Vaz; Ferreira Lanza, Daniel Carlos; Kobarg, Jorg] Univ Estadual Campinas, Inst Biol, Programa Posgrad Biol Func & Mol, Dept Bioquim, Campinas, SP, Brazil.
   [da Silva, Julio Cesar] Lab Nacl Luz Sincrotron, Campinas, SP, Brazil.
   [da Silva, Julio Cesar] Univ Estadual Campinas, Inst Fis Gleb Wataghin, Campinas, SP, Brazil.
RP Kobarg, J (corresponding author), Ctr Nacl Pesquisa Energia & Mat, Lab Nacl Biociencias, Rua Giuseppe Maximo Scolfaro 10 000,C P 6192, BR-13084971 Campinas, SP, Brazil.
RI Leme, Adriana F Paes/C-9679-2012; da Silva, Julio Cesar/A-5240-2011;
   Kobarg, Jorg/T-4736-2019; Meirelles, Gabriela Vaz/H-4151-2013
OI Leme, Adriana F Paes/0000-0001-7959-147X; da Silva, Julio
   Cesar/0000-0001-8035-0550; Kobarg, Jorg/0000-0002-9419-0145; Meirelles,
   Gabriela Vaz/0000-0003-4371-0419
FU Fundacao de Amparo a Pesquisa do Estado Sao Paulo (FAPESP)Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Conselho Nacional de
   Pesquisa e Desenvolvimento (CNPq)National Council for Scientific and
   Technological Development (CNPq); Associacao Brasileira de Tecnologia de
   Luz Sincrotron (ABTLuS)
FX We thank Maria Eugenia Camargo, Thais C D Dombroski, Bianca A Pauletti,
   Carla C Judice, Jackeline de Lima, and Janine S Sabino for technical
   assistance We are also grateful to Dr Kleber G Franchini for help m
   providing the THP1 cells, and to Dr Sara T O Saad for the use of the
   confocal microscope This work was supported by Fundacao de Amparo a
   Pesquisa do Estado Sao Paulo (FAPESP), Conselho Nacional de Pesquisa e
   Desenvolvimento (CNPq), and the Associacao Brasileira de Tecnologia de
   Luz Sincrotron (ABTLuS)
CR Ahmed S, 2009, NAT GENET, V41, P585, DOI 10.1038/ng.354
   Albers M, 2005, MOL CELL PROTEOMICS, V4, P205, DOI 10.1074/mcp.M400169-MCP200
   Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47
   Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019
   Ameri K, 2004, BLOOD, V103, P1876, DOI 10.1182/blood-2003-06-1859
   Ameri K, 2008, INT J BIOCHEM CELL B, V40, P14, DOI 10.1016/j.biocel.2007.01.020
   Assmann EM, 2006, J BIOL CHEM, V281, P9869, DOI 10.1074/jbc.M513280200
   Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272
   Barabasi AL, 2003, SCI AM, V288, P60, DOI 10.1038/scientificamerican0503-60
   Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509
   BARTEL PL, 1995, METHOD ENZYMOL, V254, P241
   Baschal EE, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-32
   Belham C, 2003, J BIOL CHEM, V278, P34897, DOI 10.1074/jbc.M303663200
   Bi MX, 2005, EMBO J, V24, P3470, DOI 10.1038/sj.emboj.7600777
   Bowers AJ, 2004, GENE, V328, P135, DOI 10.1016/j.gene.2003.12.002
   Capra M, 2006, CANCER RES, V66, P8147, DOI 10.1158/0008-5472.CAN-05-3489
   Chen D, 2007, ONCOGENE, V26, P5029, DOI 10.1038/sj.onc.1210327
   Chen J, 2006, BIOCHEM BIOPH RES CO, V341, P1059, DOI 10.1016/j.bbrc.2005.12.228
   Chen YM, 2008, CELL CYCLE, V7, P3194, DOI 10.4161/cc.7.20.6815
   Chiang SH, 2003, EMBO J, V22, P2679, DOI 10.1093/emboj/cdg262
   CHIEN CT, 1991, P NATL ACAD SCI USA, V88, P9578, DOI 10.1073/pnas.88.21.9578
   Dunker AK, 2005, FEBS J, V272, P5129, DOI 10.1111/j.1742-4658.2005.04948.x
   Dunker AK, 2002, BIOCHEMISTRY-US, V41, P6573, DOI 10.1021/bi012159+
   Ekman D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-6-r45
   Erdos P, 1959, PUBL MATH-DEBRECEN, V6, P290, DOI DOI 10.2307/1999405
   Ewing RM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100134
   Fletcher L, 2005, BBA-MOL CELL RES, V1744, P89, DOI 10.1016/j.bbamcr.2005.01.007
   Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299
   Ge H, 2001, NAT GENET, V29, P482, DOI 10.1038/ng776
   Ge H, 2003, TRENDS GENET, V19, P551, DOI 10.1016/j.tig.2003.08.009
   Hahn A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-112
   Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509
   Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555
   Hanna SL, 2000, MICROBIOL-UK, V146, P2495, DOI 10.1099/00221287-146-10-2495
   Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540
   Hong ZH, 2008, NUCLEIC ACIDS RES, V36, P2939, DOI 10.1093/nar/gkn146
   Hsieh JJD, 1999, P NATL ACAD SCI USA, V96, P23, DOI 10.1073/pnas.96.1.23
   Hunter T, 2000, CELL, V100, P113, DOI 10.1016/S0092-8674(00)81688-8
   Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138
   Kim HJ, 1999, MOL CELL BIOL, V19, P6323
   Kodani A, 2009, MOL BIOL CELL, V20, P1192, DOI 10.1091/mbc.E08-08-0834
   Kunin V, 2004, MOL BIOL EVOL, V21, P1171, DOI 10.1093/molbev/msh085
   Lee HK, 2004, GENOME RES, V14, P1085, DOI 10.1101/gr.1910904
   Lee MY, 2008, CELL CYCLE, V7, P2705, DOI 10.4161/cc.7.17.6551
   Lee REC, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-271
   Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403
   Liu SM, 2002, DEVELOPMENT, V129, P5839, DOI 10.1242/dev.00173
   Lizcano JM, 2002, J BIOL CHEM, V277, P27839, DOI 10.1074/jbc.M202042200
   LU KP, 1994, J BIOL CHEM, V269, P6603
   Mahjoub MR, 2005, J AM SOC NEPHROL, V16, P3485, DOI 10.1681/ASN.2005080824
   Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762
   Masaki M, 2003, EUR J BIOCHEM, V270, P76, DOI 10.1046/j.1432-1033.2003.03363.x
   Matsuda A, 2003, ONCOGENE, V22, P3307, DOI 10.1038/sj.onc.1206406
   McHale K, 2008, MODERN PATHOL, V21, P565, DOI 10.1038/modpathol.2008.7
   Melixetian M, 2009, NAT CELL BIOL, V11, P1247, DOI 10.1038/ncb1969
   Nassirpour R, 2010, MOL CANCER RES, V8, P717, DOI 10.1158/1541-7786.MCR-09-0291
   Noguchi K, 2004, J BIOL CHEM, V279, P32716, DOI 10.1074/jbc.M404104200
   O'Regan L, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-25
   O'Regan L, 2009, MOL CELL BIOL, V29, P3975, DOI 10.1128/MCB.01867-08
   Pugh DJR, 2006, BMC STRUCT BIOL, V6, DOI 10.1186/1472-6807-6-1
   Roig J, 2005, MOL BIOL CELL, V16, P4827, DOI 10.1091/mbc.E05-04-0315
   Roig J, 2002, GENE DEV, V16, P1640, DOI 10.1101/gad.972202
   Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209
   Simons A, 1997, ONCOGENE, V14, P145, DOI 10.1038/sj.onc.1200825
   Sonoda E, 2001, DEV CELL, V1, P759, DOI 10.1016/S1534-5807(01)00088-0
   Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029
   Surpili MJ, 2003, BIOCHEMISTRY-US, V42, P15369, DOI 10.1021/bi034575v
   Takeno A, 2008, BRIT J CANCER, V99, P1307, DOI 10.1038/sj.bjc.6604682
   Tsunoda N, 2009, CANCER SCI, V100, P111, DOI 10.1111/j.1349-7006.2008.01007.x
   Upadhya P, 2000, P NATL ACAD SCI USA, V97, P217, DOI 10.1073/pnas.97.1.217
   VOJTEK AB, 1995, METHOD ENZYMOL, V255, P331
   Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002
   Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918
   Yin MJ, 2003, J BIOL CHEM, V278, P52454, DOI 10.1074/jbc.M308080200
   Yissachar N, 2006, FEBS LETT, V580, P6489, DOI 10.1016/j.febslet.2006.10.069
   Yoshitake Y, 2004, CLIN CANCER RES, V10, P6437, DOI 10.1158/1078-0432.CCR-04-0841
   Zhou SF, 2000, MOL CELL BIOL, V20, P2400, DOI 10.1128/MCB.20.7.2400-2410.2000
NR 77
TC 20
Z9 35
U1 1
U2 6
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1535-3893
J9 J PROTEOME RES
JI J. Proteome Res.
PD DEC
PY 2010
VL 9
IS 12
BP 6298
EP 6316
DI 10.1021/pr100562w
PG 19
WC Biochemical Research Methods
SC Biochemistry & Molecular Biology
GA 688NI
UT WOS:000284856200019
PM 20873783
DA 2020-11-30
ER

PT J
AU Lanza, DCF
   Meirelles, GV
   Alborghetti, MR
   Abrile, CH
   Lenz, G
   Kobarg, J
AF Lanza, Daniel C. F.
   Meirelles, Gabriela V.
   Alborghetti, Marcos R.
   Abrile, Camila H.
   Lenz, Guido
   Kobarg, Joerg
TI FEZ1 interacts with CLASP2 and NEK1 through coiled-coil regions and
   their cellular colocalization suggests centrosomal functions and
   regulation by PKC
SO MOLECULAR AND CELLULAR BIOCHEMISTRY
LA English
DT Article
DE NIMA; CLIP; Cytoskeleton; Tubulin
ID PROTEIN; KINASE; MICROTUBULES; COOPERATE; CILIA; GENE
AB FEZ1 was initially described as a neuronal protein that influences axonal development and cell polarization. CLASP2 and NEK1 proteins are present in a centrosomal complex and participate in cell cycle and cell division mechanisms, but their functions were always described individually. Here, we report that NEK1 and CLASP2 colocalize with FEZ1 in a perinuclear region in mammalian cells, and observed that coiled-coil interactions occur between FEZ1/CLASP2 and FEZ1/NEK1 in vitro. These three proteins colocalize and interact with endogenous gamma-tubulin. Furthermore, we found that CLASP2 is phosphorylated and interacts with active PKC isoforms, and that FEZ1/CLASP2 colocalization is inhibited by PMA treatment. Our results provide evidence that these three proteins cooperate in centrosomal functions and open new directions for future studies.
C1 [Lanza, Daniel C. F.; Meirelles, Gabriela V.; Alborghetti, Marcos R.; Abrile, Camila H.; Kobarg, Joerg] Assoc Brasileira Tecnol Luz Sincrotron, Ctr Biol Mol Estrutural, BR-13084971 Campinas, SP, Brazil.
   [Lanza, Daniel C. F.; Meirelles, Gabriela V.; Alborghetti, Marcos R.; Kobarg, Joerg] Univ Estadual Campinas, Inst Biol, Campinas, SP, Brazil.
   [Lenz, Guido] Univ Fed Rio Grande do Sul, Dept Biofis, Porto Alegre, RS, Brazil.
RP Kobarg, J (corresponding author), Assoc Brasileira Tecnol Luz Sincrotron, Ctr Biol Mol Estrutural, Rua Giuseppe Maximo Scolfaro 10-000,CP 6192, BR-13084971 Campinas, SP, Brazil.
EM jkobarg@lnls.br
RI Kobarg, Jorg/T-4736-2019; Lenz, Guido/A-7618-2008; Alborghetti,
   Marcos/K-7547-2012; Meirelles, Gabriela Vaz/H-4151-2013
OI Kobarg, Jorg/0000-0002-9419-0145; Alborghetti,
   Marcos/0000-0003-4517-5579; Meirelles, Gabriela Vaz/0000-0003-4371-0419
FU Fundacao de Amparo a Pesquisa do Estado Sao Paulo; Conselho Nacional de
   Pesquisa e DesenvolvimentoNational Council for Scientific and
   Technological Development (CNPq); LNLS
FX Financially supported by: Fundacao de Amparo a Pesquisa do Estado Sao
   Paulo, Conselho Nacional de Pesquisa e Desenvolvimento and LNLS. We
   thank Maria Eugenia Camargo and Jessica Santana Bernachi for technical
   assistance. We are also grateful to Dr. Alexandre J. C. Quaresma for
   help in providing critical reagents.
CR Assmann EM, 2006, J BIOL CHEM, V281, P9869, DOI 10.1074/jbc.M513280200
   Bisgrove BW, 2006, DEVELOPMENT, V133, P4131, DOI 10.1242/dev.02595
   Blasius TL, 2007, J CELL BIOL, V176, P11, DOI 10.1083/jcb.200605099
   Bloom L, 1997, P NATL ACAD SCI USA, V94, P3414, DOI 10.1073/pnas.94.7.3414
   Efimov A, 2007, DEV CELL, V12, P917, DOI 10.1016/j.devcel.2007.04.002
   Ikuta J, 2007, BIOCHEM BIOPH RES CO, V353, P127, DOI 10.1016/j.bbrc.2006.11.142
   Kumar P, 2009, J CELL BIOL, V184, P895, DOI 10.1083/jcb.200901042
   Kuroda S, 1999, J CELL BIOL, V144, P403, DOI 10.1083/jcb.144.3.403
   Lanza DCF, 2008, EXP CELL RES, V314, P2028, DOI 10.1016/j.yexcr.2008.02.012
   Lanza DCF, 2009, PROTEINS, V74, P104, DOI 10.1002/prot.22135
   Lee S, 2005, HUM MOL GENET, V14, P627, DOI 10.1093/hmg/ddi059
   Lin FM, 2003, P NATL ACAD SCI USA, V100, P5286, DOI 10.1073/pnas.0836980100
   LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162
   Mahjoub MR, 2005, J AM SOC NEPHROL, V16, P3485, DOI 10.1681/ASN.2005080824
   Mimori-Kiyosue Y, 2005, J CELL BIOL, V168, P141, DOI 10.1083/jcb.200405094
   O'Regan L, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-25
   Pereira AL, 2006, MOL BIOL CELL, V17, P4526, DOI 10.1091/mbc.E06-07-0579
   Sakae N, 2008, HUM MOL GENET, V17, P3191, DOI 10.1093/hmg/ddn215
   Shalom O, 2008, FEBS LETT, V582, P1465, DOI 10.1016/j.febslet.2008.03.036
   Surpili MJ, 2003, BIOCHEMISTRY-US, V42, P15369, DOI 10.1021/bi034575v
   SUZUKI T, 2005, J BIOL CHEM, V280
   Upadhya P, 2000, P NATL ACAD SCI USA, V97, P217, DOI 10.1073/pnas.97.1.217
   Vogler C, 1999, J AM SOC NEPHROL, V10, P2534
   White MC, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-29
NR 24
TC 13
Z9 13
U1 0
U2 6
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0300-8177
EI 1573-4919
J9 MOL CELL BIOCHEM
JI Mol. Cell. Biochem.
PD MAY
PY 2010
VL 338
IS 1-2
BP 35
EP 45
DI 10.1007/s11010-009-0317-9
PG 11
WC Cell Biology
SC Cell Biology
GA 584IP
UT WOS:000276745400004
PM 19924516
DA 2020-11-30
ER

PT J
AU Montone, KT
   Palmer, J
   Chiu, AC
   Kennedy, DW
   Lanza, DC
   Livolsi, VA
   Feldman, MD
   Nachamkin, I
AF Montone, K. T.
   Palmer, J.
   Chiu, A. C.
   Kennedy, D. W.
   Lanza, D. C.
   Livolsi, V. A.
   Feldman, M. D.
   Nachamkin, I.
TI In Situ Hybridization (ISH) for Species Specific Fungal rRNA in Acute
   Necrotizing Invasive Fungal Rhinosinusitis
SO LABORATORY INVESTIGATION
LA English
DT Meeting Abstract
CT 99th Annual Meeting of the
   United-States-and-Canadian-Academy-of-Pathology
CY MAR 20-26, 2010
CL Washington, DC
SP US & Canadian Acad Pathol
C1 [Montone, K. T.; Palmer, J.; Chiu, A. C.; Kennedy, D. W.; Lanza, D. C.; Livolsi, V. A.; Feldman, M. D.; Nachamkin, I.] Univ Penn, Philadelphia, PA 19104 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 0023-6837
J9 LAB INVEST
JI Lab. Invest.
PD FEB
PY 2010
VL 90
SU 1
MA 1243
BP 277A
EP 277A
PG 1
WC Medicine, Research & Experimental; Pathology
SC Research & Experimental Medicine; Pathology
GA 553AR
UT WOS:000274337301259
DA 2020-11-30
ER

PT J
AU Montone, KT
   Livolsi, VA
   Feldman, MD
   Kennedy, DW
   Lanza, DC
   Chiu, AG
   Palmer, J
   Nachamkin, I
AF Montone, K. T.
   Livolsi, V. A.
   Feldman, M. D.
   Kennedy, D. W.
   Lanza, D. C.
   Chiu, A. G.
   Palmer, J.
   Nachamkin, I.
TI Fungal Rhinosinusitis: A Retrospective Review of 397 Patients at a
   Single University Medical Center
SO LABORATORY INVESTIGATION
LA English
DT Meeting Abstract
CT 99th Annual Meeting of the
   United-States-and-Canadian-Academy-of-Pathology
CY MAR 20-26, 2010
CL Washington, DC
SP US & Canadian Acad Pathol
C1 [Montone, K. T.; Livolsi, V. A.; Feldman, M. D.; Kennedy, D. W.; Lanza, D. C.; Chiu, A. G.; Palmer, J.; Nachamkin, I.] Univ Penn, Philadelphia, PA 19104 USA.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 0023-6837
J9 LAB INVEST
JI Lab. Invest.
PD FEB
PY 2010
VL 90
SU 1
MA 1242
BP 277A
EP 277A
PG 1
WC Medicine, Research & Experimental; Pathology
SC Research & Experimental Medicine; Pathology
GA 553AR
UT WOS:000274337301258
DA 2020-11-30
ER

PT J
AU Montone, KT
   Palmer, J
   Chiu, AC
   Kennedy, DW
   Lanza, DC
   Livolsi, VA
   Feldman, MD
   Nachamkin, I
AF Montone, K. T.
   Palmer, J.
   Chiu, A. C.
   Kennedy, D. W.
   Lanza, D. C.
   Livolsi, V. A.
   Feldman, M. D.
   Nachamkin, I.
TI In Situ Hybridization (ISH) for Determination of Fungal rRNA
   Preservation in Sinonasal Fungal Disease
SO LABORATORY INVESTIGATION
LA English
DT Meeting Abstract
CT 99th Annual Meeting of the
   United-States-and-Canadian-Academy-of-Pathology
CY MAR 20-26, 2010
CL Washington, DC
SP US & Canadian Acac Pathol
C1 [Montone, K. T.; Palmer, J.; Chiu, A. C.; Kennedy, D. W.; Lanza, D. C.; Livolsi, V. A.; Feldman, M. D.; Nachamkin, I.] Univ Penn, Philadelphia, PA 19104 USA.
RI Nachamkin, Irving/Q-3673-2019
NR 0
TC 0
Z9 0
U1 0
U2 0
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 0023-6837
J9 LAB INVEST
JI Lab. Invest.
PD FEB
PY 2010
VL 90
SU 1
MA 1943
BP 436A
EP 436A
PG 1
WC Medicine, Research & Experimental; Pathology
SC Research & Experimental Medicine; Pathology
GA 553AR
UT WOS:000274337301958
DA 2020-11-30
ER

PT J
AU Montone, KT
   Palmer, J
   Chiu, AC
   Kennedy, DW
   Lanza, DC
   Livolsi, VA
   Feldman, MD
   Nachamkin, I
AF Montone, K. T.
   Palmer, J.
   Chiu, A. C.
   Kennedy, D. W.
   Lanza, D. C.
   Livolsi, V. A.
   Feldman, M. D.
   Nachamkin, I.
TI In Situ Hybridization (ISH) for Species Specific Fungal rRNA in Acute
   Necrotizing Invasive Fungal Rhinosinusitis
SO MODERN PATHOLOGY
LA English
DT Meeting Abstract
CT 99th Annual Meeting of the
   United-States-and-Canadian-Academy-of-Pathology
CY MAR 20-26, 2010
CL Washington, DC
SP US & Canadian Acad Pathol
C1 [Montone, K. T.; Palmer, J.; Chiu, A. C.; Kennedy, D. W.; Lanza, D. C.; Livolsi, V. A.; Feldman, M. D.; Nachamkin, I.] Univ Penn, Philadelphia, PA 19104 USA.
RI Nachamkin, Irving/Q-3673-2019
NR 0
TC 0
Z9 0
U1 0
U2 0
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 0893-3952
J9 MODERN PATHOL
JI Mod. Pathol.
PD FEB
PY 2010
VL 23
SU 1
MA 1243
BP 277A
EP 277A
PG 1
WC Pathology
SC Pathology
GA 556HX
UT WOS:000274582501577
DA 2020-11-30
ER

PT J
AU Montone, KT
   Livolsi, VA
   Feldman, MD
   Kennedy, DW
   Lanza, DC
   Chiu, AG
   Palmer, J
   Nachamkin, I
AF Montone, K. T.
   Livolsi, V. A.
   Feldman, M. D.
   Kennedy, D. W.
   Lanza, D. C.
   Chiu, A. G.
   Palmer, J.
   Nachamkin, I.
TI Fungal Rhinosinusitis: A Retrospective Review of 397 Patients at a
   Single University Medical Center
SO MODERN PATHOLOGY
LA English
DT Meeting Abstract
CT 99th Annual Meeting of the
   United-States-and-Canadian-Academy-of-Pathology
CY MAR 20-26, 2010
CL Washington, DC
SP US & Canadian Acad Pathol
C1 [Montone, K. T.; Livolsi, V. A.; Feldman, M. D.; Kennedy, D. W.; Lanza, D. C.; Chiu, A. G.; Palmer, J.; Nachamkin, I.] Univ Penn, Philadelphia, PA 19104 USA.
RI Nachamkin, Irving/Q-3673-2019
NR 0
TC 0
Z9 0
U1 0
U2 0
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 0893-3952
J9 MODERN PATHOL
JI Mod. Pathol.
PD FEB
PY 2010
VL 23
SU 1
MA 1242
BP 277A
EP 277A
PG 1
WC Pathology
SC Pathology
GA 556HX
UT WOS:000274582501576
DA 2020-11-30
ER

PT J
AU Montone, KT
   Palmer, J
   Chiu, AC
   Kennedy, DW
   Lanza, DC
   Livolsi, VA
   Feldman, MD
   Nachamkin, I
AF Montone, K. T.
   Palmer, J.
   Chiu, A. C.
   Kennedy, D. W.
   Lanza, D. C.
   Livolsi, V. A.
   Feldman, M. D.
   Nachamkin, I.
TI In Situ Hybridization (ISH) for Determination of Fungal rRNA
   Preservation in Sinonasal Fungal Disease
SO MODERN PATHOLOGY
LA English
DT Meeting Abstract
CT 99th Annual Meeting of the
   United-States-and-Canadian-Academy-of-Pathology
CY MAR 20-26, 2010
CL Washington, DC
SP US & Canadian Acac Pathol
C1 [Montone, K. T.; Palmer, J.; Chiu, A. C.; Kennedy, D. W.; Lanza, D. C.; Livolsi, V. A.; Feldman, M. D.; Nachamkin, I.] Univ Penn, Philadelphia, PA 19104 USA.
NR 0
TC 1
Z9 1
U1 0
U2 0
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 0893-3952
J9 MODERN PATHOL
JI Mod. Pathol.
PD FEB
PY 2010
VL 23
SU 1
MA 1943
BP 436A
EP 436A
PG 1
WC Pathology
SC Pathology
GA 556HX
UT WOS:000274582502624
DA 2020-11-30
ER

PT J
AU Quaresma, AJC
   Bressan, GC
   Gava, LM
   Lanza, DCF
   Ramos, CHI
   Kobarg, J
AF Quaresma, Alexandre J. C.
   Bressan, G. C.
   Gava, L. M.
   Lanza, D. C. F.
   Ramos, C. H. I.
   Kobarg, Joerg
TI Human hnRNP Q re-localizes to cytoplasmic granules upon PMA,
   thapsigargin, arsenite and heat-shock treatments
SO EXPERIMENTAL CELL RESEARCH
LA English
DT Article
DE Protein-protein interactions; Stress granules; Protein bodies; Sub
   cellular localization
ID PROTEIN-KINASE-C; MESSENGER-RNA DECAY; DETERMINING GENE-PRODUCT; CHAIN
   BINDING-PROTEIN; PROCESSING BODIES; STRESS; INTERACTS; SITES;
   IDENTIFICATION; APOPTOSIS
AB Eukaryotic gene expression is regulated on different levels ranging from pre-mRNA processing to translation. One of the most characterized families of RNA-binding proteins is the group of hnRNPs: heterogenous nuclear ribonucleoproteins. Members of this protein family play important roles in gene expression control and mRNAs metabolism. In the cytoplasm, several hnRNPs proteins are involved in RNA-related processes and they can be frequently found in two specialized structures, known as GW-bodies (GWbs), previously known as processing bodies: PBs, and stress granules, which may be formed in response to specific stimuli. GWbs have been early reported to be involved in the mRNA decay process, acting as a site of mRNA degradation. In a similar way, stress granules (SGs) have been described as cytoplasmic aggregates, which contain accumulated mRNAs in cells under stress conditions and present reduced or inhibited translation. Here, we characterized the hnRNP Q localization after different stress conditions. hnRNP Q is a predominantly nuclear protein that exhibits a modular organization and several RNA-related functions. Our data suggest that the nuclear localization of hnRNP Q might be modified after different treatments, such as: PMA, thapsigargin, arsenite and heat shock. Under different stress conditions, hnRNP Q can fully co-localize with the endoplasmatic reticulum specific chaperone, BiP. However, under stress, this protein only co-localizes partially with the proteins: GW182 - GWbs marker protein and TIA-1 stress granule component. (C) 2009 Elsevier Inc. All rights reserved.
C1 [Quaresma, Alexandre J. C.; Bressan, G. C.; Lanza, D. C. F.; Kobarg, Joerg] LNLS, Brazilian Synchrotron Light Lab, BR-13083970 Campinas, SP, Brazil.
   [Bressan, G. C.; Gava, L. M.; Lanza, D. C. F.; Kobarg, Joerg] Univ Estadual Campinas, Inst Biol, BR-13083970 Campinas, SP, Brazil.
   [Gava, L. M.; Ramos, C. H. I.] Univ Estadual Campinas, Inst Chem, BR-13083970 Campinas, SP, Brazil.
RP Kobarg, J (corresponding author), Lab Nacl Luz Sincrotron, Ctr Biol Mol Estructural, Rua Giuseppe Maximo Scolfaro 10-000,CP 6192, BR-13084971 Campinas, SP, Brazil.
EM jkobarg@lnls.br
RI Gava, Lisandra/I-7704-2012; Quaresma, Alexandre Jose
   Christino/E-4229-2010; Kobarg, Jorg/T-4736-2019; Ramos, CH/C-1571-2012
OI Kobarg, Jorg/0000-0002-9419-0145; Ramos, CH/0000-0002-7246-9081
FU Fundacao de Amparo a Pesquisa do Estado Sao Paulo (FAPESP)Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [05/00235-1]; Conselho
   Nacional de Pesquisa e Desenvolvimento (CNPq)National Council for
   Scientific and Technological Development (CNPq); LNLS
FX This work was financially supported by the Fundacao de Amparo a Pesquisa
   do Estado Sao Paulo (FAPESP), through the projects SmolbNet, CEPID,
   05/00235-1 (personal grant to j.K.), as well as by PhD fellowships to
   AJ.C.Q., G.C.B, G.L, L.M.G. and D.C.F.L. Further financial Support was
   from the Conselho Nacional de Pesquisa e Desenvolvimento (CNPq) and the
   LNLS. We thank Maria Eugenia R. Carnargo, V.M. Soares and Zildene D.
   Correa for technical assistance.
CR Anderson P, 2002, J CELL SCI, V115, P3227
   Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082
   Assmann EM, 2006, J BIOL CHEM, V281, P9869, DOI 10.1074/jbc.M513280200
   Bannai H, 2004, J BIOL CHEM, V279, P53427, DOI 10.1074/jbc.M409732200
   Bashkirov VI, 1997, J CELL BIOL, V136, P761, DOI 10.1083/jcb.136.4.761
   Blanc V, 2001, J BIOL CHEM, V276, P10272, DOI 10.1074/jbc.M006435200
   BOLE DG, 1986, J CELL BIOL, V102, P1558, DOI 10.1083/jcb.102.5.1558
   Borges JC, 2005, PROTEIN PEPTIDE LETT, V12, P257, DOI 10.2174/0929866053587165
   Borges JC, 2006, ARCH BIOCHEM BIOPHYS, V452, P46, DOI 10.1016/j.abb.2006.05.006
   Brengues M, 2005, SCIENCE, V310, P486, DOI 10.1126/science.1115791
   Chen CYA, 2003, MOL CELL BIOL, V23, P4805, DOI 10.1128/MCB.23.14.4805-4813.2003
   Cho SC, 2007, MOL CELL BIOL, V27, P368, DOI 10.1128/MCB.00814-06
   Cougot N, 2004, J CELL BIOL, V165, P31, DOI 10.1083/jcb.200309008
   COULDWELL WT, 1994, FEBS LETT, V345, P43, DOI 10.1016/0014-5793(94)00415-3
   Daugaard M, 2007, FEBS LETT, V581, P3702, DOI [10.1016/j.febslet.2007.05.039, 10.1016/j.febsiet.2007.05.039]
   DiazMeco MT, 1996, CELL, V86, P777, DOI 10.1016/S0092-8674(00)80152-X
   Eystathioy T, 2003, RNA, V9, P1171, DOI 10.1261/rna.5810203
   Eystathioy T, 2002, MOL BIOL CELL, V13, P1338, DOI 10.1091/mbc.01-11-0544
   Ferraiuolo MA, 2005, J CELL BIOL, V170, P913, DOI 10.1083/jcb.200504039
   Gilks N, 2004, MOL BIOL CELL, V15, P5383, DOI 10.1091/mbc.E04-08-0715
   Grosset C, 2000, CELL, V103, P29, DOI 10.1016/S0092-8674(00)00102-1
   Harris CE, 1999, J VIROL, V73, P72, DOI 10.1128/JVI.73.1.72-80.1999
   Hellen CUT, 2001, GENE DEV, V15, P1593, DOI 10.1101/gad.891101
   Holcik M, 2000, TRENDS GENET, V16, P469, DOI 10.1016/S0168-9525(00)02106-5
   Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618
   Hresko RC, 2002, J BIOL CHEM, V277, P25233, DOI 10.1074/jbc.M202556200
   Hua YM, 2004, FEBS LETT, V572, P69, DOI 10.1016/j.febslet.2004.07.010
   Ingelfinger D, 2002, RNA, V8, P1489, DOI 10.1017/S1355838202021726
   Iwasaki H, 2008, BIOCHEM BIOPH RES CO, V372, P314, DOI 10.1016/j.bbrc.2008.05.051
   Kanai Y, 2004, NEURON, V43, P513, DOI 10.1016/j.neuron.2004.07.022
   Kedersha N, 2002, MOL BIOL CELL, V13, P195, DOI 10.1091/mbc.01-05-0221
   Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088
   Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431
   KIKKAWA U, 1989, ANNU REV BIOCHEM, V58, P31, DOI 10.1146/annurev.bi.58.070189.000335
   Kim TD, 2005, MOL CELL BIOL, V25, P3232, DOI 10.1128/MCB.25.8.3232-3246.2005
   Kim YK, 2002, BIOCHEM BIOPH RES CO, V297, P224, DOI 10.1016/S0006-291X(02)02154-X
   Kuroda S, 1999, J CELL BIOL, V144, P403, DOI 10.1083/jcb.144.3.403
   Lanza DCF, 2009, PROTEINS, V74, P104, DOI 10.1002/prot.22135
   Laroia G, 1999, SCIENCE, V284, P499, DOI 10.1126/science.284.5413.499
   Larsson C, 2006, CELL SIGNAL, V18, P276, DOI 10.1016/j.cellsig.2005.07.010
   Lau PP, 2001, BIOCHEM BIOPH RES CO, V282, P977, DOI 10.1006/bbrc.2001.4679
   Liu JD, 2005, NAT CELL BIOL, V7, P719, DOI 10.1038/ncb1274
   Mellor H, 1998, BIOCHEM J, V332, P281, DOI 10.1042/bj3320281
   MOCHLYROSEN D, 1995, SCIENCE, V268, P247, DOI 10.1126/science.7716516
   Moore MJ, 2005, SCIENCE, V309, P1514, DOI 10.1126/science.1111443
   Moraes KCM, 2003, BIOL CHEM, V384, P25, DOI 10.1515/BC.2003.004
   Moser JJ, 2007, J NEUROSCI RES, V85, P3619, DOI 10.1002/jnr.21439
   Mourelatos Z, 2001, EMBO J, V20, P5443, DOI 10.1093/emboj/20.19.5443
   MUNRO S, 1986, CELL, V46, P291, DOI 10.1016/0092-8674(86)90746-4
   Nery FC, 2004, J BIOL CHEM, V279, P11444, DOI 10.1074/jbc.M306672200
   NISHIZUKA Y, 1995, FASEB J, V9, P484
   Passos DO, 2006, BIOCHEM BIOPH RES CO, V346, P517, DOI 10.1016/j.bbrc.2006.05.152
   PELHAM HRB, 1986, CELL, V46, P959, DOI 10.1016/0092-8674(86)90693-8
   PROSTKO CR, 1991, J BIOL CHEM, V266, P19790
   Quaresma AJC, 2006, BIOCHEM BIOPH RES CO, V350, P288, DOI 10.1016/j.bbrc.2006.09.044
   Rossoll W, 2002, HUM MOL GENET, V11, P93, DOI 10.1093/hmg/11.1.93
   Rossoll W, 2003, J CELL BIOL, V163, P801, DOI 10.1083/jcb.200304128
   Ruchalski K, 2006, J BIOL CHEM, V281, P7873, DOI 10.1074/jbc.M513728200
   SARNOW P, 1989, P NATL ACAD SCI USA, V86, P5795, DOI 10.1073/pnas.86.15.5795
   Schechtman D, 2001, ONCOGENE, V20, P6339, DOI 10.1038/sj.onc.1204778
   Sen GL, 2005, NAT CELL BIOL, V7, P633, DOI 10.1038/ncb1265
   Sheth U, 2003, SCIENCE, V300, P805, DOI 10.1126/science.1082320
   Shirai Y, 2002, J BIOCHEM, V132, P663, DOI 10.1093/oxfordjournals.jbchem.a003271
   Singh R, 2005, NAT STRUCT MOL BIOL, V12, P645, DOI 10.1038/nsmb961
   Stoneley M, 2004, ONCOGENE, V23, P3200, DOI 10.1038/sj.onc.1207551
   Teixeira D, 2005, RNA, V11, P371, DOI 10.1261/rna.7258505
   WILKINSON SE, 1993, BIOCHEM J, V294, P335, DOI 10.1042/bj2940335
   Wilson GM, 1999, J BIOL CHEM, V274, P33374, DOI 10.1074/jbc.274.47.33374
   Yang F, 2006, MOL CELL BIOL, V26, P8803, DOI 10.1128/MCB.00090-06
NR 69
TC 24
Z9 24
U1 0
U2 5
PU ELSEVIER INC
PI SAN DIEGO
PA 525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0014-4827
EI 1090-2422
J9 EXP CELL RES
JI Exp. Cell Res.
PD APR 1
PY 2009
VL 315
IS 6
BP 968
EP 980
DI 10.1016/j.yexcr.2009.01.012
PG 13
WC Oncology; Cell Biology
SC Oncology; Cell Biology
GA 424RV
UT WOS:000264586500006
PM 19331829
DA 2020-11-30
ER

PT J
AU Lanza, DCF
   Silva, JC
   Assmann, EM
   Quaresma, AJC
   Bressan, GC
   Torriani, IL
   Kobarg, J
AF Lanza, Daniel C. F.
   Silva, Julio C.
   Assmann, Eliana M.
   Quaresma, Alexandre J. C.
   Bressan, Gustavo C.
   Torriani, Iris L.
   Kobarg, Joerg
TI Human FEZ1 has characteristics of a natively unfolded protein and
   dimerizes in solution
SO PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS
LA English
DT Article
DE SAXS; spectroscopy; protein-protein interactions; microtubular
   transport; circular dichroism; limited proteolysis; axonal transport
ID INTRINSIC DISORDER; FASCICULATION-AND-ELONGATION-PROTEIN-ZETA-1 FEZ1;
   INTERACTION NETWORK; HUB PROTEINS; PREDICTION; REGIONS; SEQUENCE;
   MACROMOLECULES; IDENTIFICATION; FASCICULATION
AB The fasciculation and elongation protein Zeta 1 (FEZ1) is the mammalian orthologue of the Caenorhabditis elegans protein UNC-76, which is necessary for axon growth. Human FEZ1 interacts with Protein Kinase C (PKC) and several regulatory proteins involved in functions ranging from microtubule associated transport to transcriptional regulation. Theoretical prediction, circular dichroism, fluorescence spectroscopy, and limited proteolysis of recombinant FEZ1 suggest that it contains disordered regions, especially in its N-terminal region, and that it may belong to the group of natively unfolded proteins. Small angle X-ray scattering experiments indicated a mainly disordered conformation, proved that FEZ1 is a dimer of elongated shape and provided overall dimensional parameters for the protein. In vitro pull down experiments confirmed these results and demonstrated that dimerization involves the N-terminus. Ab-initio 3D low resolution models of the full-length conformation of the dimeric constructs 6xHis-FEZ1(1-392) and 6xHis-FEZ1(1-227) were obtained. Furthermore, we performed in vitro phosphorylation assays of FEZ1 with PKC. The phosphorylation occur-red mainly in its C-terminal region, and does not cause any significant conformational changes, but nonetheless inhibited its interaction with the FEZ1 interacting domain of the protein CLASP2 in vitro. The C terminus of FEZ1 has been reported to bind to several interacting proteins. This suggests that FEZ1 binding and transport function of interacting proteins may be subject to regulation by phosphorylation.
C1 [Kobarg, Joerg] Lab Nacl Luz Sincrotron, Ctr Biol Mol Estrutural, BR-13084971 Campinas, SP, Brazil.
   [Lanza, Daniel C. F.; Quaresma, Alexandre J. C.; Bressan, Gustavo C.; Kobarg, Joerg] Univ Estadual Campinas, Inst Biol, Campinas, SP, Brazil.
   [Silva, Julio C.; Torriani, Iris L.] Univ Estadual Campinas, Inst Fis Gleb Wataghin, Campinas, SP, Brazil.
RP Kobarg, J (corresponding author), Lab Nacl Luz Sincrotron, Ctr Biol Mol Estrutural, Rua Giuseppe Maximo Scolfaro 10-000,CP 6192, BR-13084971 Campinas, SP, Brazil.
EM jkobarg@lnls.br
RI Quaresma, Alexandre Jose Christino/E-4229-2010; da Silva, Julio
   Cesar/A-5240-2011; Kobarg, Jorg/T-4736-2019; Torriani, Iris
   L/E-5686-2010
OI da Silva, Julio Cesar/0000-0001-8035-0550; Kobarg,
   Jorg/0000-0002-9419-0145; 
FU Fundacao de Amparo a Pesquisa do Estado Sao Paulo (FAPESP)Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); CEPID [05/00235-1];
   Conselho Nacional de Pesquisa e Desenvolvimento (CNPq)National Council
   for Scientific and Technological Development (CNPq)
FX Grant sponsors: Fundacao de Amparo a Pesquisa do Estado Sao Paulo
   (FAPESP), projects SmolbNet, CEPID, grant number: 05/00235-1, Conselho
   Nacional de Pesquisa e Desenvolvimento (CNPq), the LNLS.
CR Assmann EM, 2006, J BIOL CHEM, V281, P9869, DOI 10.1074/jbc.M513280200
   Blasius TL, 2007, J CELL BIOL, V176, P11, DOI 10.1083/jcb.200605099
   Bloom L, 1997, P NATL ACAD SCI USA, V94, P3414, DOI 10.1073/pnas.94.7.3414
   CALMETTES P, 1994, BIOPHYS CHEM, V53, P105, DOI 10.1016/0301-4622(94)00081-6
   Cavalcanti LP, 2004, REV SCI INSTRUM, V75, P4541, DOI 10.1063/1.1804956
   Cheng JL, 2005, DATA MIN KNOWL DISC, V11, P213, DOI 10.1007/s10618-005-0001-y
   Coeytaux K, 2005, BIOINFORMATICS, V21, P1891, DOI 10.1093/bioinformatics/bti266
   Dafforn TR, 2004, EMBO REP, V5, P1046, DOI 10.1038/sj.embor.7400276
   DEBYE P, 1947, J PHYS COLLOID CHEM, V51, P18, DOI 10.1021/j150451a002
   DeLano W.L., 2002, PYMOL MOL GRAPHICS S
   Denning DP, 2002, J BIOL CHEM, V277, P33447, DOI 10.1074/jbc.M203499200
   Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541
   Dosztanyi Z, 2006, J PROTEOME RES, V5, P2985, DOI 10.1021/pr060171o
   Dunker AK, 2005, FEBS J, V272, P5129, DOI 10.1111/j.1742-4658.2005.04948.x
   Ekman D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-6-r45
   Feigin L. A., 1987, STRUCTURE ANAL SMALL, P59
   Fontana A, 2004, ACTA BIOCHIM POL, V51, P299
   Fujita T, 2007, BIOCHEM BIOPH RES CO, V361, P605, DOI 10.1016/j.bbrc.2007.07.050
   Fujita T, 2004, BIOCHEM BIOPH RES CO, V313, P738, DOI 10.1016/j.bbrc.2003.12.006
   Galzitskaya OV, 2006, MOL BIOL+, V40, P341
   Garbuzynskiy SO, 2004, PROTEIN SCI, V13, P2871, DOI 10.1110/ps.04881304
   Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI DOI 10.1385/1-59259-890-0:571
   Glatter O., 1982, SMALL ANGLE XRAY SCA, P17
   Guinier A., 1955, SMALL ANGLE SCATTERI, P5
   Haynes C, 2006, PLOS COMPUT BIOL, V2, P890, DOI 10.1371/journal.pcbi.0020100
   Honda A, 2004, MOL BRAIN RES, V122, P89, DOI 10.1016/j.molbrainres.2003.11.020
   Ikuta J, 2007, BIOCHEM BIOPH RES CO, V353, P127, DOI 10.1016/j.bbrc.2006.11.142
   Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138
   Kuroda S, 1999, J CELL BIOL, V144, P403, DOI 10.1083/jcb.144.3.403
   LANZA DCF, 2008, EXP CELL RES, DOI DOI 10.1016/J.YEXCR
   Li J, 2002, NEUROTOXICOLOGY, V23, P553, DOI 10.1016/S0161-813X(02)00066-9
   Linding R, 2003, NUCLEIC ACIDS RES, V31, P3701, DOI 10.1093/nar/gkg519
   Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002
   LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162
   MACCALLUM RM, CASP 6 M
   Mimori-Kiyosue Y, 2005, J CELL BIOL, V168, P141, DOI 10.1083/jcb.200405094
   Moncoq K, 2004, BIOPHYS J, V87, P4056, DOI 10.1529/biophysj.104.048645
   Naghavi MH, 2005, GENE DEV, V19, P1105, DOI 10.1101/gad.1290005
   Obradovic Z, 2003, PROTEINS, V53, P566, DOI 10.1002/prot.10532
   Obradovic Z, 2005, PROTEINS, V61, P176, DOI 10.1002/prot.20735
   Okumura F, 2004, J BIOL CHEM, V279, P53533, DOI 10.1074/jbc.M402916200
   Oldfield CJ, 2005, BIOCHEMISTRY-US, V44, P1989, DOI 10.1021/bi047993o
   Orthaber D, 2000, J APPL CRYSTALLOGR, V33, P218, DOI 10.1107/S0021889899015216
   Patil A, 2006, FEBS LETT, V580, P2041, DOI 10.1016/j.febslet.2006.03.003
   Perez J, 2001, J MOL BIOL, V308, P721, DOI 10.1006/jmbi.2001.4611
   Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537
   Rizos AK, 2006, J NON-CRYST SOLIDS, V352, P4451, DOI 10.1016/j.jnoncrysol.2006.01.137
   Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3
   Romero P, 1997, GENOME INFORMATICS, V8, P110, DOI DOI 10.11234/GI1990.8.110
   Shimizu K, 1998, J BIOL CHEM, V273, P6591, DOI 10.1074/jbc.273.12.6591
   Singh GP, 2007, PROTEINS, V68, P602, DOI 10.1002/prot.21497
   Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029
   Suzuki T, 2005, J BIOL CHEM, V280, P24948, DOI 10.1074/jbc.M411499200
   Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6
   SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663
   Tidow H, 2007, P NATL ACAD SCI USA, V104, P12324, DOI 10.1073/pnas.0705069104
   Tompa P, 2005, FEBS LETT, V579, P3346, DOI 10.1016/j.febslet.2005.03.072
   Uversky VN, 1999, BIOCHEMISTRY-US, V38, P15009, DOI 10.1021/bi990752+
   Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z
   Uversky VN, 2002, PROTEIN SCI, V11, P739, DOI 10.1110/ps.4210102
   Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268
   Vucetic S, 2003, PROTEINS, V52, P573, DOI 10.1002/prot.10437
   Vullo A, 2006, NUCLEIC ACIDS RES, V34, pW164, DOI 10.1093/nar/gkl166
   Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002
   Wolf E, 1997, PROTEIN SCI, V6, P1179, DOI 10.1002/pro.5560060606
   Yang ZR, 2005, BIOINFORMATICS, V21, P3369, DOI 10.1093/bioinformatics/bti534
NR 66
TC 25
Z9 26
U1 0
U2 6
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0887-3585
EI 1097-0134
J9 PROTEINS
JI Proteins
PD JAN
PY 2009
VL 74
IS 1
BP 104
EP 121
DI 10.1002/prot.22135
PG 18
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 384PY
UT WOS:000261757900010
PM 18615714
DA 2020-11-30
ER

PT J
AU Lanza, DCF
   Trindade, DM
   Assmann, EM
   Kobarg, J
AF Lanza, Daniel C. F.
   Trindade, Daniel M.
   Assmann, Eliana M.
   Kobarg, Joerg
TI Over-expression of GFP-FEZ1 causes generation of multi-lobulated nuclei
   mediated by microtubules in HEK293 cells
SO EXPERIMENTAL CELL RESEARCH
LA English
DT Article
DE microtubule transport; flower-like nuclei; multi-lobulated nuclei;
   centrosome
ID PROTEIN; FEZ1; IDENTIFICATION; REGION
AB FEZ1 (Fasciculation and elongation protein zeta 1) is an ortholog of the Caenorhabditis elegans protein UNC-76, involved in neuronal development and axon outgrowth, in that worm. Mammalian FEZ1 has already been reported to cooperate with PKC-zeta in the differentiation and polarization of PC12 neuronal cells. Furthermore, FEZ1 is associated with kinesin 1 and JIP1 to form a cargo-complex responsible for microtubule based transport of mitochondria along axons. FEZ1 can also be classified as a hub protein, since it was reported to interact with over 40 different proteins in yeast two-hybrid screens, including at least nine nuclear proteins. Here, we transiently over-expressed GFP-FEZ1full in human HEK293 and HeLa cells in order to study the sub-cellular localization of GFP-FEZ1. We observed that over 40% of transiently transfected cells at 3 days post-transfection develop multi-lobulated nuclei, which are also called flower-like nuclei. We further demonstrated that GFP-FEZ1 localizes either to the cytoplasm or the nuclear fraction, and that the appearance of the flower-like nuclei depends on intact microtubule function. Finally, we show that FEZ1 co-localizes with both, alpha- and especially with gamma-tubulin, which localizes as a centrosome like structure at the center of the multiple lobules. In summary, our data suggest that FEZ1 has an important centrosomal function and supply new mechanistic insights to the formation. of flower-like nuclei, which are a phenotypical hallmark of human leukemia cells. (c) 2008 Elsevier Inc. All rights reserved.
C1 [Kobarg, Joerg] Ctr Biol Mol Estruct, Lab Nacl Luz Sincroton, BR-13084971 Campinas, SP, Brazil.
   [Lanza, Daniel C. F.; Trindade, Daniel M.; Kobarg, Joerg] Univ Estadual Campinas, Inst Biol, Campinas, SP, Brazil.
RP Kobarg, J (corresponding author), Ctr Biol Mol Estruct, Lab Nacl Luz Sincroton, Rua Giuseppe Maximo Scolfaro 10-000,CP 6192, BR-13084971 Campinas, SP, Brazil.
EM jkobarg@lnls.br
RI Trindade, Daniel Maragno/J-6085-2012; Kobarg, Jorg/T-4736-2019
OI Trindade, Daniel Maragno/0000-0002-8005-8784; Kobarg,
   Jorg/0000-0002-9419-0145
CR Assmann EM, 2006, J BIOL CHEM, V281, P9869, DOI 10.1074/jbc.M513280200
   Blasius TL, 2007, J CELL BIOL, V176, P11, DOI 10.1083/jcb.200605099
   Bloom L, 1997, P NATL ACAD SCI USA, V94, P3414, DOI 10.1073/pnas.94.7.3414
   Faragher AJ, 2003, MOL BIOL CELL, V14, P2876, DOI 10.1091/mbc.E03-02-0108
   Feige E, 2006, BBA-MOL CELL RES, V1763, P272, DOI 10.1016/j.bbamcr.2006.01.009
   Fujita T, 2007, BIOCHEM BIOPH RES CO, V361, P605, DOI 10.1016/j.bbrc.2007.07.050
   Fukuda R, 2005, P NATL ACAD SCI USA, V102, P15213, DOI 10.1073/pnas.0507184102
   Huang J, 1996, CANCER LETT, V106, P29, DOI 10.1016/0304-3835(96)04293-0
   Ikuta J, 2007, BIOCHEM BIOPH RES CO, V353, P127, DOI 10.1016/j.bbrc.2006.11.142
   Kuroda S, 1999, J CELL BIOL, V144, P403, DOI 10.1083/jcb.144.3.403
   Naghavi MH, 2005, GENE DEV, V19, P1105, DOI 10.1101/gad.1290005
   Nakayama Y, 2005, EXP CELL RES, V304, P570, DOI 10.1016/j.yexcr.2004.11.027
   Passos DO, 2006, BIOCHEM BIOPH RES CO, V346, P517, DOI 10.1016/j.bbrc.2006.05.152
   Sato Y, 1998, J NEUROL SCI, V160, P92, DOI 10.1016/S0022-510X(98)00233-0
   Shaw G, 2002, FASEB J, V16, P869, DOI 10.1096/fj.01-0995fje
   Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029
   Surpili MJ, 2003, BIOCHEMISTRY-US, V42, P15369, DOI 10.1021/bi034575v
   Suzuki T, 2005, J BIOL CHEM, V280, P24948, DOI 10.1074/jbc.M411499200
NR 18
TC 13
Z9 14
U1 0
U2 2
PU ELSEVIER INC
PI SAN DIEGO
PA 525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0014-4827
EI 1090-2422
J9 EXP CELL RES
JI Exp. Cell Res.
PD JUN 10
PY 2008
VL 314
IS 10
BP 2028
EP 2039
DI 10.1016/j.yexcr.2008.02.012
PG 12
WC Oncology; Cell Biology
SC Oncology; Cell Biology
GA 312AI
UT WOS:000256641100005
PM 18439996
DA 2020-11-30
ER

EF